Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",A1BG,Alpha-1B-glycoprotein,24235,177,1.83 [0.80-4.15],0.1515170666791459
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AAMDC,Mth938 domain-containing protein,23566,168,1.10 [0.83-1.44],0.5049667993184546
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AARSD1,Alanyl-tRNA editing protein Aarsd1,27620,196,1.11 [0.89-1.39],0.3506847970228088
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ABCA2,ATP-binding cassette sub-family A member 2,23421,172,0.93 [0.62-1.39],0.7278918319433483
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ABHD14B,Protein ABHD14B,27460,195,0.97 [0.78-1.21],0.8145184050325783
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ABL1,Tyrosine-protein kinase ABL1,27620,196,0.98 [0.81-1.18],0.8465694376352787
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ABO,Histo-blood group ABO system transferase,24199,176,1.06 [0.96-1.17],0.2490557255140569
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ABRAXAS2,BRISC complex subunit Abraxas 2,23421,172,1.11 [0.89-1.37],0.3657103114717496
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",27092,194,1.11 [0.96-1.29],0.1567522693263688
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",23735,176,1.05 [0.87-1.27],0.612055507342522
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24188,179,1.06 [0.91-1.24],0.4559367269945572
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACAN,Aggrecan core protein,27498,196,1.12 [0.72-1.76],0.6055705620637224
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACE,Angiotensin-converting enzyme,24199,176,0.87 [0.50-1.52],0.6297054573630076
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACE2,Angiotensin-converting enzyme 2,27233,194,1.09 [0.84-1.40],0.521555566272295
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACHE,Acetylcholinesterase,23677,173,1.15 [0.74-1.79],0.5389049497758791
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACOT13,Acyl-coenzyme A thioesterase 13,24062,176,1.03 [0.91-1.17],0.6670083897449158
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,27743,197,0.89 [0.69-1.16],0.3841059547160721
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACP1,Low molecular weight phosphotyrosine protein phosphatase,23501,175,1.09 [0.80-1.49],0.5745361536980963
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACP5,Tartrate-resistant acid phosphatase type 5,27869,199,1.34 [0.92-1.95],0.1310422246394042
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACP6,Lysophosphatidic acid phosphatase type 6,27926,194,1.05 [0.87-1.28],0.6096980731004769
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACRBP,Acrosin-binding protein,24051,179,1.24 [0.89-1.74],0.2077412881330449
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACRV1,Acrosomal protein SP-10,23501,175,1.03 [0.69-1.56],0.8708489359991954
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACSL1,Long-chain-fatty-acid--CoA ligase 1,23421,172,0.87 [0.57-1.32],0.5079686604543168
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACTA2,"Actin, aortic smooth muscle",27233,194,1.10 [0.84-1.44],0.4918991205936819
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACTN2,Alpha-actinin-2,23421,172,1.04 [0.80-1.35],0.7552412635906823
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACTN4,Alpha-actinin-4,27187,191,1.11 [0.76-1.62],0.5957713207596995
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACVRL1,Serine/threonine-protein kinase receptor R3,27507,196,1.39 [0.84-2.32],0.2016439464673758
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACY1,Aminoacylase-1,27743,197,1.11 [0.91-1.36],0.3114412758759429
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,23421,172,1.15 [0.89-1.49],0.2767220354108343
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACYP1,Acylphosphatase-1,23581,172,1.08 [0.87-1.35],0.4693314405131709
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADA,Adenosine deaminase,28030,197,1.36 [0.97-1.89],0.0733664573942358
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADA2,Adenosine deaminase 2,27564,193,1.04 [0.76-1.41],0.8190999713787391
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,23501,175,1.01 [0.70-1.48],0.9446106877898204
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,27233,194,1.04 [0.68-1.57],0.8675384443523617
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,27549,196,0.94 [0.65-1.35],0.7392013487226103
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,28030,197,0.99 [0.69-1.41],0.9464273274787252
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,27934,197,1.08 [0.69-1.70],0.7278504530529145
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24062,176,0.87 [0.53-1.41],0.567776876397128
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,23501,175,1.35 [0.91-1.99],0.1342502841806175
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,28081,200,1.45 [0.84-2.50],0.1873769901349349
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,27620,196,1.19 [0.89-1.59],0.2340664285583642
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,27233,194,1.47 [1.11-1.94],0.0069664259898053
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,23501,175,0.94 [0.63-1.42],0.7740228654482149
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,27840,197,1.24 [0.94-1.64],0.1289816965613633
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTSL2,ADAMTS-like protein 2,24186,178,1.04 [0.65-1.64],0.8807886525279562
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTSL4,ADAMTS-like protein 4,23566,168,0.87 [0.46-1.63],0.6567062829464636
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTSL5,ADAMTS-like protein 5,24188,179,1.00 [0.69-1.44],0.9977099168239963
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,27092,194,1.33 [1.07-1.65],0.0103927558545695
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADD1,Alpha-adducin,23677,173,1.11 [0.90-1.37],0.3147213473423171
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRB3,Adhesion G protein-coupled receptor B3,27507,196,0.91 [0.62-1.33],0.611491715196386
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRD1,Adhesion G-protein coupled receptor D1,23677,173,1.77 [1.22-2.57],0.0027250391682921
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRE1,Adhesion G protein-coupled receptor E1,24062,176,1.16 [0.90-1.49],0.2529862449169462
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRE2,Adhesion G protein-coupled receptor E2,27880,196,0.96 [0.61-1.50],0.8488024202458309
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRE5,Adhesion G protein-coupled receptor E5,27945,200,1.00 [0.66-1.52],0.9938873932720323
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRF5,Adhesion G protein-coupled receptor F5,24188,179,0.93 [0.57-1.49],0.7513385153734489
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRG1,Adhesion G-protein coupled receptor G1,27620,196,0.83 [0.63-1.09],0.1778727931507174
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRG2,Adhesion G-protein coupled receptor G2,27743,197,1.44 [0.90-2.30],0.1280692936237446
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRV1,Adhesion G-protein coupled receptor V1,23404,170,0.97 [0.79-1.21],0.8036883273618906
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADH1B,All-trans-retinol dehydrogenase,23677,173,1.03 [0.85-1.25],0.7602530456889113
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,27233,194,1.07 [0.93-1.24],0.3339925938659512
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADIPOQ,Adiponectin,24235,177,1.09 [0.87-1.35],0.457196630083393
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADM,Pro-adrenomedullin,27975,194,1.16 [0.73-1.87],0.5256654568808659
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADRA2A,Alpha-2A adrenergic receptor,23421,172,0.95 [0.78-1.17],0.6526149174798463
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AFAP1,Actin filament-associated protein 1,23677,173,0.95 [0.80-1.13],0.5408157554190629
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AFM,Afamin,24235,177,1.46 [0.67-3.14],0.3382674345595837
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AFP,Alpha-fetoprotein,27467,196,1.08 [0.90-1.30],0.3856912182045429
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AGBL2,Cytosolic carboxypeptidase 2,23404,170,1.13 [0.96-1.33],0.1504227387307569
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AGER,Advanced glycosylation end product-specific receptor,27695,195,1.21 [0.89-1.65],0.232217006485651
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AGR2,Anterior gradient protein 2 homolog,26825,191,1.11 [0.98-1.26],0.087313845718271
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AGR3,Anterior gradient protein 3,27044,194,1.18 [0.96-1.45],0.1160978124600635
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AGRN,Agrin,27880,196,1.29 [0.89-1.86],0.1821299291928203
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AGRP,Agouti-related protein,28030,197,1.04 [0.83-1.32],0.708667958660669
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AGT,Angiotensinogen,24199,176,0.70 [0.41-1.20],0.1977889974102306
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AGXT,Serine--pyruvate aminotransferase,27743,197,1.07 [0.91-1.25],0.4199774378875017
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AHCY,Adenosylhomocysteinase,27743,197,1.04 [0.86-1.24],0.7116245590899901
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AHNAK,Neuroblast differentiation-associated protein AHNAK,23566,168,1.82 [1.23-2.70],0.0027494177091066
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AHNAK2,Protein AHNAK2,23566,168,1.18 [0.71-1.96],0.5141318508708936
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24051,179,1.03 [0.85-1.26],0.7427392458311342
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AHSG,Alpha-2-HS-glycoprotein,24199,176,1.49 [0.87-2.54],0.1422183415168332
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AHSP,Alpha-hemoglobin-stabilizing protein,27705,197,0.96 [0.84-1.11],0.5952351298721392
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AIDA,"Axin interactor, dorsalization-associated protein",23510,172,1.08 [0.93-1.26],0.3255562152615766
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AIF1,Allograft inflammatory factor 1,27092,194,1.21 [0.95-1.53],0.1261105924915436
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AIF1L,Allograft inflammatory factor 1-like,23566,168,0.99 [0.77-1.27],0.9298347043698236
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",27569,194,1.08 [0.96-1.22],0.2176138446180955
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AK1,Adenylate kinase isoenzyme 1,27743,197,1.00 [0.82-1.21],0.981198182440734
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AK2,"Adenylate kinase 2, mitochondrial",24131,176,1.07 [0.94-1.23],0.3174300383777551
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AKAP12,A-kinase anchor protein 12,23677,173,0.90 [0.45-1.80],0.7594431091014737
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AKR1B1,Aldo-keto reductase family 1 member B1,27092,194,1.06 [0.90-1.24],0.521841056035868
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AKR1B10,Aldo-keto reductase family 1 member B10,23510,172,1.03 [0.81-1.30],0.8323950000977947
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AKR1C4,Aldo-keto reductase family 1 member C4,27233,194,0.97 [0.76-1.23],0.7851617523046993
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AKR7L,Aflatoxin B1 aldehyde reductase member 4,23501,175,1.05 [0.87-1.28],0.5989924359980651
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AKT1S1,Proline-rich AKT1 substrate 1,27063,192,1.16 [0.96-1.41],0.1192185659761066
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AKT2,RAC-beta serine/threonine-protein kinase,24149,177,1.05 [0.94-1.18],0.3988527013706839
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AKT3,RAC-gamma serine/threonine-protein kinase,26962,193,0.98 [0.78-1.23],0.8528786036341731
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ALCAM,CD166 antigen,28081,200,1.90 [1.02-3.54],0.0419752125011275
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ALDH1A1,Retinal dehydrogenase 1,27746,198,1.07 [0.85-1.34],0.5525631698018364
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ALDH2,"Aldehyde dehydrogenase, mitochondrial",24051,179,0.83 [0.60-1.15],0.2654141660444635
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",27657,196,1.15 [0.97-1.37],0.1110637297067387
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24149,177,0.99 [0.73-1.34],0.9442340127468368
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ALMS1,Alstrom syndrome protein 1,23735,176,1.02 [0.75-1.38],0.9042615191867088
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ALPI,Intestinal-type alkaline phosphatase,23501,175,1.00 [0.88-1.13],0.957378289135526
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ALPP,"Alkaline phosphatase, placental type",27620,196,1.02 [0.91-1.15],0.6954189622441285
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMBN,Ameloblastin,27187,191,0.56 [0.33-0.97],0.0391804533907554
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMBP,Protein AMBP,27937,194,1.30 [0.69-2.47],0.421322891949306
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24186,178,0.82 [0.47-1.43],0.4841310958591991
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMFR,E3 ubiquitin-protein ligase AMFR,27063,192,1.12 [0.94-1.34],0.2160362194959766
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMIGO1,Amphoterin-induced protein 1,23510,172,1.11 [0.87-1.43],0.4041547436731874
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMIGO2,Amphoterin-induced protein 2,27620,196,0.97 [0.55-1.69],0.9077126119878656
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMN,Protein amnionless,27187,191,1.11 [0.86-1.45],0.4218416383666016
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMOT,Angiomotin,23677,173,0.97 [0.69-1.36],0.8464974771716265
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMOTL2,Angiomotin-like protein 2,23970,178,1.05 [0.79-1.40],0.7215633133834323
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMPD3,AMP deaminase 3,24131,176,1.04 [0.86-1.26],0.6805452650060033
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,22643,164,0.94 [0.68-1.29],0.6862144350074324
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMY2A,Pancreatic alpha-amylase,26650,195,0.88 [0.67-1.16],0.3719925692565557
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMY2B,Alpha-amylase 2B,25849,188,0.85 [0.64-1.12],0.2400610681871672
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANG,Angiogenin,27652,194,1.11 [0.77-1.58],0.5801109782168461
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANGPT1,Angiopoietin-1,27645,193,1.03 [0.89-1.20],0.6835095739463858
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANGPT2,Angiopoietin-2,27975,194,1.11 [0.81-1.52],0.5051075392670408
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANGPTL1,Angiopoietin-related protein 1,27367,192,0.90 [0.58-1.39],0.6329951843865519
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANGPTL2,Angiopoietin-related protein 2,27794,196,0.79 [0.58-1.09],0.1496683862468248
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANGPTL3,Angiopoietin-related protein 3,27742,194,1.01 [0.71-1.43],0.947955101240478
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANGPTL4,Angiopoietin-related protein 4,27832,196,0.91 [0.69-1.19],0.4871542832238882
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANGPTL7,Angiopoietin-related protein 7,27975,194,0.77 [0.55-1.09],0.1386771624306824
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANK2,Ankyrin-2,23421,172,0.98 [0.80-1.21],0.8782400481850274
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,23501,175,0.99 [0.83-1.19],0.9511598303690882
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANKRA2,Ankyrin repeat family A protein 2,23311,173,0.94 [0.72-1.22],0.6233639608061036
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANKRD54,Ankyrin repeat domain-containing protein 54,27092,194,1.08 [0.88-1.33],0.4792919680085118
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,23566,168,0.95 [0.67-1.36],0.7997075919823378
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANPEP,Aminopeptidase N,27788,193,1.64 [1.09-2.48],0.0181930120170827
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANXA1,Annexin A1,23532,172,1.03 [0.75-1.41],0.8785918598874144
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANXA10,Annexin A10,27063,192,1.04 [0.89-1.21],0.648387221528466
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANXA11,Annexin A11,27661,197,1.03 [0.85-1.24],0.7751351853661825
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANXA2,Annexin A2,23203,165,1.24 [1.03-1.48],0.019977965771661
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANXA3,Annexin A3,27934,197,1.02 [0.85-1.22],0.8236203065272689
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANXA4,Annexin A4,27603,196,1.05 [0.89-1.25],0.5474108779243743
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANXA5,Annexin A5,26981,191,1.06 [0.70-1.61],0.7769957540324208
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AOC1,Amiloride-sensitive amine oxidase [copper-containing],27187,191,1.15 [0.95-1.40],0.1532943536266162
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AOC3,Membrane primary amine oxidase,27837,194,1.43 [0.94-2.16],0.0914628811518419
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AP1G2,AP-1 complex subunit gamma-like 2,24051,179,1.00 [0.84-1.20],0.9783667208490576
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AP2B1,AP-2 complex subunit beta,23510,172,1.13 [0.85-1.50],0.4173408398433943
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AP3B1,AP-3 complex subunit beta-1,24062,176,1.16 [0.97-1.40],0.1091233242190101
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AP3S2,AP-3 complex subunit sigma-2,24131,176,1.11 [0.82-1.50],0.5000701632540028
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,27620,196,1.16 [0.89-1.49],0.2683694716009746
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APCS,Serum amyloid P-component,24016,176,1.62 [1.08-2.43],0.0193557441402701
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,27878,193,1.09 [0.88-1.34],0.4205163788319884
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APLP1,Amyloid-like protein 1,27743,197,1.05 [0.82-1.34],0.7077003203711705
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOA1,Apolipoprotein A-I,24235,177,0.83 [0.48-1.44],0.5149264756324766
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOA2,Apolipoprotein A-II,24199,176,0.72 [0.53-0.97],0.0335491473228887
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOA4,Apolipoprotein A-IV,24235,177,1.06 [0.72-1.55],0.7643904880260687
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOB,Apolipoprotein B-100,24199,176,0.76 [0.41-1.41],0.3801441162692479
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOBR,Apolipoprotein B receptor,23566,168,0.88 [0.62-1.23],0.4524197889900005
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOC1,Apolipoprotein C-I,24183,177,1.22 [0.84-1.77],0.2981616927061254
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOD,Apolipoprotein D,23116,171,0.91 [0.63-1.31],0.6176842842815988
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOE,Apolipoprotein E,24235,177,1.04 [0.87-1.25],0.6720685813232459
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOF,Apolipoprotein F,24199,176,1.11 [0.60-2.05],0.7439703756614937
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOH,Beta-2-glycoprotein 1,27746,198,0.94 [0.66-1.34],0.723508405752895
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOL1,Apolipoprotein L1,24199,176,1.02 [0.82-1.26],0.881539173276699
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOM,Apolipoprotein M,27789,194,1.20 [0.74-1.93],0.4586908678070462
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APP,Amyloid-beta precursor protein,27706,198,1.15 [0.95-1.38],0.1436482920913308
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APPL2,DCC-interacting protein 13-beta,23677,173,1.00 [0.88-1.14],0.985003491020332
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APRT,Adenine phosphoribosyltransferase,27510,196,0.91 [0.71-1.18],0.4904885801260581
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARAF,Serine/threonine-protein kinase A-Raf,23735,176,0.98 [0.79-1.22],0.8639504730018296
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AREG,Amphiregulin,27620,196,0.74 [0.57-0.97],0.0280306996888851
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARF6,ADP-ribosylation factor 6,24062,176,1.10 [0.96-1.26],0.1789273832468071
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARFIP1,Arfaptin-1,24149,177,1.00 [0.81-1.23],0.9792081078231536
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARG1,Arginase-1,27594,193,1.01 [0.80-1.28],0.9237815849819544
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARG2,"Arginase-2, mitochondrial",24051,179,1.06 [0.79-1.44],0.6879788635039543
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGAP1,Rho GTPase-activating protein 1,27092,194,1.04 [0.79-1.36],0.8016248790283875
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGAP25,Rho GTPase-activating protein 25,27092,194,1.09 [0.88-1.34],0.4313715358458088
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGAP30,Rho GTPase-activating protein 30,23735,176,1.07 [0.75-1.52],0.7218063805620296
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGAP45,Rho GTPase-activating protein 45,23677,173,1.03 [0.86-1.23],0.7619184202214614
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGAP5,Rho GTPase-activating protein 5,23311,173,1.09 [0.91-1.30],0.3468952936711992
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGEF1,Rho guanine nucleotide exchange factor 1,24131,176,1.07 [0.91-1.25],0.4136067034847546
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGEF10,Rho guanine nucleotide exchange factor 10,24149,177,1.01 [0.87-1.18],0.8635133931802921
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGEF12,Rho guanine nucleotide exchange factor 12,27699,197,1.03 [0.91-1.16],0.6551290311298248
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGEF5,Rho guanine nucleotide exchange factor 5,23404,170,0.93 [0.75-1.14],0.465692050933909
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARID3A,AT-rich interactive domain-containing protein 3A,23404,170,1.03 [0.72-1.47],0.8797983827245325
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARID4B,AT-rich interactive domain-containing protein 4B,27063,192,1.09 [0.83-1.43],0.5521599446456811
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARL13B,ADP-ribosylation factor-like protein 13B,23421,172,1.10 [0.90-1.34],0.3609947659148174
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,23421,172,1.26 [0.89-1.80],0.1900663829772927
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARMCX2,Armadillo repeat-containing X-linked protein 2,23404,170,1.12 [0.92-1.36],0.2775312256100311
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARNT,Aryl hydrocarbon receptor nuclear translocator,27187,191,1.32 [0.99-1.77],0.0629539737875542
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,23421,172,1.10 [0.86-1.41],0.4392377572113944
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARSA,Arylsulfatase A,27746,198,1.11 [0.84-1.46],0.4686459373133084
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARSB,Arylsulfatase B,27620,196,1.26 [1.01-1.57],0.0401860366877419
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ART3,Ecto-ADP-ribosyltransferase 3,27837,194,0.99 [0.67-1.46],0.9609437849379248
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ART5,Ecto-ADP-ribosyltransferase 5,23404,170,0.97 [0.76-1.22],0.777804667201383
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARTN,Artemin,27187,191,0.93 [0.69-1.26],0.6476455700277723
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ASAH1,Acid ceramidase,23957,176,1.16 [0.86-1.54],0.3279756333009069
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ASAH2,Neutral ceramidase,27549,196,1.00 [0.79-1.28],0.9715405894553216
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ASGR1,Asialoglycoprotein receptor 1,27549,196,0.78 [0.50-1.21],0.2629615552951584
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ASGR2,Asialoglycoprotein receptor 2,24199,176,1.10 [0.63-1.91],0.7361203012200165
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ASPN,Asporin,24188,179,1.26 [0.77-2.04],0.3578265610160861
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ASPSCR1,Tether containing UBX domain for GLUT4,24149,177,1.14 [0.93-1.41],0.2030087632460941
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ASRGL1,Isoaspartyl peptidase/L-asparaginase,23566,168,1.06 [0.91-1.22],0.4537491274980861
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ASS1,Argininosuccinate synthase,23421,172,1.08 [0.90-1.29],0.3986230977783265
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATF2,Cyclic AMP-dependent transcription factor ATF-2,27063,192,1.11 [0.95-1.29],0.1926074507753248
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATF4,Cyclic AMP-dependent transcription factor ATF-4,23311,173,1.42 [0.99-2.03],0.0536396704227266
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATG16L1,Autophagy-related protein 16-1,24062,176,1.02 [0.86-1.21],0.7967543460012108
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATG4A,Cysteine protease ATG4A,27092,194,1.00 [0.81-1.24],0.9792278169806016
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATOX1,Copper transport protein ATOX1,27840,197,1.05 [0.88-1.25],0.6032636838048746
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,23421,172,0.91 [0.66-1.26],0.5743943364252634
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,23421,172,1.09 [0.70-1.69],0.7080141570653371
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,23421,172,1.21 [0.88-1.65],0.2464959086410512
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP1B4,Protein ATP1B4,23311,173,0.89 [0.62-1.28],0.5330118828925579
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP2B4,Plasma membrane calcium-transporting ATPase 4,23421,172,1.01 [0.80-1.26],0.9485588253952644
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP5F1D,"ATP synthase subunit delta, mitochondrial",23421,172,1.07 [0.83-1.38],0.5832079577421567
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP5IF1,"ATPase inhibitor, mitochondrial",27880,196,0.98 [0.88-1.10],0.7422770695373748
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP5PO,"ATP synthase subunit O, mitochondrial",27063,192,1.08 [0.81-1.43],0.6141511270443845
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP6AP2,Renin receptor,27092,194,1.51 [1.23-1.86],9.562886882560154e-05
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP6V1D,V-type proton ATPase subunit D,27620,196,0.81 [0.49-1.33],0.4059292461908166
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP6V1F,V-type proton ATPase subunit F,27012,192,1.05 [0.87-1.27],0.6160491791589824
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP6V1G1,V-type proton ATPase subunit G 1,23566,168,1.03 [0.84-1.27],0.7480774215941355
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP6V1G2,V-type proton ATPase subunit G 2,23421,172,0.95 [0.81-1.10],0.4697378914392569
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATRAID,All-trans retinoic acid-induced differentiation factor,24062,176,1.01 [0.61-1.66],0.9759289323747792
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATRN,"Attractin, Isoform 2",24235,177,3.96 [1.65-9.49],0.0020236986146851
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATXN10,Ataxin-10,27063,192,1.00 [0.84-1.20],0.9590076385048956
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATXN2,Ataxin-2,23404,170,1.11 [1.00-1.24],0.0602601681830243
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATXN2L,Ataxin-2-like protein,24149,177,1.16 [0.89-1.52],0.2825812471816872
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATXN3,Ataxin-3,24131,176,1.09 [0.87-1.37],0.448198725878869
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AXIN1,Axin-1,27699,197,1.01 [0.89-1.16],0.8570657636673155
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AXL,Tyrosine-protein kinase receptor UFO,27837,194,1.43 [0.91-2.25],0.1193581038319846
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AZI2,5-azacytidine-induced protein 2,24149,177,1.13 [0.88-1.45],0.3417526425797726
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AZU1,Azurocidin,26855,195,1.04 [0.89-1.21],0.6404770015651517
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",B2M,Beta-2-microglobulin,24235,177,1.21 [0.84-1.74],0.3129000859085521
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,23421,172,1.07 [0.53-2.18],0.8442088705335618
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",23566,168,1.59 [1.06-2.38],0.0249662422631102
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",B4GALT1,"Beta-1,4-galactosyltransferase 1",27880,196,0.88 [0.55-1.40],0.5938525776741881
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",B4GAT1,"Beta-1,4-glucuronyltransferase 1",27746,198,1.18 [0.70-1.98],0.5374714763543833
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BABAM1,BRISC and BRCA1-A complex member 1,23501,175,1.18 [0.75-1.87],0.4768040065051457
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BACH1,Transcription regulator protein BACH1,27699,197,0.98 [0.83-1.17],0.8577066706980572
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BAG3,BAG family molecular chaperone regulator 3,27507,196,0.90 [0.66-1.23],0.5124086057161015
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BAG4,BAG family molecular chaperone regulator 4,23501,175,1.09 [0.82-1.45],0.5342258779011217
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BAG6,Large proline-rich protein BAG6,27233,194,1.16 [0.82-1.63],0.4159115116505074
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,27092,194,1.12 [0.92-1.36],0.2775226434236334
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BAMBI,BMP and activin membrane-bound inhibitor homolog,27092,194,1.29 [0.86-1.93],0.2231843266907106
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BANK1,B-cell scaffold protein with ankyrin repeats,27699,197,1.01 [0.90-1.14],0.8554368910347877
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BAP18,Chromatin complexes subunit BAP18,24131,176,1.05 [0.86-1.29],0.6008824150738297
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BATF,Basic leucine zipper transcriptional factor ATF-like,23510,172,0.94 [0.78-1.12],0.4809864132364962
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BAX,Apoptosis regulator BAX,27021,191,1.04 [0.90-1.20],0.5744787775976691
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCAM,Basal cell adhesion molecule,27746,198,1.28 [0.76-2.14],0.3543979331211417
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCAN,Brevican core protein,27549,196,1.05 [0.72-1.54],0.7875706500223852
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24188,179,0.98 [0.61-1.56],0.930093362376788
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",23404,170,0.80 [0.58-1.09],0.1540181079625759
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCHE,Cholinesterase,23752,173,1.87 [1.10-3.18],0.0211347588698263
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCL2,Apoptosis regulator Bcl-2,24062,176,1.06 [0.82-1.37],0.65534666479638
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCL2L1,Bcl-2-like protein 1,24131,176,1.06 [0.91-1.22],0.4564923644068361
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",27699,197,1.06 [0.80-1.40],0.6876586075738732
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCL2L15,Bcl-2-like protein 15,23501,175,1.06 [0.83-1.34],0.6390329598250803
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCL7A,B-cell CLL/lymphoma 7 protein family member A,23311,173,1.04 [0.83-1.29],0.7507499401002653
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCL7B,B-cell CLL/lymphoma 7 protein family member B,24051,179,1.27 [0.97-1.65],0.0796004630694855
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCR,Breakpoint cluster region protein,27699,197,1.06 [0.92-1.21],0.4331494784967674
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BDNF,Brain-derived neurotrophic factor,24186,178,1.07 [0.90-1.28],0.4255117991198772
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BECN1,Beclin-1,23566,168,1.14 [0.90-1.44],0.279227613671562
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BEX3,Protein BEX3,23311,173,1.04 [0.77-1.40],0.8100161297538879
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BGLAP,Osteocalcin,24186,178,0.92 [0.79-1.08],0.3236096567109345
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BGN,Biglycan,27045,194,1.02 [0.92-1.13],0.747680721422455
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BHLHE40,Class E basic helix-loop-helix protein 40,23404,170,0.79 [0.63-1.00],0.046739488143893
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,23421,172,1.13 [0.65-1.98],0.6662888115108471
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BID,BH3-interacting domain death agonist,27699,197,0.98 [0.81-1.17],0.7961337405030776
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BIN2,Bridging integrator 2,27746,198,0.98 [0.86-1.13],0.8267564467542109
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BIRC2,Baculoviral IAP repeat-containing protein 2,27092,194,1.12 [0.92-1.37],0.2577139995615328
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BLMH,Bleomycin hydrolase,28081,200,1.28 [0.88-1.86],0.2042792734805766
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BLNK,B-cell linker protein,23501,175,0.99 [0.68-1.46],0.9669998147316472
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,23404,170,1.08 [0.90-1.30],0.4312319456778345
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24131,176,1.10 [0.78-1.57],0.5793159339234095
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BLVRB,Flavin reductase,27746,198,1.07 [0.89-1.28],0.4804894621291244
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BMP10,Bone morphogenetic protein 10,23677,173,0.77 [0.47-1.28],0.312390358493148
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BMP4,Bone morphogenetic protein 4,27507,196,0.91 [0.69-1.21],0.5178523774700784
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BMP6,Bone morphogenetic protein 6,27189,194,0.95 [0.71-1.28],0.7393481914758728
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BMPER,BMP-binding endothelial regulator protein,23677,173,1.69 [0.94-3.03],0.0788970526073672
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24188,179,1.12 [0.75-1.67],0.5897917394289895
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,23501,175,1.03 [0.74-1.42],0.8657579453587992
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BOC,Brother of CDO,27233,194,1.68 [0.99-2.87],0.0548675394021761
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BOLA1,BolA-like protein 1,23404,170,1.00 [0.77-1.30],0.994184865371816
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BOLA2_BOLA2B,BolA-like protein 2,23566,168,1.08 [0.83-1.40],0.5732959151673989
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BPIFA2,BPI fold-containing family A member 2,22698,165,0.89 [0.77-1.02],0.0982778831602973
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BPIFB1,BPI fold-containing family B member 1,27671,198,1.01 [0.83-1.23],0.9128731771130656
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BPIFB2,BPI fold-containing family B member 2,24140,178,0.84 [0.67-1.05],0.1253552704984095
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BRAP,BRCA1-associated protein,23852,176,1.08 [0.95-1.24],0.2499672641538636
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BRD1,Bromodomain-containing protein 1,23735,176,0.81 [0.49-1.33],0.4086820122141369
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BRD2,Bromodomain-containing protein 2,23404,170,1.15 [0.77-1.71],0.4923169426134224
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BRD3,Bromodomain-containing protein 3,23421,172,1.05 [0.79-1.40],0.723935363525392
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BRDT,Bromodomain testis-specific protein,23421,172,1.18 [0.81-1.73],0.3852201634486421
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BRK1,Protein BRICK1,27063,192,1.26 [0.95-1.68],0.1033536861633965
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BRME1,Break repair meiotic recombinase recruitment factor 1,23404,170,1.03 [0.74-1.43],0.8712124365209083
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BRSK2,Serine/threonine-protein kinase BRSK2,24149,177,1.10 [0.77-1.56],0.6052412431743951
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BSG,Basigin,27984,196,1.37 [0.72-2.64],0.3389698539548844
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BSND,Barttin,23311,173,1.19 [0.82-1.72],0.3675373009764183
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,27981,197,0.85 [0.67-1.07],0.1612429399432494
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BST2,Bone marrow stromal antigen 2,27981,197,1.07 [0.85-1.34],0.5544995185610917
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BTC,Probetacellulin,27092,194,0.96 [0.81-1.14],0.6539059776556597
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BTD,Biotinidase,24235,177,2.33 [1.14-4.74],0.0201104522822492
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BTLA,B- and T-lymphocyte attenuator,23311,173,1.14 [1.00-1.30],0.0519213411607668
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BTN1A1,Butyrophilin subfamily 1 member A1,24005,179,0.91 [0.63-1.30],0.5884034281099784
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BTN2A1,Butyrophilin subfamily 2 member A1,27880,196,1.18 [0.72-1.93],0.5230411847177219
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BTN3A2,Butyrophilin subfamily 3 member A2,27699,197,0.96 [0.69-1.34],0.8098461499768934
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BTNL10,Butyrophilin-like protein 10,23311,173,1.12 [0.81-1.55],0.5064140059280349
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C19orf12,Protein C19orf12,27063,192,0.90 [0.72-1.12],0.3344368041833405
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1GALT1C1,C1GALT1-specific chaperone 1,23421,172,1.27 [0.85-1.91],0.2471879569842515
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1QA,Complement C1q subcomponent subunit A,27887,196,0.76 [0.44-1.30],0.3126666135436067
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24149,177,1.12 [0.93-1.33],0.2276578912492054
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1QL2,Complement C1q-like protein 2,23501,175,0.78 [0.55-1.11],0.170871733084759
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,27837,194,1.08 [0.80-1.46],0.6049250343592562
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,23677,173,0.97 [0.66-1.42],0.871781424182649
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24149,177,0.95 [0.61-1.47],0.8083501135785909
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,23628,172,0.88 [0.66-1.18],0.3845403938757957
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1R,Complement C1r subcomponent,24235,177,1.14 [0.57-2.30],0.7121464103914195
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1RL,Complement C1r subcomponent-like protein,24197,176,1.81 [0.85-3.86],0.1259244132922669
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1S,Complement C1s subcomponent,24235,177,1.11 [0.56-2.21],0.766524774605455
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C2,Complement C2,27789,194,1.03 [0.60-1.78],0.9041575684948956
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C2CD2L,Phospholipid transfer protein C2CD2L,27012,192,1.22 [0.95-1.58],0.1214582608166512
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C2orf69,UPF0565 protein C2orf69,23510,172,1.15 [0.93-1.43],0.1934489754626125
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C3,Complement C3,22986,170,0.88 [0.62-1.24],0.4511139494251341
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C4BPB,C4b-binding protein beta chain,27840,197,1.09 [0.81-1.48],0.5694994198313548
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C5,Complement C5,24235,177,1.40 [0.57-3.43],0.463256172615489
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C7,Complement component C7,23654,173,0.75 [0.48-1.19],0.2227065397000693
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C7orf50,Uncharacterized protein C7orf50,24131,176,1.51 [1.02-2.24],0.0417215807033825
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C8B,Complement component C8 beta chain,24235,177,1.70 [1.06-2.73],0.0281394308360493
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C9,Complement component C9,24199,176,0.88 [0.66-1.17],0.375058746065696
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C9orf40,Uncharacterized protein C9orf40,24062,176,1.02 [0.86-1.21],0.8202407378127102
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA1,Carbonic anhydrase 1,27101,193,1.13 [0.92-1.37],0.2423093105056833
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA11,Carbonic anhydrase-related protein 11,27092,194,0.88 [0.57-1.34],0.5477908519333986
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA12,Carbonic anhydrase 12,27620,196,1.15 [0.79-1.67],0.4676863557996745
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA13,Carbonic anhydrase 13,27447,195,1.04 [0.92-1.18],0.4991707428072793
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA14,Carbonic anhydrase 14,27975,194,1.30 [0.90-1.88],0.1566620321468262
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA2,Carbonic anhydrase 2,27656,196,1.00 [0.84-1.19],0.98114563774306
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA3,Carbonic anhydrase 3,28032,200,1.12 [0.93-1.36],0.2394585976635987
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA4,Carbonic anhydrase 4,28081,200,1.11 [0.65-1.88],0.6995752633277112
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA5A,"Carbonic anhydrase 5A, mitochondrial",27233,194,0.96 [0.84-1.11],0.6043159255925332
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA6,Carbonic anhydrase 6,27658,198,0.91 [0.75-1.11],0.3681373407329599
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA7,Carbonic anhydrase 7,23735,176,1.00 [0.66-1.51],0.9947820420389394
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA8,Carbonic anhydrase-related protein,23501,175,1.11 [0.67-1.82],0.6924732037687704
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA9,Carbonic anhydrase 9,27975,194,1.01 [0.76-1.34],0.9633607729205712
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CABP2,Calcium-binding protein 2,23510,172,1.12 [0.91-1.37],0.2876980089825514
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,23404,170,0.67 [0.40-1.12],0.128074344169714
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,23421,172,0.98 [0.76-1.27],0.8974268671811813
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,23404,170,0.95 [0.74-1.22],0.6888502059006263
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24149,177,1.06 [0.89-1.25],0.5086912941200408
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CACYBP,Calcyclin-binding protein,23629,173,0.98 [0.85-1.13],0.8016645202248306
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CADPS,Calcium-dependent secretion activator 1,23510,172,0.97 [0.69-1.34],0.8325703939698923
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CALB1,Calbindin,27620,196,0.81 [0.61-1.07],0.138973440779542
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CALB2,Calretinin,27063,192,0.97 [0.64-1.47],0.8790004671942311
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CALCA,Calcitonin,27498,196,0.96 [0.76-1.21],0.7376682083145338
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CALCB,Calcitonin gene-related peptide 2,24131,176,1.07 [0.76-1.52],0.6967507475386108
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,27884,194,0.97 [0.86-1.10],0.6514893114192136
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,23566,168,1.03 [0.85-1.25],0.7421255028286604
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CALY,Neuron-specific vesicular protein calcyon,23421,172,0.76 [0.49-1.19],0.2312598492747173
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,27092,194,1.01 [0.76-1.35],0.9248836984693156
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,23510,172,1.18 [0.92-1.51],0.182210671376458
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24149,177,1.00 [0.88-1.15],0.9725331680700008
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CANT1,Soluble calcium-activated nucleotidase 1,27667,197,1.47 [0.79-2.72],0.2249873494384685
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CAPG,Macrophage-capping protein,27529,191,0.97 [0.78-1.21],0.7945195257527125
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CAPN3,Calpain-3,24051,179,0.94 [0.63-1.40],0.7452128382787603
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CAPS,Calcyphosin,24131,176,0.96 [0.81-1.14],0.64369018682191
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CARHSP1,Calcium-regulated heat-stable protein 1,27063,192,1.05 [0.83-1.33],0.6907190924416378
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASC3,Protein CASC3,23510,172,1.32 [0.95-1.83],0.1031165607570876
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASP1,Caspase-1,27063,192,1.04 [0.86-1.24],0.71135021412285
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASP10,Caspase-10,27063,192,0.92 [0.77-1.10],0.3760212730377416
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASP2,Caspase-2,27699,197,1.01 [0.84-1.22],0.9065149260207418
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASP3,Caspase-3,28081,200,1.02 [0.89-1.17],0.7917682322694567
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASP4,Caspase-4,23735,176,0.98 [0.89-1.06],0.5776774961624216
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASP7,Caspase-7,24131,176,1.10 [0.93-1.30],0.2778886503981107
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASP8,Caspase-8,27888,194,1.02 [0.83-1.24],0.8759529700725641
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASP9,Caspase-9,23501,175,1.05 [0.83-1.31],0.7025233564038351
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASQ2,Calsequestrin-2,23421,172,0.88 [0.63-1.22],0.431293151888475
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CAT,Catalase,23829,173,1.06 [0.82-1.38],0.6340186531075396
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CBLIF,Cobalamin binding intrinsic factor,27698,197,0.92 [0.78-1.10],0.3662776242933258
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CBLN1,Cerebellin-1,23404,170,0.98 [0.85-1.15],0.8437888760412159
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CBLN4,Cerebellin-4,27975,194,1.29 [0.88-1.90],0.1980067031079607
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CBS,Cystathionine beta-synthase,23566,168,0.90 [0.67-1.23],0.5166234603876525
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CBX2,Chromobox protein homolog 2,23421,172,1.14 [0.83-1.57],0.4129934312620346
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,27549,196,1.02 [0.86-1.20],0.8603873872654217
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCAR2,Cell cycle and apoptosis regulator protein 2,24131,176,1.30 [1.09-1.55],0.0037770091064932
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCDC134,Coiled-coil domain-containing protein 134,24051,179,1.17 [0.89-1.54],0.2556884731655144
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCDC28A,Coiled-coil domain-containing protein 28A,23510,172,0.95 [0.57-1.56],0.8282204569339205
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCDC50,Coiled-coil domain-containing protein 50,24149,177,0.91 [0.75-1.11],0.3654508987950363
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCDC80,Coiled-coil domain-containing protein 80,27743,197,1.14 [0.80-1.64],0.4721071656829927
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,23566,168,0.97 [0.76-1.23],0.7879586367104859
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL11,Eotaxin,28030,197,1.61 [1.17-2.21],0.0035014649761863
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL13,C-C motif chemokine 13,27979,197,1.21 [1.01-1.44],0.0366394091358792
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL14,C-C motif chemokine 14,27652,194,1.06 [0.77-1.45],0.7330215474037787
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL15,C-C motif chemokine 15,28081,200,1.07 [0.81-1.42],0.6237271869821079
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL16,C-C motif chemokine 16,28081,200,1.14 [0.89-1.45],0.3013950065649867
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL17,C-C motif chemokine 17,27704,196,1.10 [0.96-1.27],0.154589145584479
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL18,C-C motif chemokine 18,27341,193,1.03 [0.87-1.23],0.6998340886444061
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL19,C-C motif chemokine 19,27981,197,1.03 [0.94-1.13],0.5263257774041404
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL2,C-C motif chemokine 2,27507,196,1.24 [0.99-1.56],0.0660214954784916
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL20,C-C motif chemokine 20,28030,197,1.06 [0.92-1.21],0.4192475916534172
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL21,C-C motif chemokine 21,27880,196,1.05 [0.78-1.40],0.7508682346623665
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL22,C-C motif chemokine 22,27484,195,1.07 [0.84-1.36],0.5977670793553991
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL23,C-C motif chemokine 23,27880,196,0.93 [0.69-1.27],0.6581242992355885
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL24,C-C motif chemokine 24,27832,196,1.17 [1.01-1.36],0.0349029644842557
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL25,C-C motif chemokine 25,28030,197,1.16 [0.90-1.49],0.2492296082977191
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL26,C-C motif chemokine 26,27699,197,1.03 [0.90-1.18],0.6816102309707586
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL27,C-C motif chemokine 27,27743,197,1.22 [0.99-1.50],0.0681820956432912
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL28,C-C motif chemokine 28,27611,196,0.92 [0.74-1.15],0.4639341151761411
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL3,C-C motif chemokine 3,27699,197,1.15 [0.97-1.37],0.1116720945453619
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL4,C-C motif chemokine 4,27790,196,1.17 [1.00-1.37],0.0495213479208622
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL5,C-C motif chemokine 5,27837,194,1.04 [0.92-1.18],0.5260435050727086
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL7,C-C motif chemokine 7,27699,197,1.14 [0.94-1.38],0.1844526549503756
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL8,C-C motif chemokine 8,27937,194,1.08 [0.88-1.33],0.4735110609395349
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCN1,CCN family member 1,27572,196,1.13 [0.96-1.32],0.147236481330666
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCN2,CCN family member 2,27742,195,1.06 [0.86-1.31],0.59256268669618
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCN3,CCN family member 3,28041,200,1.11 [0.77-1.60],0.5695513487964143
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCN4,CCN family member 4,27975,194,0.98 [0.72-1.34],0.9065988112605136
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCN5,CCN family member 5,27746,198,0.79 [0.58-1.10],0.1593815521469394
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCND2,G1/S-specific cyclin-D2,23735,176,1.31 [0.88-1.95],0.1870122846528149
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCNE1,G1/S-specific cyclin-E1,23501,175,1.14 [1.01-1.28],0.0318392710918715
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCS,Copper chaperone for superoxide dismutase,27549,196,0.98 [0.76-1.27],0.8875516612014254
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCT5,T-complex protein 1 subunit epsilon,27092,194,1.03 [0.78-1.36],0.8367147642865546
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD101,Immunoglobulin superfamily member 2,24062,176,1.36 [0.98-1.90],0.0661089184520904
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD109,CD109 antigen,27746,198,1.10 [0.75-1.60],0.6227917992538929
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD14,Monocyte differentiation antigen CD14,27142,192,1.13 [0.83-1.53],0.4473269663344275
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD160,CD160 antigen,28030,197,0.95 [0.72-1.25],0.712429522605821
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD163,Scavenger receptor cysteine-rich type 1 protein M130,27837,194,1.17 [0.88-1.57],0.2844298576414084
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD164,Sialomucin core protein 24,27746,198,1.28 [0.90-1.84],0.1718333044213211
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD164L2,CD164 sialomucin-like 2 protein,23510,172,0.85 [0.57-1.28],0.4438792845613495
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD177,CD177 antigen,27703,198,1.02 [0.92-1.12],0.7493061985588981
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD1C,T-cell surface glycoprotein CD1c,27840,197,1.18 [0.69-2.01],0.5395980718421838
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD2,T-cell surface antigen CD2,23421,172,0.75 [0.48-1.18],0.2117077911764029
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD200,OX-2 membrane glycoprotein,27699,197,1.05 [0.65-1.71],0.8337983542436624
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD200R1,Cell surface glycoprotein CD200 receptor 1,27610,197,0.84 [0.58-1.23],0.3743433080289841
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD207,C-type lectin domain family 4 member K,27156,191,1.13 [0.81-1.58],0.4699041487810534
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD209,CD209 antigen,27809,199,1.18 [0.86-1.64],0.3054424454576981
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD22,B-cell receptor CD22,28030,197,1.17 [0.86-1.60],0.3046293888998485
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD226,CD226 antigen,23501,175,1.25 [0.89-1.76],0.2043798435042697
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD244,Natural killer cell receptor 2B4,28030,197,1.23 [0.77-1.96],0.3843543521559411
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD248,Endosialin,24186,178,0.91 [0.64-1.31],0.6172493429515545
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD27,CD27 antigen,27840,197,0.86 [0.62-1.19],0.3533380813856027
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD274,Programmed cell death 1 ligand 1,27549,196,1.15 [0.81-1.63],0.4336263329445267
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD276,CD276 antigen,27745,195,1.07 [0.75-1.53],0.692084310658954
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD28,T-cell-specific surface glycoprotein CD28,27092,194,1.04 [0.73-1.47],0.848794852342011
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD2AP,CD2-associated protein,27743,197,1.06 [0.87-1.29],0.5663115256074375
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD300A,CMRF35-like molecule 8,23677,173,1.18 [0.72-1.94],0.5032619570403246
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD300C,CMRF35-like molecule 6,27981,197,1.11 [0.77-1.61],0.5629639834802755
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD300E,CMRF35-like molecule 2,27872,194,1.23 [0.90-1.68],0.1985116994276686
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD300LF,CMRF35-like molecule 1,27975,194,1.01 [0.82-1.24],0.935315379444104
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD300LG,CMRF35-like molecule 9,27746,198,1.00 [0.71-1.40],0.989090957379979
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD302,CD302 antigen,27620,196,1.11 [0.73-1.70],0.6134538328902965
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD33,Myeloid cell surface antigen CD33,27840,197,1.13 [0.96-1.33],0.1417942256550638
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD34,Hematopoietic progenitor cell antigen CD34,27890,197,1.04 [0.62-1.75],0.8895592820447257
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD36,Platelet glycoprotein 4,23501,175,1.25 [0.91-1.72],0.1616574853198231
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,27620,196,1.25 [0.83-1.89],0.2774166001984445
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD3D,T-cell surface glycoprotein CD3 delta chain,23404,170,0.84 [0.53-1.34],0.4587908710937984
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD3E,T-cell surface glycoprotein CD3 epsilon chain,23735,176,1.04 [0.70-1.54],0.8408544708575396
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD3G,T-cell surface glycoprotein CD3 gamma chain,23501,175,0.98 [0.83-1.15],0.7743649988672283
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD4,T-cell surface glycoprotein CD4,27653,197,1.09 [0.73-1.64],0.6662717114450842
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD40,Tumor necrosis factor receptor superfamily member 5,27742,196,1.02 [0.79-1.31],0.8886415611439454
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD40LG,CD40 ligand,28030,197,0.99 [0.85-1.17],0.932401314517008
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD46,Membrane cofactor protein,27556,193,1.14 [0.73-1.76],0.5634294314397257
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD48,CD48 antigen,27832,196,0.80 [0.52-1.23],0.308492274670872
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD5,T-cell surface glycoprotein CD5,27937,194,0.90 [0.61-1.32],0.5816190258447558
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD55,Complement decay-accelerating factor,26757,183,1.30 [0.82-2.08],0.2656599449854032
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD58,Lymphocyte function-associated antigen 3,27705,195,1.21 [0.59-2.47],0.6092264784814507
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD59,CD59 glycoprotein,26717,194,1.20 [0.68-2.14],0.5250531945381839
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD5L,CD5 antigen-like,24092,176,0.91 [0.67-1.25],0.5641136056745102
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD6,T-cell differentiation antigen CD6,27984,196,1.07 [0.84-1.35],0.5775857196453151
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD63,CD63 antigen,27507,196,1.11 [0.87-1.41],0.4130545844940084
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD69,Early activation antigen CD69,27611,197,1.02 [0.88-1.17],0.8147778992248266
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD7,T-cell antigen CD7,23451,173,1.10 [0.78-1.54],0.5831056563434819
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD70,CD70 antigen,27699,197,0.96 [0.71-1.30],0.7911398730364788
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD72,B-cell differentiation antigen CD72,23677,173,1.25 [0.89-1.76],0.2001401305769636
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD74,HLA class II histocompatibility antigen gamma chain,27981,197,0.75 [0.52-1.09],0.1352116689905385
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD79B,B-cell antigen receptor complex-associated protein beta chain,28030,197,0.87 [0.65-1.18],0.3772361514280422
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD80,T-lymphocyte activation antigen CD80,24188,179,1.12 [0.74-1.70],0.5921530680033898
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD82,CD82 antigen,23735,176,0.97 [0.68-1.38],0.8621080267859674
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD83,CD83 antigen,27699,197,1.14 [0.79-1.65],0.4878269658946702
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD84,SLAM family member 5,27699,197,1.10 [0.73-1.65],0.6376786637739886
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD86,T-lymphocyte activation antigen CD86,24062,176,1.07 [0.65-1.74],0.7975375271949154
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD8A,T-cell surface glycoprotein CD8 alpha chain,27981,197,1.00 [0.77-1.29],0.9945533645285526
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD93,Complement component C1q receptor,26675,190,1.14 [0.75-1.72],0.5388136102892516
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD99,CD99 antigen,27746,198,1.30 [0.68-2.47],0.430057872948535
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD99L2,CD99 antigen-like protein 2,27746,198,1.37 [0.81-2.30],0.2377356560113236
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDA,Cytidine deaminase,24139,178,1.07 [0.80-1.43],0.6679149243718135
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDAN1,Codanin-1,24131,176,1.12 [0.64-1.97],0.6798469424468933
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDC123,Cell division cycle protein 123 homolog,23311,173,1.07 [0.87-1.31],0.5376298963516644
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDC25A,M-phase inducer phosphatase 1,23311,173,1.18 [0.87-1.60],0.294391710285904
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDC26,Anaphase-promoting complex subunit CDC26,24021,176,1.06 [0.86-1.30],0.5876197815697439
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDC27,Cell division cycle protein 27 homolog,27092,194,0.97 [0.78-1.20],0.7820368098234302
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDC37,Hsp90 co-chaperone Cdc37,27840,197,0.99 [0.85-1.15],0.9148374160034768
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDC42BPB,Serine/threonine-protein kinase MRCK beta,24062,176,1.01 [0.88-1.17],0.853284742849526
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDCP1,CUB domain-containing protein 1,27549,196,1.11 [0.86-1.43],0.4349196979700656
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH1,Cadherin-1,26803,183,1.10 [0.80-1.50],0.567036315180562
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH15,Cadherin-15,27930,197,1.02 [0.76-1.35],0.908245795217727
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH17,Cadherin-17,27743,197,1.03 [0.86-1.25],0.7190992818692677
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH2,Cadherin-2,27743,197,1.04 [0.73-1.49],0.8238680612188436
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH22,Cadherin-22,23735,176,1.10 [0.69-1.77],0.6808986717187058
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH23,Cadherin-23,24131,176,0.80 [0.46-1.40],0.436744047095113
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH3,Cadherin-3,27981,197,0.87 [0.60-1.24],0.4309117595616206
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH4,Cadherin-4,23404,170,1.05 [0.78-1.41],0.7503827346653325
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH5,Cadherin-5,28081,200,1.16 [0.78-1.74],0.4602520931850712
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH6,Cadherin-6,27743,197,1.02 [0.74-1.42],0.8893523020619812
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDHR1,Cadherin-related family member 1,27063,192,0.93 [0.69-1.27],0.6648565713877861
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDHR2,Cadherin-related family member 2,27620,196,0.96 [0.82-1.14],0.6581213311521622
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDHR5,Cadherin-related family member 5,27743,197,1.19 [0.85-1.65],0.3144575503262801
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDK1,Cyclin-dependent kinase 1,23311,173,1.07 [0.73-1.59],0.7190303142820482
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24149,177,1.17 [0.94-1.46],0.1703255619227244
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDKL5,Cyclin-dependent kinase-like 5,23404,170,1.15 [0.90-1.46],0.2724286310701894
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDKN1A,Cyclin-dependent kinase inhibitor 1,27620,196,0.99 [0.88-1.12],0.8714130091668052
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,27620,196,0.97 [0.85-1.11],0.6717418527204368
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDNF,Cerebral dopamine neurotrophic factor,27620,196,1.11 [0.75-1.65],0.5857126688850582
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,27794,196,2.00 [1.25-3.19],0.003768895085748
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDSN,Corneodesmosin,27937,195,1.27 [0.95-1.70],0.1072625136080499
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,27795,196,1.10 [0.63-1.91],0.7474680813843164
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24062,176,1.18 [0.98-1.41],0.0759500814234928
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,23735,176,0.94 [0.75-1.17],0.5592278200360501
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24062,176,1.14 [0.80-1.64],0.4720824425793205
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,23735,176,1.41 [1.09-1.82],0.0086621590050708
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,27699,197,0.91 [0.78-1.06],0.24138228370984
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,27092,194,0.89 [0.68-1.18],0.4242754993366493
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,26735,193,1.12 [0.92-1.36],0.2535629755723653
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24186,178,1.29 [0.92-1.80],0.1408230412260346
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,27233,194,1.12 [0.87-1.44],0.3648360739798768
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEBPA,CCAAT/enhancer-binding protein alpha,23501,175,1.38 [1.09-1.76],0.0084664048046093
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEBPB,CCAAT/enhancer-binding protein beta,27233,194,1.22 [0.90-1.66],0.204593718736468
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CELA2A,Chymotrypsin-like elastase family member 2A,24186,178,0.99 [0.78-1.27],0.9660300120864972
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CELA3A,Chymotrypsin-like elastase family member 3A,28033,200,0.97 [0.77-1.21],0.7663122245328623
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,23677,173,0.90 [0.54-1.50],0.6805829298889217
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEMIP2,Cell surface hyaluronidase,23501,175,1.03 [0.68-1.55],0.8887269121771343
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEND1,Cell cycle exit and neuronal differentiation protein 1,23404,170,0.95 [0.73-1.24],0.7136474294709401
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CENPF,Centromere protein F,23735,176,1.05 [0.81-1.36],0.7081165861228592
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CENPJ,Centromere protein J,23735,176,1.09 [0.90-1.30],0.3738047847651983
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP112,Centrosomal protein of 112 kDa,23421,172,1.03 [0.76-1.41],0.8405274434066315
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP152,Centrosomal protein of 152 kDa,23311,173,0.97 [0.69-1.36],0.8496730286101762
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP164,Centrosomal protein of 164 kDa,27187,191,1.08 [0.90-1.29],0.4067353034671535
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP170,Centrosomal protein of 170 kDa,23566,168,1.01 [0.84-1.23],0.9052815259155892
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP20,Centrosomal protein 20,27092,194,1.01 [0.85-1.20],0.9120697904208708
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP290,Centrosomal protein of 290 kDa,23735,176,1.14 [0.90-1.45],0.2865739558095592
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP350,Centrosome-associated protein 350,23311,173,1.12 [0.77-1.62],0.5617304676693948
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP43,Centrosomal protein 43,27013,193,1.07 [0.89-1.29],0.4426889148079775
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP85,Centrosomal protein of 85 kDa,27092,194,0.94 [0.77-1.16],0.5672130310314987
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CERT,Ceramide transfer protein,27063,192,1.03 [0.84-1.27],0.7861252656040882
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CES1,Liver carboxylesterase 1,27805,197,1.03 [0.87-1.21],0.7408134518261553
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CES2,Cocaine esterase,27620,196,0.90 [0.71-1.15],0.4142896055693722
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CES3,Carboxylesterase 3,27620,196,1.05 [0.88-1.26],0.5950520908067479
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CETN2,Centrin-2,27063,192,1.07 [0.89-1.29],0.4639420936716666
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CETN3,Centrin-3,24062,176,1.11 [0.93-1.33],0.2568833996726753
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFB,Complement factor B,23774,174,2.04 [1.31-3.17],0.0016063867901509
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFC1,Cryptic protein,27092,194,1.23 [0.96-1.56],0.0967347281773335
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFD,Complement factor D,24235,177,1.12 [0.53-2.39],0.7605374291817079
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFH,Complement factor H,22797,171,2.27 [1.21-4.26],0.0105876707688128
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFHR2,Complement factor H-related protein 2,24049,175,0.93 [0.73-1.20],0.5843444124899658
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFHR4,Complement factor H-related protein 4,24192,177,0.97 [0.80-1.18],0.7460803829437634
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFHR5,Complement factor H-related protein 5,23874,175,1.18 [0.83-1.69],0.3618604910133152
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFI,Complement factor I,24235,177,2.49 [1.22-5.07],0.0121340193716404
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFP,Properdin,24235,177,1.49 [0.96-2.30],0.076946567605707
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CGA,Glycoprotein hormones alpha chain,27746,198,1.35 [1.20-1.52],6.755739868863542e-07
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24199,176,1.10 [0.88-1.36],0.3953315404227414
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CGN,Cingulin,23510,172,0.89 [0.61-1.30],0.549463261718786
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CGREF1,Cell growth regulator with EF hand domain protein 1,27743,197,0.94 [0.70-1.28],0.7097488629575925
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,27092,194,0.97 [0.79-1.19],0.767698722158096
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHAD,Chondroadherin,23677,173,1.01 [0.77-1.33],0.9568642930851252
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24131,176,1.35 [0.96-1.90],0.0863882125260272
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHCHD6,MICOS complex subunit MIC25,24051,179,1.24 [0.80-1.93],0.3324278480060243
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHEK2,Serine/threonine-protein kinase Chk2,27233,194,1.00 [0.69-1.45],0.9933842383214168
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHGA,Chromogranin-A,24186,178,1.18 [1.02-1.37],0.0245432133851586
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHGB,Secretogranin-1,27878,197,1.09 [0.79-1.50],0.5975522840386378
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHI3L1,Chitinase-3-like protein 1,27107,190,1.08 [0.91-1.28],0.3933698623253842
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHIT1,Chitotriosidase-1,27852,200,1.02 [0.94-1.12],0.5978300292381544
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHL1,Neural cell adhesion molecule L1-like protein,27794,194,1.11 [0.75-1.64],0.5983988334107563
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHM,Rab proteins geranylgeranyltransferase component A 1,23510,172,1.17 [0.93-1.47],0.1866070849085986
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHMP1A,Charged multivesicular body protein 1a,27549,196,0.98 [0.84-1.15],0.8247613842325219
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHMP6,Charged multivesicular body protein 6,24188,179,1.12 [0.87-1.44],0.3933307427065128
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHP1,Calcineurin B homologous protein 1,23404,170,1.03 [0.85-1.25],0.776424004209721
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHRDL1,Chordin-like protein 1,27832,196,1.04 [0.69-1.57],0.8600883182152274
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHRDL2,Chordin-like protein 2,27743,197,0.76 [0.61-0.95],0.0138353218330944
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHRM1,Muscarinic acetylcholine receptor M1,23510,172,0.90 [0.59-1.35],0.6022444449272149
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CIAPIN1,Anamorsin,27840,197,1.04 [0.86-1.26],0.6959486866951538
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CILP,Cartilage intermediate layer protein 1,24186,178,0.92 [0.70-1.19],0.5112033840984603
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CINP,Cyclin-dependent kinase 2-interacting protein,23735,176,0.91 [0.65-1.28],0.5961097545183233
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CIRBP,Cold-inducible RNA-binding protein,24062,176,1.09 [0.93-1.26],0.2812168872814878
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CIT,Citron Rho-interacting kinase,23510,172,1.05 [0.77-1.43],0.7532301099155677
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CKAP4,Cytoskeleton-associated protein 4,27895,196,0.95 [0.58-1.55],0.8396374110279226
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CKB,Creatine kinase B-type,24186,178,1.04 [0.82-1.31],0.76736675276851
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",27653,195,0.92 [0.78-1.09],0.3140650355634499
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLASP1,CLIP-associating protein 1,23311,173,1.08 [0.89-1.30],0.4417872397162024
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLC,Galectin-10,27702,197,0.95 [0.79-1.15],0.6226047965106999
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC10A,C-type lectin domain family 10 member A,27549,196,1.10 [0.77-1.56],0.6154355245707865
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC11A,C-type lectin domain family 11 member A,27695,198,0.85 [0.66-1.11],0.2293167278517897
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC12A,C-type lectin domain family 12 member A,23501,175,1.27 [0.64-2.49],0.4928041144770845
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC14A,C-type lectin domain family 14 member A,27746,198,1.04 [0.70-1.56],0.8350210487604743
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC1A,C-type lectin domain family 1 member A,27233,194,1.15 [0.78-1.70],0.4746639454320752
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC1B,C-type lectin domain family 1 member B,27981,197,1.02 [0.89-1.16],0.7965111322642613
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC2L,C-type lectin domain family 2 member L,23510,172,1.07 [0.82-1.40],0.6163231279550153
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC3B,Tetranectin,23650,173,1.97 [1.06-3.64],0.0317186004589024
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC4A,C-type lectin domain family 4 member A,27699,197,1.30 [0.90-1.89],0.1681361038829538
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC4C,C-type lectin domain family 4 member C,27699,197,1.06 [0.80-1.39],0.6988266917862528
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC4D,C-type lectin domain family 4 member D,27699,197,1.00 [0.82-1.23],0.9781621181145947
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC4G,C-type lectin domain family 4 member G,27699,197,1.48 [1.02-2.15],0.0412934225708059
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC4M,C-type lectin domain family 4 member M,24139,177,1.06 [0.78-1.43],0.7210508283941293
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC5A,C-type lectin domain family 5 member A,27654,197,1.46 [0.95-2.24],0.0856108317283447
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC6A,C-type lectin domain family 6 member A,27092,194,1.07 [0.82-1.41],0.6186997457980028
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC7A,C-type lectin domain family 7 member A,28030,197,1.09 [0.86-1.37],0.4799463424307262
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLGN,Calmegin,23510,172,1.24 [0.91-1.69],0.1666407015009093
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLIC5,Chloride intracellular channel protein 5,23510,172,0.84 [0.51-1.36],0.4688168349813337
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLINT1,Clathrin interactor 1,23311,173,0.77 [0.54-1.11],0.1679592500024144
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLIP2,CAP-Gly domain-containing linker protein 2,27699,197,0.98 [0.88-1.10],0.7653453698165167
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLMP,CXADR-like membrane protein,27975,194,1.81 [0.99-3.32],0.0555603353877896
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLNS1A,Methylosome subunit pICln,23510,172,1.10 [0.72-1.68],0.648385988904236
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",27498,196,1.03 [0.90-1.17],0.7096460434158718
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLPS,Colipase,27705,197,1.01 [0.84-1.22],0.882017348481971
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLSPN,Claspin,27012,192,0.89 [0.59-1.32],0.5531927821091938
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLSTN1,Calsyntenin-1,27063,192,1.05 [0.83-1.33],0.6982787752939781
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLSTN2,Calsyntenin-2,28030,197,1.07 [0.78-1.47],0.6565959838879751
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLSTN3,Calsyntenin-3,24131,176,1.25 [0.80-1.93],0.3240439995187857
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLTA,Clathrin light chain A,27233,194,1.15 [0.90-1.48],0.269873168865898
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLU,Clusterin,24235,177,1.02 [0.67-1.57],0.9212789957107852
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLUL1,Clusterin-like protein 1,27702,197,1.01 [0.77-1.33],0.9490938787315638
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CMC1,COX assembly mitochondrial protein homolog,24188,179,1.08 [0.92-1.26],0.3563373822546755
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CMIP,C-Maf-inducing protein,24051,179,1.06 [0.89-1.25],0.5431256876219677
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNDP1,Beta-Ala-His dipeptidase,27837,194,1.00 [0.76-1.31],0.9794105231559188
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNGB3,Cyclic nucleotide-gated cation channel beta-3,23404,170,1.00 [0.77-1.30],0.9839411431799354
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",23520,168,1.13 [0.94-1.35],0.202665527361411
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNPY2,Protein canopy homolog 2,27233,194,1.10 [0.91-1.33],0.3414864384682372
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNPY4,Protein canopy homolog 4,27620,196,1.00 [0.85-1.19],0.9648690842884606
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNST,Consortin,27743,197,0.99 [0.89-1.12],0.92899873812042
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNTF,Ciliary neurotrophic factor,23404,170,0.84 [0.54-1.30],0.4302623604014265
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNTN1,Contactin-1,28081,200,1.21 [0.77-1.91],0.4136917808348025
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNTN2,Contactin-2,27975,194,1.01 [0.76-1.33],0.9673031045724598
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNTN3,Contactin-3,27746,198,1.75 [1.21-2.52],0.0027227136046782
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNTN4,Contactin-4,27746,198,2.34 [1.39-3.92],0.0012826240031015
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNTN5,Contactin-5,27806,196,1.33 [0.95-1.86],0.0942467380323077
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNTNAP2,Contactin-associated protein-like 2,27699,197,1.30 [0.96-1.76],0.0917764650955277
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNTNAP4,Contactin-associated protein-like 4,23510,172,1.04 [0.91-1.18],0.6110577144571714
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COCH,Cochlin,24188,179,1.21 [0.90-1.63],0.1988213628401622
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL15A1,Collagen alpha-1(XV) chain,24186,178,1.30 [0.75-2.25],0.3559685365756417
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL18A1,Collagen alpha-1(XVIII) chain,27857,200,1.05 [0.61-1.80],0.8550559716989876
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL1A1,Collagen alpha-1(I) chain,28081,200,1.25 [0.77-2.02],0.3656713298536257
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL24A1,Collagen alpha-1(XXIV) chain,24062,176,1.15 [0.88-1.51],0.2967202393863513
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL28A1,Collagen alpha-1(XXVIII) chain,23510,172,1.09 [0.89-1.33],0.3875414028394049
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL2A1,Collagen alpha-1(II) chain,23566,168,1.03 [0.86-1.23],0.7612857884991167
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL3A1,Collagen alpha-1(III) chain,24186,178,0.80 [0.43-1.49],0.4901189950119098
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL4A1,Collagen alpha-1(IV) chain,27743,197,1.10 [0.81-1.50],0.5429824769246744
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL4A4,Collagen alpha-4(IV) chain,23695,176,1.05 [0.80-1.39],0.7138919715031286
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL5A1,Collagen alpha-1(V) chain,23677,173,0.76 [0.52-1.12],0.1612861202253086
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL6A3,Collagen alpha-3(VI) chain,28081,200,1.23 [0.86-1.76],0.2672014743379061
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL9A1,Collagen alpha-1(IX) chain,27699,197,0.93 [0.71-1.23],0.6215027997841359
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL9A2,Collagen alpha-2(IX) chain,23735,176,1.11 [0.84-1.48],0.4598326045534504
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COLEC12,Collectin-12,27745,195,1.46 [0.89-2.39],0.1325399634552681
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COMMD1,COMM domain-containing protein 1,23566,168,1.13 [0.90-1.43],0.3017989790811501
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COMMD9,COMM domain-containing protein 9,24051,179,1.02 [0.72-1.46],0.8949860202816469
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COMP,Cartilage oligomeric matrix protein,27431,191,1.22 [0.83-1.77],0.3085936822030808
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COMT,Catechol O-methyltransferase,26945,193,1.05 [0.90-1.22],0.5266973510346853
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COPB2,Coatomer subunit beta',23421,172,0.94 [0.66-1.33],0.7296310197695401
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COPE,Coatomer subunit epsilon,27063,192,1.11 [0.87-1.41],0.4189097471137875
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",23566,168,1.12 [0.82-1.52],0.4812386364319666
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CORO1A,Coronin-1A,27157,198,1.01 [0.88-1.16],0.9151599803658862
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CORO6,Coronin-6,23404,170,0.79 [0.51-1.22],0.2918183944549546
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",27620,196,1.12 [0.94-1.34],0.1884240174239784
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COX6B1,Cytochrome c oxidase subunit 6B1,24188,179,0.98 [0.63-1.53],0.9432126566749318
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPA1,Carboxypeptidase A1,28081,200,1.10 [0.89-1.37],0.3806136354565613
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPA2,Carboxypeptidase A2,27882,197,0.93 [0.76-1.13],0.462247443229577
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPA4,Carboxypeptidase A4,23194,171,1.06 [0.75-1.49],0.7347923996575186
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPB1,Carboxypeptidase B,28081,200,0.97 [0.78-1.22],0.8023681475209007
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPB2,Carboxypeptidase B2,24183,177,2.38 [1.29-4.37],0.0053356143602451
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPE,Carboxypeptidase E,27769,194,0.86 [0.63-1.17],0.334069996987937
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPLX2,Complexin-2,23311,173,1.35 [0.93-1.96],0.1112959483502779
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPM,Carboxypeptidase M,27848,197,1.52 [1.07-2.16],0.0193162001794412
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",23501,175,1.44 [0.90-2.30],0.1292794840853793
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPPED1,Serine/threonine-protein phosphatase CPPED1,27981,197,1.17 [0.97-1.41],0.0916006430992497
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPQ,Carboxypeptidase Q,24138,178,0.99 [0.67-1.47],0.9572333464643676
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPTP,Ceramide-1-phosphate transfer protein,23421,172,0.91 [0.63-1.32],0.6108142286022973
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPVL,Probable serine carboxypeptidase CPVL,27938,194,1.12 [0.81-1.53],0.4946356647440443
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPXM1,Probable carboxypeptidase X1,27840,197,1.10 [0.92-1.32],0.3115297748697673
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPXM2,Inactive carboxypeptidase-like protein X2,24188,179,1.26 [0.72-2.19],0.4210855956498313
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CR1,Complement receptor type 1,24105,175,1.20 [0.82-1.76],0.3514765217403846
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CR2,Complement receptor type 2,27837,194,1.03 [0.79-1.36],0.8228257494485443
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,27092,194,0.92 [0.79-1.08],0.3154173261560697
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRADD,Death domain-containing protein CRADD,27498,196,1.06 [0.90-1.25],0.4867934155315699
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CREB3,Cyclic AMP-responsive element-binding protein 3,23311,173,1.14 [0.90-1.43],0.2788829032618675
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CREBZF,CREB/ATF bZIP transcription factor,23311,173,1.39 [0.86-2.23],0.1795615249688863
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CREG1,Protein CREG1,27390,196,1.07 [0.76-1.50],0.7108283354674926
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRELD1,Protein disulfide isomerase CRELD1,23677,173,0.97 [0.66-1.43],0.8847367579408308
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRELD2,Protein disulfide isomerase CRELD2,27832,196,1.00 [0.78-1.27],0.9679234582775254
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRH,Corticoliberin,27045,194,0.81 [0.70-0.95],0.0081317397981643
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRHBP,Corticotropin-releasing factor-binding protein,27745,195,1.13 [0.72-1.77],0.5881224094958609
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRHR1,Corticotropin-releasing factor receptor 1,27233,194,1.04 [0.85-1.26],0.7119553509024761
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRIM1,Cysteine-rich motor neuron 1 protein,27880,196,0.95 [0.51-1.76],0.8708954468941615
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRIP2,Cysteine-rich protein 2,27549,196,1.13 [0.81-1.58],0.4731590595672058
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRISP2,Cysteine-rich secretory protein 2,27975,194,0.92 [0.75-1.13],0.4143931212896825
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRISP3,Cysteine-rich secretory protein 3,23974,175,0.89 [0.52-1.52],0.6658648581153497
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRKL,Crk-like protein,27792,196,0.99 [0.88-1.11],0.8514507413951972
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRLF1,Cytokine receptor-like factor 1,27880,196,0.85 [0.53-1.35],0.493440538108205
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRNN,Cornulin,26941,188,1.13 [0.92-1.37],0.2411153541156905
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRTAC1,Cartilage acidic protein 1,28081,200,0.78 [0.52-1.17],0.2324928940840671
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRTAM,Cytotoxic and regulatory T-cell molecule,27549,196,0.80 [0.62-1.03],0.0844951195363107
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRTAP,Cartilage-associated protein,23510,172,1.03 [0.77-1.37],0.8531688033437216
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRX,Cone-rod homeobox protein,27233,194,1.14 [1.04-1.25],0.0065770185755161
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRYBB1,Beta-crystallin B1,24188,179,1.04 [0.83-1.29],0.7501770093742812
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRYBB2,Beta-crystallin B2,24131,176,0.92 [0.71-1.19],0.51949410864531
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRYGD,Gamma-crystallin D,24131,176,0.99 [0.85-1.15],0.8651774800282215
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRYM,Ketimine reductase mu-crystallin,23404,170,0.98 [0.81-1.19],0.8373671014504858
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRYZL1,Quinone oxidoreductase-like protein 1,23566,168,1.02 [0.87-1.20],0.8015616002505239
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSDE1,Cold shock domain-containing protein E1,23421,172,1.06 [0.95-1.19],0.2824300901441753
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSF1,Macrophage colony-stimulating factor 1,27880,196,1.13 [0.71-1.79],0.6009304972563474
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSF1R,Macrophage colony-stimulating factor 1 receptor,24199,176,1.37 [0.97-1.95],0.0768629760439393
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSF2,Granulocyte-macrophage colony-stimulating factor,23421,172,1.03 [0.69-1.54],0.892516996099524
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,27549,196,1.25 [1.04-1.51],0.0203116374693363
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSF2RB,Cytokine receptor common subunit beta,23501,175,1.11 [0.80-1.55],0.5240676501063483
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSF3,Granulocyte colony-stimulating factor,27187,191,1.21 [0.94-1.56],0.1323415767749255
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSF3R,Granulocyte colony-stimulating factor receptor,23501,175,1.17 [0.76-1.82],0.4729005415371399
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSH1,Chorionic somatomammotropin hormone 1,24199,176,0.90 [0.58-1.40],0.6514684543411171
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSNK1D,Casein kinase I isoform delta,23501,175,1.13 [0.92-1.40],0.2492229072882525
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSNK2A1,Casein kinase II subunit alpha,24149,177,1.15 [0.84-1.57],0.3716636348536772
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSPG4,Chondroitin sulfate proteoglycan 4,24186,178,0.80 [0.52-1.23],0.3062364385463699
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSPG5,Chondroitin sulfate proteoglycan 5,23404,170,0.93 [0.68-1.27],0.635620298890005
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSRP3,Cysteine and glycine-rich protein 3,23421,172,0.96 [0.82-1.13],0.6326182071308499
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CST1,Cystatin-SN,20974,162,1.06 [0.91-1.24],0.4759842719749849
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CST3,Cystatin-C,27796,191,1.23 [0.78-1.94],0.3686995704613459
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CST5,Cystatin-D,27271,190,0.99 [0.78-1.25],0.921982845077386
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CST6,Cystatin-M,27004,194,1.07 [0.81-1.40],0.6421682740535346
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CST7,Cystatin-F,27790,196,1.02 [0.89-1.17],0.7544293185859238
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSTB,Cystatin-B,27358,198,1.24 [0.93-1.66],0.1421413945112275
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTAG1A_CTAG1B,Cancer/testis antigen 1,23688,176,0.99 [0.74-1.32],0.9395266818206484
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTBS,Di-N-acetylchitobiase,23838,175,1.09 [0.64-1.87],0.7449218983510768
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTF1,Cardiotrophin-1,27233,194,1.07 [0.93-1.24],0.3536596299992849
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTHRC1,Collagen triple helix repeat-containing protein 1,24186,178,1.35 [0.81-2.23],0.2503248329075486
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTLA4,Cytotoxic T-lymphocyte protein 4,24186,178,0.72 [0.44-1.18],0.1961879405014321
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTNNA1,Catenin alpha-1,23404,170,1.01 [0.68-1.51],0.9428057772408835
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTRB1,Chymotrypsinogen B,27746,198,1.11 [0.88-1.41],0.3657239023688995
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTRC,Chymotrypsin-C,27748,196,0.93 [0.76-1.14],0.4849368314113452
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTRL,Chymotrypsin-like protease CTRL-1,24131,176,0.90 [0.72-1.12],0.330239051346578
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSB,Cathepsin B,27772,199,1.00 [0.79-1.26],0.9967637821218897
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSC,Dipeptidyl peptidase 1,27709,195,1.04 [0.77-1.39],0.8140850910576191
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSD,Cathepsin D,25901,179,0.85 [0.59-1.22],0.3697685087547878
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSE,Cathepsin E,23677,173,0.90 [0.68-1.20],0.4723980043336567
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSF,Cathepsin F,27840,197,0.90 [0.66-1.22],0.4877583053015784
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSH,Pro-cathepsin H,27153,193,1.07 [0.89-1.27],0.4728586818237605
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSL,Cathepsin L1,27743,197,1.61 [0.97-2.69],0.065446033677121
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSO,Cathepsin O,28030,197,0.90 [0.60-1.37],0.6299406832043761
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSS,Cathepsin S,21767,154,1.08 [0.57-2.05],0.8175290539824743
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSV,Cathepsin L2,27895,194,0.81 [0.60-1.09],0.1645404303216523
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSZ,Cathepsin Z,27743,193,1.04 [0.69-1.57],0.8425903676041196
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CUZD1,CUB and zona pellucida-like domain-containing protein 1,23510,172,1.11 [0.75-1.62],0.6087378170606392
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CWC15,Spliceosome-associated protein CWC15 homolog,23924,176,1.15 [0.95-1.41],0.1531774138000409
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CX3CL1,Fractalkine,27549,196,0.79 [0.54-1.16],0.2276895983421665
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXADR,Coxsackievirus and adenovirus receptor,27699,197,0.98 [0.77-1.25],0.8706484864638562
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL1,Growth-regulated alpha protein,27701,195,1.04 [0.92-1.18],0.546279412109309
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL10,C-X-C motif chemokine 10,27880,196,1.04 [0.87-1.25],0.6379334120543994
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL11,C-X-C motif chemokine 11,27981,197,0.98 [0.83-1.14],0.7751515452273857
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL12,Stromal cell-derived factor 1,27187,191,0.79 [0.57-1.08],0.1432397628526797
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL13,C-X-C motif chemokine 13,27981,197,0.89 [0.72-1.10],0.2745026255400977
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL14,C-X-C motif chemokine 14,27187,191,1.04 [0.85-1.26],0.7211743201771794
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL16,C-X-C motif chemokine 16,28034,200,1.46 [0.87-2.45],0.1562499904550095
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL17,C-X-C motif chemokine 17,28030,197,1.14 [0.86-1.49],0.3663444362639074
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL3,C-X-C motif chemokine 3,27742,196,1.01 [0.88-1.15],0.911379599318253
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL5,C-X-C motif chemokine 5,27654,195,1.09 [0.97-1.21],0.1337354165779697
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL6,C-X-C motif chemokine 6,28030,197,1.08 [0.92-1.27],0.3214328976206901
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL8,Interleukin-8,27514,191,1.15 [0.97-1.37],0.0987905825423006
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL9,C-X-C motif chemokine 9,27880,196,1.13 [0.95-1.35],0.1559087506991746
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CYB5A,Cytochrome b5,23311,173,0.92 [0.74-1.13],0.4226783891725797
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CYB5R2,NADH-cytochrome b5 reductase 2,23774,174,1.22 [0.95-1.56],0.1204975099003927
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",23421,172,1.13 [0.98-1.30],0.0970400469132139
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CYTH3,Cytohesin-3,23311,173,1.11 [0.93-1.33],0.2483172561185448
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CYTL1,Cytokine-like protein 1,24186,178,0.89 [0.48-1.66],0.7111499911789354
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DAAM1,Disheveled-associated activator of morphogenesis 1,23677,173,1.00 [0.84-1.20],0.9727177644601646
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DAB2,Disabled homolog 2,27975,194,0.99 [0.88-1.10],0.7993203233531722
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DAG1,Dystroglycan,27880,196,1.04 [0.80-1.35],0.7873053429350498
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DAND5,DAN domain family member 5,23501,175,1.11 [0.87-1.42],0.3987944797893927
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DAPK2,Death-associated protein kinase 2,23501,175,1.05 [0.82-1.35],0.6847957054868541
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,27699,197,1.01 [0.91-1.13],0.7956253679638761
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DARS1,"Aspartate--tRNA ligase, cytoplasmic",27498,196,0.97 [0.82-1.15],0.7225686926913758
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DBH,Dopamine beta-hydroxylase,24150,175,0.86 [0.77-0.97],0.011454958003913
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DBI,Acyl-CoA-binding protein,27614,197,1.10 [0.94-1.29],0.230102148336626
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DBN1,Drebrin,23501,175,1.19 [0.91-1.55],0.2034628391890207
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DBNL,Drebrin-like protein,27880,196,0.98 [0.85-1.12],0.7429822505887593
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",27840,197,1.04 [0.73-1.48],0.8363049735060673
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCC,Netrin receptor DCC,23510,172,0.76 [0.37-1.55],0.4485523495082105
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCDC2C,Doublecortin domain-containing protein 2C,23311,173,1.19 [0.98-1.45],0.0809307830144784
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCLRE1C,Protein artemis,23311,173,1.49 [1.03-2.16],0.0327725663162268
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCN,Decorin,27233,194,1.04 [0.59-1.84],0.885321985333239
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCTD,Deoxycytidylate deaminase,23677,173,1.03 [0.88-1.20],0.7513872829995234
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCTN1,Dynactin subunit 1,27975,194,0.96 [0.79-1.17],0.6963239724486194
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCTN2,Dynactin subunit 2,27620,196,0.98 [0.85-1.12],0.7335922535680026
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCTN6,Dynactin subunit 6,27063,192,0.94 [0.78-1.13],0.5146185649084776
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCTPP1,dCTP pyrophosphatase 1,27743,197,1.19 [0.80-1.77],0.3882630575462809
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCUN1D1,DCN1-like protein 1,23404,170,1.04 [0.86-1.25],0.7129103821943054
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCUN1D2,DCN1-like protein 2,23311,173,0.94 [0.78-1.13],0.5068017585123719
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCXR,L-xylulose reductase,27840,197,1.13 [0.90-1.43],0.2869413131723196
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDA1,DET1- and DDB1-associated protein 1,23421,172,1.06 [0.75-1.49],0.7524568519251094
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",27620,196,1.31 [1.01-1.70],0.0412775441894131
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDC,Aromatic-L-amino-acid decarboxylase,27698,197,1.25 [0.97-1.60],0.0839112871645451
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDHD2,Phospholipase DDHD2,24149,177,1.12 [0.90-1.39],0.3065285241365433
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDI2,Protein DDI1 homolog 2,23677,173,0.98 [0.81-1.17],0.7913638364978907
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDR1,Epithelial discoidin domain-containing receptor 1,27981,197,1.13 [0.67-1.92],0.6432370279677865
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDT,D-dopachrome decarboxylase,24186,178,1.24 [0.89-1.71],0.2051891640827856
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDX1,ATP-dependent RNA helicase DDX1,24062,176,1.15 [0.90-1.47],0.2661285290355075
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDX25,ATP-dependent RNA helicase DDX25,23510,172,1.12 [0.80-1.57],0.5183293951509501
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDX39A,ATP-dependent RNA helicase DDX39A,23501,175,1.87 [1.16-3.00],0.0100517117556068
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDX4,Probable ATP-dependent RNA helicase DDX4,23501,175,1.21 [0.97-1.51],0.0873905346426477
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDX53,Probable ATP-dependent RNA helicase DDX53,23510,172,0.95 [0.63-1.44],0.820928754518686
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDX58,Antiviral innate immune response receptor RIG-I,27092,194,1.10 [0.90-1.35],0.3503308004410422
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",27699,197,1.04 [0.91-1.18],0.5612784293530687
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DEFA1_DEFA1B,Neutrophil defensin 1,27168,186,0.92 [0.71-1.19],0.5378720420588199
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DEFB103A_DEFB103B,Beta-defensin 103,23320,174,1.35 [1.04-1.75],0.025038955301293
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DEFB104A_DEFB104B,Beta-defensin 104,23404,170,1.09 [0.86-1.38],0.4940475513525677
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DEFB116,Beta-defensin 116,23404,170,0.91 [0.74-1.12],0.3923229156524721
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DEFB118,Beta-defensin 118,23404,170,0.97 [0.75-1.26],0.824605767486407
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DEFB4A_DEFB4B,Beta-defensin 4A,27366,194,1.04 [0.95-1.13],0.3717047569594767
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DENND2B,DENN domain-containing protein 2B,23421,172,1.20 [0.95-1.51],0.1288820093815101
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DENR,Density-regulated protein,23501,175,1.00 [0.78-1.29],0.997069804719442
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DFFA,DNA fragmentation factor subunit alpha,28030,197,1.03 [0.85-1.23],0.7837772088537979
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DGCR6,Protein DGCR6,23404,170,0.92 [0.65-1.29],0.6294090542180764
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DGKA,Diacylglycerol kinase alpha,23501,175,1.12 [0.86-1.46],0.3998964521510242
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DGKZ,Diacylglycerol kinase zeta,27187,191,0.86 [0.60-1.26],0.445511061628588
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DHODH,Dihydroorotate dehydrogenase,23421,172,1.10 [0.83-1.45],0.5155801200778385
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DHPS,Deoxyhypusine synthase,24051,179,1.00 [0.71-1.40],0.9840509315916192
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24131,176,1.06 [0.80-1.42],0.6801496911822777
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DIABLO,"Diablo homolog, mitochondrial",27654,197,1.01 [0.90-1.13],0.9198104115455592
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DIPK1C,Divergent protein kinase domain 1C,23510,172,0.98 [0.70-1.38],0.9179811189063498
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DIPK2B,Divergent protein kinase domain 2B,23677,173,1.41 [0.83-2.38],0.1986141054929717
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DKK1,Dickkopf-related protein 1,27981,197,1.14 [0.93-1.41],0.2013355622503543
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DKK3,Dickkopf-related protein 3,28081,200,0.83 [0.54-1.28],0.4057873741958641
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DKK4,Dickkopf-related protein 4,27508,196,0.83 [0.62-1.10],0.1955880326055989
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DKKL1,Dickkopf-like protein 1,27620,196,0.94 [0.82-1.08],0.3950920570265799
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DLG4,Disks large homolog 4,24131,176,1.02 [0.83-1.25],0.8638049359014943
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DLGAP5,Disks large-associated protein 5,24149,177,1.11 [0.89-1.39],0.3455835582269866
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DLK1,Protein delta homolog 1,28081,200,1.16 [0.92-1.46],0.2221708240435961
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DLL1,Delta-like protein 1,27840,197,1.10 [0.72-1.69],0.6637701017927737
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DLL4,Delta-like protein 4,23566,168,1.09 [0.95-1.25],0.2364191179249333
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DMD,Dystrophin,23566,168,1.06 [0.81-1.40],0.6628525638521772
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DMP1,Dentin matrix acidic phosphoprotein 1,23566,168,0.83 [0.67-1.03],0.0836576248623578
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJA1,DnaJ homolog subfamily A member 1,23311,173,1.33 [1.05-1.68],0.0198984033752543
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJA2,DnaJ homolog subfamily A member 2,27941,197,0.98 [0.84-1.14],0.8052769867791024
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJA4,DnaJ homolog subfamily A member 4,24131,176,1.15 [0.95-1.39],0.1410843274593273
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJB1,DnaJ homolog subfamily B member 1,27620,196,1.04 [0.91-1.20],0.5533445576051735
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJB14,DnaJ homolog subfamily B member 14,24062,176,1.08 [0.87-1.33],0.5013019335313924
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJB2,DnaJ homolog subfamily B member 2,23677,173,1.06 [0.82-1.38],0.6581258546116416
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJB6,DnaJ homolog subfamily B member 6,23450,172,1.04 [0.88-1.24],0.6250666532642397
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJB8,DnaJ homolog subfamily B member 8,27233,194,1.13 [0.93-1.38],0.2163037856045903
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJC21,DnaJ homolog subfamily C member 21,24131,176,1.09 [0.75-1.57],0.6588606454316944
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJC6,Putative tyrosine-protein phosphatase auxilin,23566,168,1.09 [0.92-1.30],0.3222581409354934
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJC9,DnaJ homolog subfamily C member 9,24062,176,1.13 [0.94-1.36],0.1802919567076973
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNER,Delta and Notch-like epidermal growth factor-related receptor,27700,195,1.27 [0.76-2.12],0.3520938372087627
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNLZ,DNL-type zinc finger protein,23404,170,0.90 [0.75-1.07],0.2349267964699558
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNM1,Dynamin-1,24062,176,1.04 [0.92-1.18],0.5488180350217773
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNM3,Dynamin-3,24149,177,0.95 [0.73-1.24],0.7166176081509505
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNMBP,Dynamin-binding protein,27549,196,0.98 [0.80-1.20],0.821282421589306
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNPEP,Aspartyl aminopeptidase,24131,176,1.08 [0.84-1.38],0.5433486779148928
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,27840,196,1.07 [0.85-1.36],0.5536707676006998
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DOC2B,Double C2-like domain-containing protein beta,23510,172,1.04 [0.70-1.55],0.8380566024036862
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DOCK9,Dedicator of cytokinesis protein 9,23404,170,1.00 [0.89-1.14],0.9441302509340188
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DOK1,Docking protein 1,24131,176,1.03 [0.93-1.15],0.582702790289824
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DOK2,Docking protein 2,27743,197,0.99 [0.89-1.09],0.7962581197451271
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DPEP1,Dipeptidase 1,27498,196,1.26 [0.97-1.63],0.0796228910886513
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DPEP2,Dipeptidase 2,27620,196,0.83 [0.53-1.30],0.4227900605515018
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DPP10,Inactive dipeptidyl peptidase 10,27699,197,0.97 [0.67-1.40],0.8534593193154686
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DPP4,Dipeptidyl peptidase 4,27211,191,1.73 [1.14-2.63],0.0106173721708937
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DPP6,Dipeptidyl aminopeptidase-like protein 6,27620,196,1.00 [0.68-1.47],0.9986468507500902
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DPP7,Dipeptidyl peptidase 2,27509,197,0.98 [0.79-1.21],0.8493201728998023
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DPT,Dermatopontin,28081,200,1.04 [0.65-1.66],0.8752731158861622
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DPY30,Protein dpy-30 homolog,27878,193,1.11 [0.91-1.36],0.3159146820162193
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DRAXIN,Draxin,27549,196,0.94 [0.70-1.26],0.6801833497483115
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DRG2,Developmentally-regulated GTP-binding protein 2,27620,196,1.05 [0.84-1.32],0.6416042377709312
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DSC2,Desmocollin-2,27456,197,1.03 [0.71-1.51],0.8631588997699655
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DSCAM,Down syndrome cell adhesion molecule,24149,177,0.99 [0.66-1.48],0.9422572693330152
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DSG2,Desmoglein-2,27746,198,1.02 [0.64-1.63],0.9199587671875132
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DSG3,Desmoglein-3,27885,193,1.12 [0.76-1.63],0.5698776283195618
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DSG4,Desmoglein-4,27534,195,1.17 [0.91-1.50],0.228095458564515
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DTD1,D-aminoacyl-tRNA deacylase 1,23677,173,1.02 [0.86-1.21],0.8025444839775813
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DTNB,Dystrobrevin beta,24010,179,1.19 [0.87-1.64],0.274589299480751
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DTX2,Probable E3 ubiquitin-protein ligase DTX2,23510,172,1.15 [0.96-1.38],0.1344881624978952
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DTX3,Probable E3 ubiquitin-protein ligase DTX3,27620,196,1.52 [0.93-2.51],0.0977244811930529
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DTYMK,Thymidylate kinase,24188,179,1.13 [0.93-1.39],0.2231822745692498
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DUOX2,Dual oxidase 2,27233,194,0.84 [0.69-1.03],0.0934852583558568
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DUSP13,Dual specificity protein phosphatase 13 isoform A,24051,179,1.18 [0.85-1.64],0.3179390602699929
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DUSP29,Dual specificity phosphatase 29,23510,172,1.15 [0.95-1.39],0.1483410037146336
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DUSP3,Dual specificity protein phosphatase 3,27063,192,1.03 [0.89-1.19],0.6825089242683975
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24062,176,1.01 [0.88-1.16],0.8712990488206853
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DXO,Decapping and exoribonuclease protein,24131,176,1.25 [0.92-1.69],0.1550766866677307
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24051,179,1.06 [0.80-1.40],0.6986284397470495
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DYNLT1,Dynein light chain Tctex-type 1,23510,172,1.14 [0.97-1.35],0.1164715893386755
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DYNLT3,Dynein light chain Tctex-type 3,24051,179,1.22 [0.89-1.66],0.2218872798578964
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,27549,196,1.03 [0.90-1.17],0.7022384005507202
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EBI3_IL27,Interleukin-27,27926,194,0.74 [0.49-1.13],0.1619407564622067
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ECE1,Endothelin-converting enzyme 1,27063,192,0.80 [0.56-1.16],0.2410070199620654
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24188,179,0.93 [0.76-1.14],0.4873412247793216
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ECHS1,"Enoyl-CoA hydratase, mitochondrial",23566,168,1.04 [0.90-1.22],0.5676005305490472
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ECI2,Enoyl-CoA delta isomerase 2,23421,172,0.98 [0.78-1.24],0.8744684879734576
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ECM1,Extracellular matrix protein 1,23543,171,1.00 [0.67-1.50],0.9976493019714766
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ECSCR,Endothelial cell-specific chemotaxis regulator,23404,170,1.09 [0.84-1.42],0.5231494661487347
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EDA2R,Tumor necrosis factor receptor superfamily member 27,27975,194,1.03 [0.71-1.48],0.8808839891930649
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EDAR,Tumor necrosis factor receptor superfamily member EDAR,27699,197,1.11 [0.97-1.26],0.1450078531571064
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EDDM3B,Epididymal secretory protein E3-beta,24051,179,0.89 [0.63-1.26],0.5034756366236673
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,23421,172,1.05 [0.72-1.55],0.7890223151699762
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EDF1,Endothelial differentiation-related factor 1,24149,177,1.10 [0.92-1.33],0.2931496471320495
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,27233,194,1.36 [0.96-1.91],0.0793889053804127
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EDN1,Endothelin-1,23566,168,1.65 [1.02-2.67],0.0428977514605623
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EDNRB,Endothelin receptor type B,23501,175,1.19 [0.92-1.55],0.1892776123323571
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EEF1D,Elongation factor 1-delta,24188,179,0.98 [0.84-1.14],0.786678374791376
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EFCAB14,EF-hand calcium-binding domain-containing protein 14,24062,176,1.48 [0.95-2.32],0.0837963038105599
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EFCAB2,Dynein regulatory complex protein 8,23735,176,1.25 [0.85-1.82],0.259930142649176
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,27790,194,1.01 [0.67-1.54],0.9579660547945184
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EFHD1,EF-hand domain-containing protein D1,24149,177,0.97 [0.64-1.47],0.8919108468501433
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EFNA1,Ephrin-A1,27704,197,1.02 [0.63-1.63],0.9407455177377966
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EFNA4,Ephrin-A4,27507,196,1.11 [0.71-1.73],0.6418134242304522
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EFNB2,Ephrin-B2,23510,172,1.01 [0.79-1.28],0.9631396664363104
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EGF,Pro-epidermal growth factor,27701,196,1.00 [0.89-1.13],0.982122369426328
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EGFL7,Epidermal growth factor-like protein 7,27092,194,0.96 [0.70-1.32],0.7974962636398107
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EGFLAM,Pikachurin,24062,176,1.03 [0.65-1.63],0.9036037883018992
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EGFR,Epidermal growth factor receptor,28081,200,1.72 [0.80-3.69],0.1656956244965122
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EGLN1,Egl nine homolog 1,27699,197,1.09 [0.88-1.34],0.4405676174748424
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EHBP1,EH domain-binding protein 1,24188,179,0.98 [0.81-1.19],0.8307128651679361
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EHD3,EH domain-containing protein 3,23566,168,1.03 [0.91-1.17],0.6183356289850459
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24131,176,1.13 [0.89-1.43],0.3165751335544148
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",23974,174,1.06 [0.93-1.21],0.3714808313488341
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,23421,172,0.98 [0.79-1.22],0.8591429917855731
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,23566,168,1.26 [0.91-1.72],0.1603789504996682
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF4B,Eukaryotic translation initiation factor 4B,27549,196,1.04 [0.84-1.29],0.7066879204099508
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF4E,Eukaryotic translation initiation factor 4E,23501,175,1.05 [0.90-1.24],0.5156491446215272
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,27743,197,1.08 [0.89-1.30],0.4239976132426991
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,28030,197,0.99 [0.87-1.12],0.8197868110869556
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24149,177,1.02 [0.82-1.26],0.8818782173917615
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF5,Eukaryotic translation initiation factor 5,23421,172,1.11 [0.82-1.52],0.4993871275799781
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF5A,Eukaryotic translation initiation factor 5A-1,27187,191,1.28 [0.86-1.90],0.2239346483206096
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ELAC1,Zinc phosphodiesterase ELAC protein 1,24149,177,1.09 [0.92-1.29],0.321970407815355
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ELAVL4,ELAV-like protein 4,23404,170,0.97 [0.82-1.15],0.7412291050786345
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ELN,Elastin,24188,179,1.44 [0.96-2.15],0.074341352297542
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ELOA,Elongin-A,27620,196,1.08 [0.87-1.35],0.4678070732442847
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ELOB,Elongin-B,23421,172,0.97 [0.67-1.40],0.8799785417116005
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENAH,Protein enabled homolog,27187,191,1.32 [1.03-1.69],0.029432187106271
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENDOU,Poly(U)-specific endoribonuclease,22332,166,1.22 [0.92-1.62],0.1585246614063367
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENG,Endoglin,28081,200,1.32 [0.64-2.72],0.4511105071032405
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENO1,Alpha-enolase,27697,195,1.00 [0.85-1.17],0.9991436420676566
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENO2,Gamma-enolase,27981,197,1.02 [0.85-1.24],0.8188608316821847
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENO3,Beta-enolase,23566,168,0.98 [0.75-1.28],0.875808067462354
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENOPH1,Enolase-phosphatase E1,24051,179,1.02 [0.80-1.30],0.8779343266848627
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,23421,172,0.90 [0.53-1.55],0.709591194083537
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENPEP,Glutamyl aminopeptidase,23421,172,1.09 [0.81-1.47],0.5628422913934372
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,28081,200,1.14 [0.76-1.71],0.5380936967550676
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,27880,196,0.98 [0.73-1.33],0.9148545896693868
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,23566,168,1.24 [0.83-1.87],0.2920167095561057
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,26875,189,1.01 [0.88-1.17],0.844914867855034
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENSA,Alpha-endosulfine,24051,179,1.05 [0.80-1.37],0.7236039820050884
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,27092,194,1.21 [0.91-1.61],0.1814461035947092
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,27233,194,1.30 [0.70-2.40],0.407381094873783
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,27233,194,1.12 [0.69-1.81],0.6462997353945759
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENTR1,Endosome-associated-trafficking regulator 1,23566,168,1.07 [0.83-1.38],0.5943415520975721
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EP300,Histone acetyltransferase p300,23501,175,1.01 [0.63-1.63],0.9531031860310456
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPB41L5,Band 4.1-like protein 5,23510,172,1.04 [0.84-1.29],0.7142742683225141
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPCAM,Epithelial cell adhesion molecule,27750,196,0.91 [0.80-1.04],0.153797084174506
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPGN,Epigen,24051,179,1.04 [0.79-1.38],0.7852487222519673
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPHA1,Ephrin type-A receptor 1,27840,196,0.90 [0.62-1.29],0.5530739034028989
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPHA10,Ephrin type-A receptor 10,27063,192,1.06 [0.88-1.27],0.5484412093535439
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPHA2,Ephrin type-A receptor 2,26761,188,1.16 [0.76-1.77],0.4856992376610901
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPHA4,Ephrin type-A receptor 4,23677,173,0.99 [0.59-1.68],0.984679998141805
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPHB4,Ephrin type-B receptor 4,28081,200,1.04 [0.62-1.73],0.885279371075361
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPHB6,Ephrin type-B receptor 6,27498,196,0.85 [0.56-1.28],0.4296151025428721
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPHX2,Bifunctional epoxide hydrolase 2,27233,194,0.89 [0.72-1.11],0.3096222522297579
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPN1,Epsin-1,23735,176,0.86 [0.60-1.23],0.4028298653993291
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPO,Erythropoietin,27699,197,1.14 [0.99-1.31],0.0666240088881506
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPPK1,Epiplakin,23566,168,1.09 [0.90-1.33],0.3682557808808859
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,27927,193,1.27 [0.85-1.92],0.2457000858685551
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERBB2,Receptor tyrosine-protein kinase erbB-2,27840,197,1.19 [0.72-1.96],0.4980040603003398
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERBB3,Receptor tyrosine-protein kinase erbB-3,27664,196,2.51 [1.35-4.66],0.0034782988690178
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERBB4,Receptor tyrosine-protein kinase erbB-4,27840,197,1.17 [0.70-1.95],0.5481943616951958
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERBIN,Erbin,27620,196,1.02 [0.90-1.15],0.7703305080337013
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERC2,ERC protein 2,23510,172,0.92 [0.75-1.13],0.4443049870301859
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERCC1,DNA excision repair protein ERCC-1,23311,173,1.34 [0.95-1.90],0.0925309041445703
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EREG,Proepiregulin,27498,196,1.12 [0.96-1.30],0.1463701116750374
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERI1,3'-5' exoribonuclease 1,23735,176,1.21 [0.81-1.81],0.3590797441692797
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERMAP,Erythroid membrane-associated protein,23501,175,1.14 [0.83-1.56],0.4134929399776349
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24051,179,0.85 [0.58-1.24],0.3954114776261554
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERP29,Endoplasmic reticulum resident protein 29,23677,173,1.01 [0.90-1.15],0.8242478275189855
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERP44,Endoplasmic reticulum resident protein 44,27572,196,1.19 [0.73-1.94],0.4797135400110204
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,23421,172,0.90 [0.65-1.24],0.5151481675519477
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ESAM,Endothelial cell-selective adhesion molecule,28081,200,1.42 [0.97-2.08],0.0730679809666451
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ESM1,Endothelial cell-specific molecule 1,27745,195,0.70 [0.48-1.01],0.0563174491847871
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ESPL1,Separin,23311,173,1.03 [0.80-1.32],0.8290661478726198
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ESR1,Estrogen receptor,23501,175,1.30 [1.09-1.56],0.0043327814483515
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ESYT2,Extended synaptotagmin-2,24131,176,1.03 [0.87-1.23],0.7260576053073042
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EVI2B,Protein EVI2B,23311,173,1.12 [0.80-1.56],0.5037221853606344
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EVI5,Ecotropic viral integration site 5 protein homolog,23501,175,1.07 [0.91-1.25],0.4410935776312911
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EVPL,Envoplakin,23735,176,1.22 [0.82-1.81],0.3323445619140652
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EXOSC10,Exosome component 10,23421,172,1.23 [1.01-1.48],0.0349303751768021
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EXTL1,Exostosin-like 1,23421,172,1.05 [0.78-1.40],0.7649144944155105
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EZR,Ezrin,27981,197,1.29 [0.77-2.15],0.3285906212070203
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F10,Coagulation factor X,24199,176,1.63 [1.02-2.60],0.042100901174198
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F11,Coagulation factor XI,23880,173,1.14 [0.73-1.78],0.5706893743623977
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F11R,Junctional adhesion molecule A,27746,198,1.03 [0.82-1.28],0.8184981974858628
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F12,Coagulation factor XII,24235,177,1.18 [0.83-1.68],0.3450182252722326
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F13B,Coagulation factor XIII B chain,24092,176,1.92 [1.08-3.40],0.0261300364339055
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F2,Prothrombin,24235,177,1.26 [0.48-3.32],0.6340852276555025
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F2R,Proteinase-activated receptor 1,27832,196,1.16 [0.93-1.44],0.1820951454931576
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F3,Tissue factor,27811,192,1.06 [0.67-1.67],0.7951183760535617
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F7,Coagulation factor VII,27794,194,1.26 [0.83-1.92],0.2856748057340144
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F9,Coagulation factor IX,27789,194,1.35 [0.67-2.70],0.4025439830877233
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FABP1,"Fatty acid-binding protein, liver",27745,195,1.08 [0.94-1.23],0.2814581503196189
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FABP2,"Fatty acid-binding protein, intestinal",27743,197,1.12 [0.95-1.31],0.1722161885609262
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FABP3,"Fatty acid-binding protein, heart",24188,179,1.05 [0.78-1.41],0.769524100746579
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FABP4,"Fatty acid-binding protein, adipocyte",28081,200,1.26 [0.98-1.60],0.0687271953796104
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FABP5,Fatty acid-binding protein 5,27892,197,1.08 [0.90-1.29],0.3966288008499016
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FABP6,Gastrotropin,27188,193,1.09 [0.87-1.37],0.4628027572989593
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FABP9,Fatty acid-binding protein 9,27699,197,1.04 [0.83-1.30],0.7366398376270942
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FADD,FAS-associated death domain protein,27743,197,1.01 [0.85-1.18],0.9431016091292378
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAM13A,Protein FAM13A,24062,176,1.05 [0.85-1.29],0.6732298191176995
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAM171A2,Protein FAM171A2,24149,177,1.00 [0.92-1.10],0.9360484066737276
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAM171B,Protein FAM171B,24051,179,1.08 [0.66-1.77],0.753517899394488
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAM172A,Cotranscriptional regulator FAM172A,23566,168,1.10 [0.87-1.40],0.4161162530942794
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAM20A,Pseudokinase FAM20A,24188,179,1.88 [1.16-3.05],0.0105048445549022
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAM3B,Protein FAM3B,27620,196,0.94 [0.66-1.33],0.7265851169304468
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAM3C,Protein FAM3C,27698,197,1.31 [0.86-1.99],0.2157476954067935
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAM3D,Protein FAM3D,24062,176,1.03 [0.86-1.22],0.7671549545282095
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAP,Prolyl endopeptidase FAP,28081,200,1.38 [0.88-2.19],0.1624469426106731
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FARSA,Phenylalanine--tRNA ligase alpha subunit,23510,172,1.14 [0.94-1.39],0.1936366950268542
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAS,Tumor necrosis factor receptor superfamily member 6,27991,200,1.22 [0.87-1.70],0.2420674608534759
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FASLG,Tumor necrosis factor ligand superfamily member 6,28030,197,0.68 [0.49-0.95],0.0237546612655202
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FBLN2,Fibulin-2,24186,178,0.97 [0.61-1.55],0.8980535662797475
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FBN2,Fibrillin-2,23510,172,0.96 [0.76-1.22],0.7540005282286268
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FBP1,"Fructose-1,6-bisphosphatase 1",27743,197,1.08 [0.91-1.28],0.3767629585639589
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24188,179,1.13 [0.93-1.37],0.2189991026942498
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCAR,Immunoglobulin alpha Fc receptor,27699,197,1.12 [0.86-1.46],0.4076929069725273
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24149,177,1.19 [0.65-2.16],0.5716738275530646
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCER2,Low affinity immunoglobulin epsilon Fc receptor,27746,198,1.09 [0.84-1.42],0.5086936203248393
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,27612,194,1.09 [0.88-1.37],0.4305977113662677
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,27092,194,0.92 [0.73-1.15],0.4555576200312099
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,27748,194,1.03 [0.80-1.32],0.8411501867633172
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCN1,Ficolin-1,24150,175,1.00 [0.78-1.29],0.9959158285825332
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCN2,Ficolin-2,27613,194,1.43 [1.02-1.99],0.0352291002387259
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCRL1,Fc receptor-like protein 1,27743,197,1.14 [0.86-1.52],0.354533470030819
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCRL2,Fc receptor-like protein 2,27897,195,1.04 [0.80-1.36],0.7580342379040108
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCRL3,Fc receptor-like protein 3,27187,191,1.03 [0.81-1.31],0.8125945717560472
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCRL5,Fc receptor-like protein 5,27746,198,0.99 [0.79-1.24],0.9313179857104092
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCRL6,Fc receptor-like protein 6,27699,197,0.90 [0.74-1.08],0.243017157058903
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCRLB,Fc receptor-like B,27092,194,0.98 [0.79-1.21],0.8327024971558885
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FDX1,"Adrenodoxin, mitochondrial",23421,172,1.14 [0.93-1.40],0.2049247686245991
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FDX2,"Ferredoxin-2, mitochondrial",23421,172,1.00 [0.78-1.28],0.9996865744574992
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FEN1,Flap endonuclease 1,27092,194,0.97 [0.79-1.18],0.7356030560571138
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FES,Tyrosine-protein kinase Fes/Fps,27092,194,1.18 [0.93-1.51],0.1755830670184134
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FETUB,Fetuin-B,27789,194,0.98 [0.68-1.41],0.9153146477974332
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGA,Fibrinogen alpha chain,23647,174,1.64 [1.03-2.59],0.0356448284193829
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24149,177,1.08 [0.91-1.30],0.3703881513094373
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF12,Fibroblast growth factor 12,23501,175,0.98 [0.72-1.34],0.9130200139189428
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF16,Fibroblast growth factor 16,23501,175,0.93 [0.68-1.27],0.6424399354961234
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF19,Fibroblast growth factor 19,27880,196,1.15 [0.98-1.36],0.0894628805013645
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF2,Fibroblast growth factor 2,27699,197,1.08 [0.90-1.31],0.3993407723578973
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF20,Fibroblast growth factor 20,23501,175,1.11 [0.83-1.50],0.4841216424854675
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF21,Fibroblast growth factor 21,27926,194,1.10 [1.00-1.23],0.0610356968889795
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF23,Fibroblast growth factor 23,27931,194,1.06 [0.89-1.27],0.5174968895202788
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF3,Fibroblast growth factor 3,23501,175,1.21 [0.79-1.85],0.3803309385013779
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF5,Fibroblast growth factor 5,27187,191,1.67 [1.18-2.36],0.0040020620006147
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF6,Fibroblast growth factor 6,23501,175,1.22 [0.94-1.59],0.128715118428013
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF7,Fibroblast growth factor 7,23311,173,1.04 [0.87-1.23],0.6707548873255391
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF9,Fibroblast growth factor 9,23269,173,1.15 [0.81-1.64],0.4234425843065593
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGFBP1,Fibroblast growth factor-binding protein 1,27840,197,1.19 [0.80-1.76],0.4020693570616827
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGFBP2,Fibroblast growth factor-binding protein 2,24186,178,0.99 [0.74-1.32],0.9369054197611792
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGFBP3,Fibroblast growth factor-binding protein 3,24131,176,0.97 [0.66-1.44],0.8966456844265126
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGFR2,Fibroblast growth factor receptor 2,27840,197,1.80 [1.02-3.15],0.0413944390444438
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGFR4,Fibroblast growth factor receptor 4,23677,173,0.96 [0.73-1.26],0.7805865075208829
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGL1,Fibrinogen-like protein 1,24199,176,1.04 [0.83-1.30],0.7464470486704473
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGR,Tyrosine-protein kinase Fgr,27063,192,1.04 [0.84-1.28],0.7026796190481062
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FH,"Fumarate hydratase, mitochondrial",23404,170,0.88 [0.72-1.07],0.1947612426804649
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FHIP2A,FHF complex subunit HOOK interacting protein 2A,23421,172,0.85 [0.62-1.18],0.3409364728240063
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FHIT,Bis(5'-adenosyl)-triphosphatase,27063,192,1.07 [0.90-1.27],0.4431082037158503
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FIS1,Mitochondrial fission 1 protein,27750,196,0.99 [0.85-1.17],0.9272428314393466
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24149,177,1.07 [0.93-1.24],0.3396696148040348
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,27807,194,0.99 [0.88-1.11],0.8757861893235338
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,27549,196,1.11 [0.83-1.47],0.4849597964347473
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,27549,196,0.99 [0.87-1.13],0.8565619911091233
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,27012,192,1.04 [0.80-1.35],0.7769944683397446
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FKBPL,FK506-binding protein-like,24062,176,1.14 [0.90-1.45],0.2677425609233759
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FLI1,Friend leukemia integration 1 transcription factor,27092,194,1.07 [0.95-1.20],0.2532179771630277
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,27549,196,0.89 [0.57-1.39],0.6098600795176083
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FLT1,Vascular endothelial growth factor receptor 1,27576,195,0.85 [0.48-1.49],0.5666329343217442
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FLT3,Receptor-type tyrosine-protein kinase FLT3,27092,194,1.06 [0.70-1.60],0.7965886158017335
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FLT3LG,Fms-related tyrosine kinase 3 ligand,28030,197,1.36 [0.94-1.97],0.1074694923077085
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FLT4,Vascular endothelial growth factor receptor 3,27840,197,0.92 [0.63-1.32],0.6402159179303206
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FMNL1,Formin-like protein 1,27063,192,1.08 [0.90-1.29],0.4310028417620821
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FMR1,Synaptic functional regulator FMR1,27092,194,1.11 [0.78-1.60],0.5610916362228588
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FN1,Fibronectin,24235,177,1.34 [0.78-2.30],0.2817740104498591
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FNDC1,Fibronectin type III domain-containing protein 1,24131,176,1.03 [0.75-1.41],0.8680168217108639
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24051,179,1.43 [1.03-1.97],0.0301544195795992
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOLH1,Glutamate carboxypeptidase 2,23501,175,1.11 [0.99-1.23],0.0722473658521963
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOLR1,Folate receptor alpha,27703,196,0.99 [0.63-1.56],0.9790183137623816
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOLR2,Folate receptor beta,27981,197,0.96 [0.62-1.47],0.8355634061147943
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOLR3,Folate receptor gamma,27751,196,0.98 [0.92-1.05],0.6200877273436329
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOS,Proto-oncogene c-Fos,23269,173,1.11 [0.74-1.68],0.6060631841248205
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOSB,Protein fosB,27063,192,1.03 [0.75-1.42],0.8492770443913531
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOXJ3,Forkhead box protein J3,23501,175,1.30 [0.99-1.71],0.0633528319989858
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOXO1,Forkhead box protein O1,27699,197,1.08 [0.93-1.25],0.3172946241311988
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOXO3,Forkhead box protein O3,27092,194,1.08 [0.96-1.23],0.2105008772675136
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FRMD4B,FERM domain-containing protein 4B,23421,172,0.96 [0.78-1.19],0.7266748974542041
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FRMD7,FERM domain-containing protein 7,23510,172,0.74 [0.47-1.15],0.1818775937153142
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FRZB,Secreted frizzled-related protein 3,27453,195,0.99 [0.62-1.59],0.9787674620465554
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FSHB,Follitropin subunit beta,23566,168,1.45 [1.18-1.78],0.0003957801418725
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FST,Follistatin,27832,196,1.12 [0.88-1.42],0.3499438944213534
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FSTL1,Follistatin-related protein 1,23566,168,0.78 [0.40-1.50],0.4575934273018908
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FSTL3,Follistatin-related protein 3,27698,194,1.01 [0.66-1.53],0.9756011737378032
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FTCD,Formimidoyltransferase-cyclodeaminase,24090,176,0.99 [0.83-1.17],0.8781062003806324
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FUCA1,Tissue alpha-L-fucosidase,27919,199,1.05 [0.90-1.23],0.5242763496451149
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FUOM,Fucose mutarotase,23677,173,1.25 [1.00-1.56],0.0535448861695084
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FURIN,Furin,27840,197,1.12 [0.77-1.61],0.5606995068675713
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FUS,RNA-binding protein FUS,27049,194,1.24 [0.92-1.68],0.1574822399623391
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",23685,175,0.96 [0.75-1.21],0.7028191905876904
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,27981,197,0.81 [0.61-1.07],0.1448864439067559
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FUT8,"Alpha-(1,6)-fucosyltransferase",27549,196,1.08 [0.87-1.33],0.491101995009803
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FXN,"Frataxin, mitochondrial",27975,194,1.01 [0.85-1.19],0.9419383254738268
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FXYD5,FXYD domain-containing ion transport regulator 5,27187,191,1.04 [0.86-1.26],0.6981276359285193
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FYB1,FYN-binding protein 1,27705,197,1.01 [0.88-1.16],0.911022090516044
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FZD10,Frizzled-10,23510,172,1.18 [0.97-1.44],0.0951540895501443
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FZD8,Frizzled-8,23404,170,0.93 [0.66-1.33],0.7044128464501312
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GABARAP,Gamma-aminobutyric acid receptor-associated protein,24051,179,0.93 [0.69-1.25],0.633927953536378
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,23735,176,1.03 [0.83-1.27],0.7788891099053203
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,23404,170,0.86 [0.67-1.11],0.2496094431874229
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAD1,Glutamate decarboxylase 1,23311,173,1.17 [0.67-2.04],0.5847478213456083
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAD2,Glutamate decarboxylase 2,23501,175,0.94 [0.68-1.30],0.7122237456708689
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,23735,176,0.91 [0.67-1.25],0.5592258923962563
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,23566,168,1.04 [0.79-1.38],0.756886741913545
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAGE2A,G antigen 2A,23311,173,1.32 [1.13-1.55],0.0005815160757901
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAL,Galanin peptides,27880,196,0.77 [0.63-0.94],0.0100636019541993
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,27620,196,1.47 [0.95-2.28],0.0849870172292787
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,27975,194,0.99 [0.61-1.63],0.984006451849757
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,27187,191,1.09 [0.80-1.47],0.5898051043690993
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24188,179,1.52 [0.90-2.55],0.1164269145882191
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GALNT7,N-acetylgalactosaminyltransferase 7,27620,196,0.98 [0.54-1.79],0.9447524923621544
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAMT,Guanidinoacetate N-methyltransferase,23421,172,1.10 [0.77-1.58],0.5849832707693302
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23160,172,0.96 [0.63-1.47],0.8436796788907341
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GART,Trifunctional purine biosynthetic protein adenosine-3,24149,177,0.97 [0.56-1.67],0.9052762384816182
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAS2,Growth arrest-specific protein 2,23735,176,1.10 [0.86-1.41],0.4504025518960429
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAS6,Growth arrest-specific protein 6,27893,200,1.14 [0.70-1.84],0.6004705872617179
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GASK1A,Golgi-associated kinase 1A,23421,172,1.15 [0.82-1.62],0.4127257902990078
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAST,Gastrin,24131,176,1.12 [1.01-1.24],0.0360409249847206
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,23311,173,0.94 [0.54-1.64],0.8316987308941224
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",23566,168,1.02 [0.84-1.23],0.8753007594122462
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GBA,Lysosomal acid glucosylceramidase,23510,172,0.98 [0.75-1.28],0.8884388711081096
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GBP1,Guanylate-binding protein 1,24089,176,1.12 [0.90-1.39],0.3102847388319607
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GBP2,Guanylate-binding protein 2,27187,191,0.83 [0.67-1.03],0.0937591536098129
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GBP4,Guanylate-binding protein 4,27063,192,1.08 [0.84-1.39],0.5454873701699976
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GBP6,Guanylate-binding protein 6,23421,172,0.89 [0.63-1.25],0.5032359483446105
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GC,Vitamin D-binding protein,24235,177,1.22 [0.71-2.09],0.4750699057167111
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GCC1,GRIP and coiled-coil domain-containing protein 1,24131,176,1.03 [0.90-1.18],0.6500803626447453
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GCG,Pro-glucagon,27092,194,1.10 [0.99-1.22],0.0755402699754625
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23108,170,1.24 [0.97-1.60],0.0902374433621515
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GCLM,Glutamate--cysteine ligase regulatory subunit,23421,172,0.90 [0.65-1.26],0.5434633726008677
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",27620,196,1.03 [0.71-1.48],0.8880987866655073
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GDF15,Growth/differentiation factor 15,28081,200,1.19 [0.93-1.52],0.1693395938427921
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GDF2,Growth/differentiation factor 2,27743,197,0.93 [0.65-1.32],0.6660739310811915
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GDNF,Glial cell line-derived neurotrophic factor,27063,192,0.98 [0.70-1.37],0.8960446077667653
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GET3,ATPase GET3,24188,179,1.04 [0.81-1.32],0.762767337067169
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GFAP,Glial fibrillary acidic protein,27049,193,1.09 [0.82-1.44],0.5561527212391234
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GFER,FAD-linked sulfhydryl oxidase ALR,27092,194,1.05 [0.86-1.28],0.6325884747905005
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,27092,194,0.99 [0.90-1.10],0.8885347615477301
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GFRA1,GDNF family receptor alpha-1,27926,194,1.67 [1.08-2.59],0.0214615059192374
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GFRA2,GDNF family receptor alpha-2,27620,196,1.23 [0.68-2.23],0.4907144182213646
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GFRA3,GDNF family receptor alpha-3,27463,195,0.88 [0.56-1.38],0.5882029911105702
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GFRAL,GDNF family receptor alpha-like,23397,170,1.15 [0.91-1.45],0.2424568256048858
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GGA1,ADP-ribosylation factor-binding protein GGA1,27063,192,1.17 [1.00-1.36],0.0543874686725576
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GGACT,Gamma-glutamylaminecyclotransferase,24188,179,1.04 [0.85-1.27],0.6972984471300088
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GGCT,Gamma-glutamylcyclotransferase,24139,179,1.06 [0.79-1.42],0.7094166638467254
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GGH,Gamma-glutamyl hydrolase,27258,188,1.22 [0.84-1.76],0.2926835009046691
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GGT1,Glutathione hydrolase 1 proenzyme,27704,197,1.18 [0.92-1.51],0.2007993572958082
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GGT5,Glutathione hydrolase 5 proenzyme,27549,196,0.78 [0.45-1.37],0.3905119163220344
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GH1,Somatotropin,27698,197,0.97 [0.90-1.04],0.3408357640462875
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GH2,Growth hormone variant,27092,194,1.07 [1.00-1.14],0.0572341103201954
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GHR,Growth hormone receptor,23677,173,1.06 [0.64-1.74],0.8329561933349847
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GHRHR,Growth hormone-releasing hormone receptor,27063,192,0.99 [0.79-1.24],0.9436177674171172
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GHRL,Appetite-regulating hormone,27743,197,1.06 [0.90-1.25],0.495464811672877
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GID8,Glucose-induced degradation protein 8 homolog,24149,177,1.25 [0.88-1.77],0.2156599301130094
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GIGYF2,GRB10-interacting GYF protein 2,24149,177,0.98 [0.82-1.19],0.8584669055299361
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GIMAP7,GTPase IMAP family member 7,23677,173,1.15 [0.76-1.73],0.5086961690414471
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GIMAP8,GTPase IMAP family member 8,23311,173,1.23 [0.97-1.56],0.0939930281239031
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GIP,Gastric inhibitory polypeptide,23566,168,1.23 [0.92-1.65],0.1558837974281888
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GIPC2,PDZ domain-containing protein GIPC2,24131,176,1.24 [0.77-2.00],0.3799684095790904
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GIPC3,PDZ domain-containing protein GIPC3,24062,176,1.08 [0.93-1.25],0.3301126498194278
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GIPR,Gastric inhibitory polypeptide receptor,23501,175,0.93 [0.67-1.28],0.661549720829373
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GIT1,ARF GTPase-activating protein GIT1,23501,175,1.00 [0.86-1.16],0.9678689943853632
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GJA8,Gap junction alpha-8 protein,23311,173,0.92 [0.72-1.18],0.5238731257882784
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GKN1,Gastrokine-1,26527,187,1.35 [0.85-2.15],0.2037997314974983
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLA,Alpha-galactosidase A,23629,173,1.18 [0.80-1.74],0.410925382498123
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLB1,Beta-galactosidase,27549,196,1.10 [0.81-1.49],0.5556554120796827
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLI2,Zinc finger protein GLI2,23501,175,1.58 [1.18-2.12],0.0024146867926393
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLO1,Lactoylglutathione lyase,27233,194,1.07 [0.87-1.32],0.5224391191803133
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLOD4,Glyoxalase domain-containing protein 4,27702,196,1.07 [0.76-1.50],0.7095075708089973
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLP1R,Glucagon-like peptide 1 receptor,23404,170,0.80 [0.53-1.23],0.3154282211447283
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLRX,Glutaredoxin-1,27565,197,1.08 [0.87-1.34],0.4607419700216719
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",23677,173,1.04 [0.88-1.22],0.663289074719257
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,27063,192,0.79 [0.58-1.08],0.1345185147663734
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLYR1,Putative oxidoreductase GLYR1,24051,179,1.19 [0.98-1.44],0.0833229486202444
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GM2A,Ganglioside GM2 activator,23597,175,1.13 [0.80-1.60],0.4889347271981078
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GMFG,Glia maturation factor gamma,24188,179,1.07 [0.88-1.30],0.5025637981386437
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GMPR,GMP reductase 1,28030,197,1.08 [0.85-1.38],0.536117200995931
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GMPR2,GMP reductase 2,23677,173,1.05 [0.85-1.30],0.6449819027119474
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GNAS,Neuroendocrine secretory protein 55,24149,177,1.08 [0.93-1.26],0.3058487876474933
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,27092,194,1.10 [0.91-1.33],0.3245328259999349
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,23510,172,0.94 [0.70-1.26],0.6840781159008609
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GNLY,Granulysin,27746,198,0.84 [0.65-1.07],0.1533851924449415
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GNPDA1,Glucosamine-6-phosphate isomerase 1,23566,168,0.62 [0.36-1.06],0.0786231592555764
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GNPDA2,Glucosamine-6-phosphate isomerase 2,23677,173,1.16 [0.79-1.73],0.4477283187117886
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GOLGA3,Golgin subfamily A member 3,24149,177,1.04 [0.86-1.25],0.6944221361861751
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GOLM2,Protein GOLM2,27981,197,0.81 [0.46-1.44],0.4756448500261362
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,27699,197,1.03 [0.90-1.16],0.6916778259096529
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GORASP2,Golgi reassembly-stacking protein 2,24062,176,1.21 [0.89-1.63],0.2184988647455003
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GOT1,"Aspartate aminotransferase, cytoplasmic",24186,178,1.18 [0.84-1.65],0.3310554194838891
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GP1BA,Platelet glycoprotein Ib alpha chain,27609,194,1.10 [0.74-1.63],0.6260618067808694
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GP1BB,Platelet glycoprotein Ib beta chain,23421,172,1.14 [0.92-1.42],0.2290962724137416
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,26886,190,0.88 [0.75-1.03],0.114108774773469
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GP5,Platelet glycoprotein V,23677,173,1.33 [0.88-2.03],0.1774296231566714
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GP6,Platelet glycoprotein VI,27705,197,1.04 [0.90-1.20],0.5953296947489797
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPA33,Cell surface A33 antigen,27620,196,0.94 [0.86-1.03],0.1927624429699442
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPC1,Glypican-1,27975,194,1.24 [0.80-1.91],0.3312118678076103
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPC5,Glypican-5,27549,196,1.10 [0.88-1.38],0.3958837653450887
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPD1,Glycerol-3-phosphate dehydrogenase,24051,179,1.09 [0.83-1.43],0.5302297329823854
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPHA2,Glycoprotein hormone alpha-2,24062,176,0.98 [0.73-1.32],0.909173652554716
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPI,Glucose-6-phosphate isomerase,24199,176,1.04 [0.77-1.40],0.7830066816410186
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24062,176,0.95 [0.78-1.15],0.577066721264577
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPKOW,G-patch domain and KOW motifs-containing protein,27063,192,1.00 [0.65-1.55],0.993474937459546
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPNMB,Transmembrane glycoprotein NMB,26991,196,1.45 [0.93-2.27],0.1048834167764708
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPR101,Probable G-protein coupled receptor 101,23404,170,0.95 [0.74-1.21],0.6547271125252418
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPR158,Probable G-protein coupled receptor 158,24149,177,0.92 [0.61-1.38],0.6767717072533295
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPR15L,Protein GPR15L,24062,176,1.28 [1.02-1.60],0.0309074565376944
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPR37,Prosaposin receptor GPR37,27233,194,1.20 [0.99-1.45],0.0674994459664267
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPRC5C,G-protein coupled receptor family C group 5 member C,24051,179,1.09 [0.86-1.38],0.4889007564313177
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRAP2,GRB2-related adapter protein 2,27743,197,1.02 [0.92-1.12],0.7444648484975867
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24188,179,1.08 [0.87-1.34],0.4932519306079242
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRIK2,"Glutamate receptor ionotropic, kainate 2",24149,177,1.18 [0.87-1.62],0.2912914610069964
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",23404,170,0.98 [0.76-1.26],0.8732443256277524
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRK5,G protein-coupled receptor kinase 5,27233,194,1.15 [0.92-1.43],0.2199454700756883
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRN,Progranulin,27621,196,0.86 [0.51-1.44],0.560375526373078
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRP,Gastrin-releasing peptide,23566,168,1.09 [0.83-1.43],0.5488523699068517
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRPEL1,"GrpE protein homolog 1, mitochondrial",27620,196,1.18 [0.97-1.44],0.0998699177588867
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRSF1,G-rich sequence factor 1,23187,173,1.06 [0.89-1.27],0.5202831840949242
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GSAP,Gamma-secretase-activating protein,27092,194,1.06 [0.93-1.21],0.3641076818379007
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GSN,Gelsolin,24116,176,0.73 [0.35-1.49],0.3855403969205714
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GSR,"Glutathione reductase, mitochondrial",24056,175,1.88 [1.03-3.44],0.0394781755869115
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GSTA1,Glutathione S-transferase A1,27702,197,1.01 [0.87-1.18],0.8710334023373756
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GSTA3,Glutathione S-transferase A3,27092,194,1.01 [0.86-1.20],0.8932308558538292
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GSTM4,Glutathione S-transferase Mu 4,23421,172,0.86 [0.68-1.09],0.2132894319785179
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GSTP1,Glutathione S-transferase P,26894,191,0.96 [0.80-1.16],0.70133240985283
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GSTT2B,Glutathione S-transferase theta-2B,24131,176,1.02 [0.96-1.09],0.4781285360132821
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,23735,176,1.14 [0.97-1.34],0.1193770153013901
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GTPBP2,GTP-binding protein 2,23510,172,1.12 [0.93-1.35],0.2165992266135824
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GUCA2A,Guanylin,27618,197,1.50 [1.03-2.18],0.0323987825481748
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GUCY2C,Heat-stable enterotoxin receptor,23735,176,0.96 [0.81-1.14],0.6261416670195287
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GUK1,Guanylate kinase,23421,172,0.99 [0.70-1.41],0.9698352411097624
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GUSB,Beta-glucuronidase,27869,199,1.04 [0.85-1.29],0.6877869186413544
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GYS1,"Glycogen [starch] synthase, muscle",27233,194,1.08 [0.94-1.24],0.2649156898379414
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GZMA,Granzyme A,28030,197,1.02 [0.71-1.46],0.911628881927441
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GZMB,Granzyme B,27699,197,0.89 [0.72-1.10],0.2802391358260755
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GZMH,Granzyme H,27233,194,1.02 [0.86-1.20],0.8416483329530074
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",H2AP,Huntingtin-interacting protein M,23311,173,0.95 [0.71-1.29],0.7642049457239426
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",23421,172,1.19 [1.01-1.41],0.0399682836219833
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",27888,194,0.96 [0.81-1.13],0.612637709252098
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HAO1,Hydroxyacid oxidase 1,27975,194,1.03 [0.94-1.13],0.5429656905990823
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HARS1,"Histidine--tRNA ligase, cytoplasmic",27746,198,1.01 [0.86-1.18],0.9474015892678064
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HAVCR1,Hepatitis A virus cellular receptor 1,27937,194,1.31 [1.08-1.59],0.0070295050780545
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HAVCR2,Hepatitis A virus cellular receptor 2,27746,198,1.16 [0.81-1.68],0.4217879211942863
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HBEGF,Proheparin-binding EGF-like growth factor,27888,194,1.02 [0.86-1.22],0.7856450064626818
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HBQ1,Hemoglobin subunit theta-1,27975,194,0.95 [0.77-1.17],0.622715873818162
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HBZ,Hemoglobin subunit zeta,24188,179,1.06 [0.93-1.21],0.3872280682610641
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HCG22,Protein PBMUCL2,23421,172,1.02 [0.78-1.33],0.878109824515841
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HCLS1,Hematopoietic lineage cell-specific protein,28030,197,0.92 [0.73-1.15],0.4421199860919207
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HDAC8,Histone deacetylase 8,23501,175,1.16 [0.96-1.40],0.1294420160361264
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HDAC9,Histone deacetylase 9,23404,170,1.07 [0.86-1.32],0.5408499905475337
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HDDC2,5'-deoxynucleotidase HDDC2,24062,176,1.15 [0.84-1.58],0.3711018232434221
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HDGF,Hepatoma-derived growth factor,27940,193,1.10 [0.97-1.26],0.1457122548925619
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HDGFL2,Hepatoma-derived growth factor-related protein 2,24131,176,1.18 [0.96-1.46],0.1251548476131955
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HEBP1,Heme-binding protein 1,27233,194,1.08 [0.88-1.34],0.4526457905943856
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HEG1,Protein HEG homolog 1,23677,173,1.26 [0.73-2.17],0.4131401087428497
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HEPACAM2,HEPACAM family member 2,24131,176,1.04 [0.73-1.48],0.8229072105790209
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HEPH,Hephaestin,24188,179,1.46 [0.83-2.56],0.1862331693271665
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HEXIM1,Protein HEXIM1,27699,197,1.04 [0.89-1.21],0.6159351707041332
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HGF,Hepatocyte growth factor,28030,197,1.21 [0.85-1.72],0.2941399801397709
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HGFAC,Hepatocyte growth factor activator,23960,175,0.80 [0.51-1.27],0.3478283364452826
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,27092,194,1.01 [0.86-1.19],0.8763926315700998
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HHEX,Hematopoietically-expressed homeobox protein HHEX,24131,176,1.19 [0.99-1.43],0.0695485697288566
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HIF1A,Hypoxia-inducible factor 1-alpha,23501,175,1.16 [0.97-1.38],0.0990838870597333
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HIP1,Huntingtin-interacting protein 1,23421,172,0.87 [0.55-1.36],0.5352303394991371
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HIP1R,Huntingtin-interacting protein 1-related protein,24088,176,1.09 [0.80-1.48],0.5892618427127434
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HJV,Hemojuvelin,24149,177,1.20 [0.91-1.59],0.1929458439953383
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HK2,Hexokinase-2,27233,194,1.37 [0.90-2.10],0.1464898158940242
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",24149,177,0.71 [0.46-1.10],0.1289431323968218
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",27619,197,1.27 [0.90-1.78],0.1756668319266083
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",27699,197,0.86 [0.54-1.34],0.4987318604082194
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HMBS,Porphobilinogen deaminase,27975,194,1.00 [0.76-1.32],0.9836626620984564
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HMCN2,Hemicentin-2,23634,173,0.98 [0.76-1.27],0.9050301678892994
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",23566,168,1.03 [0.77-1.37],0.8580905660367102
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",23421,172,1.10 [0.81-1.50],0.5480395435340699
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HMMR,Hyaluronan mediated motility receptor,23271,173,1.36 [1.08-1.72],0.0095691239134953
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HMOX1,Heme oxygenase 1,27426,197,0.93 [0.71-1.23],0.6204600072082131
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HMOX2,Heme oxygenase 2,27063,192,1.13 [0.87-1.46],0.3656663651508728
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HNF1A,Hepatocyte nuclear factor 1-alpha,23510,172,0.90 [0.72-1.13],0.3572147754008271
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HNMT,Histamine N-methyltransferase,27414,196,0.98 [0.74-1.29],0.8771746352104292
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,27151,192,1.08 [0.92-1.27],0.3414235182389578
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24149,177,1.28 [1.00-1.64],0.0546371116583843
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HPCAL1,Hippocalcin-like protein 1,28030,197,1.00 [0.84-1.18],0.9632364062388766
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HPGDS,Hematopoietic prostaglandin D synthase,27092,194,1.49 [1.11-2.00],0.0078434952998856
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HPSE,Heparanase,23852,177,1.06 [0.91-1.23],0.4832241957281883
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HRAS,GTPase Hras,23689,175,1.07 [0.94-1.22],0.3048307012995584
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,23566,168,0.71 [0.45-1.13],0.1468840157248088
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HRG,Histidine-rich glycoprotein,24092,176,1.61 [1.02-2.54],0.04037554629174
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HS1BP3,HCLS1-binding protein 3,23566,168,1.10 [0.93-1.30],0.2555642158658368
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,27620,196,1.41 [1.02-1.95],0.0370305516674154
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,27975,194,1.14 [0.80-1.63],0.4716872678593624
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,23501,175,1.01 [0.62-1.63],0.9762906766409624
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSBP1,Heat shock factor-binding protein 1,23566,168,0.94 [0.80-1.10],0.4294765958291369
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,27699,197,0.78 [0.57-1.07],0.1259520941656615
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24131,176,1.00 [0.79-1.26],0.9982199045445544
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSD17B3,Testosterone 17-beta-dehydrogenase 3,23421,172,0.77 [0.55-1.07],0.1168035685300482
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,23566,168,1.24 [0.92-1.68],0.1573890345777179
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSP90B1,Endoplasmin,26927,188,1.07 [0.90-1.27],0.4272814321744943
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSPA1A,Heat shock 70 kDa protein 1A,27840,196,0.98 [0.82-1.17],0.8200037940587054
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSPA2,Heat shock-related 70 kDa protein 2,24051,179,1.34 [0.92-1.93],0.1248213325437052
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSPB1,Heat shock protein beta-1,27292,196,1.08 [0.89-1.31],0.4221200932504648
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSPB6,Heat shock protein beta-6,27975,194,0.97 [0.69-1.38],0.8827583553470751
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,27516,192,1.23 [0.75-2.02],0.4194218939227626
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HTR1A,5-hydroxytryptamine receptor 1A,23404,170,0.85 [0.69-1.06],0.1523219192034412
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HTR1B,5-hydroxytryptamine receptor 1B,23404,170,0.98 [0.69-1.38],0.890052570520654
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HTRA2,"Serine protease HTRA2, mitochondrial",27840,197,0.99 [0.81-1.22],0.9603691497842388
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HYAL1,Hyaluronidase-1,27561,193,1.76 [1.06-2.93],0.0295709537305623
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HYOU1,Hypoxia up-regulated protein 1,28081,200,1.10 [0.62-1.96],0.7450812984716464
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ICA1,Islet cell autoantigen 1,27187,191,1.01 [0.86-1.18],0.9310921576369964
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ICAM1,Intercellular adhesion molecule 1,27613,194,1.21 [0.79-1.87],0.3838054244825328
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ICAM2,Intercellular adhesion molecule 2,28081,200,0.78 [0.53-1.16],0.2279394649500219
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ICAM3,Intercellular adhesion molecule 3,28081,200,1.04 [0.63-1.70],0.8887530338156369
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ICAM4,Intercellular adhesion molecule 4,27699,197,0.84 [0.66-1.06],0.1316928826299719
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ICAM5,Intercellular adhesion molecule 5,27743,197,1.04 [0.79-1.38],0.7807558603766076
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ICOSLG,ICOS ligand,27620,196,0.99 [0.51-1.92],0.980593188907228
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ID4,DNA-binding protein inhibitor ID-4,23735,176,0.98 [0.71-1.35],0.8813272199270397
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IDI2,Isopentenyl-diphosphate delta-isomerase 2,27063,192,0.90 [0.68-1.20],0.4730242601024879
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IDO1,"Indoleamine 2,3-dioxygenase 1",23566,168,1.03 [0.82-1.30],0.779792484915958
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IDS,Iduronate 2-sulfatase,28030,197,2.00 [0.45-8.98],0.3641593640765111
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IDUA,Alpha-L-iduronidase,27975,194,0.96 [0.73-1.26],0.7648387222541551
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,23470,173,1.24 [0.87-1.77],0.2293775506453234
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,23735,176,0.93 [0.70-1.22],0.5864598272577151
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,23735,176,1.23 [0.86-1.77],0.2622455017187611
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFNAR1,Interferon alpha/beta receptor 1,24062,176,1.45 [0.89-2.34],0.1342368393481646
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFNG,Interferon gamma,27187,191,1.10 [0.99-1.23],0.0820134640026369
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFNGR1,Interferon gamma receptor 1,27880,196,1.11 [0.59-2.08],0.7387226805005831
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFNGR2,Interferon gamma receptor 2,27549,196,0.96 [0.75-1.23],0.7662073953682732
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFNL1,Interferon lambda-1,27063,192,0.92 [0.69-1.23],0.5834988782034256
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFNL2,Interferon lambda-2,23404,170,1.14 [0.94-1.39],0.1711297784967401
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFNLR1,Interferon lambda receptor 1,27699,197,0.92 [0.65-1.30],0.630763379213803
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFNW1,Interferon omega-1,23421,172,0.71 [0.44-1.15],0.1675915391504184
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFT20,Intraflagellar transport protein 20 homolog,23510,172,1.29 [0.95-1.75],0.0969317697157813
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGBP1,Immunoglobulin-binding protein 1,24149,177,1.11 [0.88-1.39],0.3816882150792402
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,23404,170,0.89 [0.64-1.23],0.4856259254785502
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24186,178,0.72 [0.41-1.25],0.244059921334834
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGF1R,Insulin-like growth factor 1 receptor,27620,196,1.03 [0.58-1.84],0.907168919647288
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,23421,172,1.22 [0.94-1.58],0.1371740970907685
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGF2R,Cation-independent mannose-6-phosphate receptor,27746,198,1.44 [0.84-2.47],0.1846994782545818
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGFBP1,Insulin-like growth factor-binding protein 1,28032,200,0.99 [0.90-1.11],0.9242164991443556
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGFBP2,Insulin-like growth factor-binding protein 2,28035,200,0.99 [0.82-1.20],0.9480694480363794
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGFBP3,Insulin-like growth factor-binding protein 3,27837,194,1.01 [0.63-1.61],0.9703458444084132
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGFBP4,Insulin-like growth factor-binding protein 4,27373,195,0.97 [0.71-1.33],0.8595810595577452
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGFBP6,Insulin-like growth factor-binding protein 6,27609,193,0.78 [0.49-1.25],0.309578122834198
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGFBP7,Insulin-like growth factor-binding protein 7,28081,200,1.18 [0.79-1.76],0.4176714482837671
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGFBPL1,Insulin-like growth factor-binding protein-like 1,27743,197,0.74 [0.51-1.08],0.1211408244421864
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGFL4,Insulin growth factor-like family member 4,23501,175,1.20 [1.04-1.38],0.0100756464151915
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGHMBP2,DNA-binding protein SMUBP-2,23421,172,1.09 [0.86-1.39],0.4827767943775183
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGLC2,Immunoglobulin lambda constant 2,24184,177,1.00 [0.55-1.81],0.9965286142187956
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGLON5,IgLON family member 5,23311,173,1.10 [0.97-1.26],0.1468688779033059
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGSF21,Immunoglobulin superfamily member 21,23566,168,0.88 [0.59-1.31],0.5309570704363009
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGSF3,Immunoglobulin superfamily member 3,27620,196,1.12 [0.81-1.57],0.4900363093498118
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGSF8,Immunoglobulin superfamily member 8,27743,197,1.16 [0.77-1.74],0.4898882046474727
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGSF9,Protein turtle homolog A,24188,179,1.07 [0.90-1.27],0.4423366867949313
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IKBKG,NF-kappa-B essential modulator,27699,197,0.99 [0.86-1.14],0.8977987769063421
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IKZF2,Zinc finger protein Helios,27092,194,1.06 [0.94-1.20],0.3178246390090651
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL10,Interleukin-10,27187,191,1.07 [0.93-1.24],0.3312475431312555
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL10RA,Interleukin-10 receptor subunit alpha,27187,191,0.95 [0.76-1.19],0.6528243919162744
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL10RB,Interleukin-10 receptor subunit beta,27880,196,0.85 [0.54-1.33],0.4695288538920585
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL11,Interleukin-11,27187,191,0.80 [0.63-1.01],0.0623705521894818
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL12A_IL12B,Interleukin-12,27620,196,0.91 [0.77-1.07],0.2631255442615633
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL12B,Interleukin-12 subunit beta,28030,197,0.84 [0.67-1.07],0.1545262031273124
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL12RB1,Interleukin-12 receptor subunit beta-1,27187,191,1.05 [0.75-1.48],0.7632446643110148
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL12RB2,Interleukin-12 receptor subunit beta-2,23501,175,1.19 [0.86-1.65],0.3018233899011643
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL13,Interleukin-13,27187,191,1.05 [0.83-1.34],0.6780797158287797
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL13RA1,Interleukin-13 receptor subunit alpha-1,27404,191,1.09 [0.59-2.01],0.7845899609859064
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL13RA2,Interleukin-13 receptor subunit alpha-2,23404,170,0.78 [0.47-1.30],0.3352164571888295
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL15,Interleukin-15,27699,197,1.54 [1.08-2.20],0.0173108712201818
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL15RA,Interleukin-15 receptor subunit alpha,27187,191,0.92 [0.64-1.33],0.6610214195154311
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL16,Pro-interleukin-16,28030,197,0.95 [0.71-1.29],0.7596468374111428
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL17A,Interleukin-17A,27157,191,1.15 [0.87-1.52],0.3393544577888698
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL17C,Interleukin-17C,27187,191,0.90 [0.74-1.10],0.2989082192337744
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL17D,Interleukin-17D,27187,191,1.01 [0.68-1.48],0.977132451066247
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL17F,Interleukin-17F,27187,191,1.05 [0.90-1.22],0.5320610031130799
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL17RA,Interleukin-17 receptor A,27746,198,1.09 [0.82-1.45],0.5521784419047957
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL17RB,Interleukin-17 receptor B,27347,194,0.86 [0.68-1.09],0.226064579577372
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL18,Interleukin-18,27656,194,1.15 [0.88-1.49],0.3052760799932461
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL18BP,Interleukin-18-binding protein,27837,194,1.06 [0.70-1.61],0.7794426617503252
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL18R1,Interleukin-18 receptor 1,28030,197,1.10 [0.76-1.60],0.6222110213439651
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL18RAP,Interleukin-18 receptor accessory protein,27376,195,1.08 [1.01-1.16],0.0335158460437526
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL19,Interleukin-19,27051,197,1.07 [0.89-1.28],0.4818786418667926
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL1A,Interleukin-1 alpha,27187,191,1.03 [0.81-1.29],0.822772822068952
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL1B,Interleukin-1 beta,27055,191,1.05 [0.84-1.31],0.697221004555606
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL1R1,Interleukin-1 receptor type 1,27704,197,1.06 [0.61-1.86],0.8304852047148665
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL1R2,Interleukin-1 receptor type 2,27702,195,1.51 [0.78-2.91],0.2199842288944701
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL1RAP,Interleukin-1 receptor accessory protein,27746,198,1.17 [0.88-1.56],0.2745238935869487
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL1RL1,Interleukin-1 receptor-like 1,27991,200,1.02 [0.77-1.34],0.9065165361913592
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL1RL2,Interleukin-1 receptor-like 2,27187,191,1.24 [0.90-1.71],0.1851173787329116
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL1RN,Interleukin-1 receptor antagonist protein,27702,195,1.11 [0.90-1.38],0.3289185593044578
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL2,Interleukin-2,27187,191,1.31 [0.87-1.98],0.1927901176691149
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL20,Interleukin-20,27187,191,1.10 [0.88-1.39],0.3915550048469084
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL20RA,Interleukin-20 receptor subunit alpha,27187,191,0.97 [0.73-1.30],0.8545264059775387
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL20RB,Interleukin-20 receptor subunit beta,23501,175,1.09 [0.78-1.52],0.6179449027513527
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL21R,Interleukin-21 receptor,23501,175,0.89 [0.67-1.19],0.4403347068513958
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL22,Interleukin-22,24051,179,1.12 [0.92-1.38],0.261459412498931
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL22RA1,Interleukin-22 receptor subunit alpha-1,27187,191,0.93 [0.69-1.27],0.6684365479001888
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL24,Interleukin-24,27187,191,1.09 [0.85-1.40],0.4955295173169791
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL25,Interleukin-25,23232,173,0.94 [0.62-1.42],0.7618718320886405
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL2RA,Interleukin-2 receptor subunit alpha,27527,198,0.91 [0.66-1.25],0.5542022607884227
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL2RB,Interleukin-2 receptor subunit beta,27187,191,0.97 [0.69-1.36],0.8476811158896843
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL2RG,Cytokine receptor common subunit gamma,24051,179,0.77 [0.51-1.19],0.2387715560078492
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL3,Interleukin-3,23311,173,0.95 [0.75-1.20],0.656973542977527
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL31,Interleukin-31,23501,175,0.90 [0.68-1.17],0.4230472034459522
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL31RA,Interleukin-31 receptor subunit alpha,23404,173,1.29 [0.91-1.84],0.1584593439035838
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL32,Interleukin-32,27699,197,1.06 [0.79-1.42],0.7066454537778513
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL33,Interleukin-33,27187,191,1.36 [0.98-1.90],0.0638736604086396
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL34,Interleukin-34,27021,191,0.88 [0.62-1.26],0.4870038528664725
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL36A,Interleukin-36 alpha,23501,175,1.15 [0.93-1.42],0.2125970189144556
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL36G,Interleukin-36 gamma,23401,173,1.02 [0.83-1.25],0.8696965295023363
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL3RA,Interleukin-3 receptor subunit alpha,27187,191,1.05 [0.70-1.57],0.8119738637723223
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL4,Interleukin-4,27187,191,0.96 [0.84-1.10],0.540137490299976
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL4R,Interleukin-4 receptor subunit alpha,27699,197,1.05 [0.74-1.50],0.7722196356938809
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL5,Interleukin-5,27187,191,0.98 [0.89-1.07],0.5992055667814911
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL5RA,Interleukin-5 receptor subunit alpha,27699,197,0.91 [0.72-1.15],0.439201861994195
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL6,Interleukin-6,27620,196,1.02 [0.86-1.22],0.7867271080179998
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL6R,Interleukin-6 receptor subunit alpha,27562,194,1.43 [0.99-2.08],0.0585721378154435
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL6ST,Interleukin-6 receptor subunit beta,27743,197,1.94 [0.98-3.83],0.0566625355886088
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL7,Interleukin-7,27699,197,0.96 [0.79-1.17],0.6876129348956215
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL7R,Interleukin-7 receptor subunit alpha,27746,198,1.07 [0.84-1.35],0.5909983720760246
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL9,Interleukin-9,23735,176,1.06 [0.84-1.35],0.6069603181626462
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,27025,192,1.10 [0.89-1.36],0.3944090130861735
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IMMT,MICOS complex subunit MIC60,24051,179,1.30 [0.99-1.71],0.0615301722384371
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IMPA1,Inositol monophosphatase 1,27549,196,0.99 [0.80-1.22],0.9164398870565056
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IMPACT,Protein IMPACT,24131,176,1.10 [0.85-1.41],0.4643520423135454
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IMPG1,Interphotoreceptor matrix proteoglycan 1,23404,170,1.08 [0.68-1.71],0.751916967009548
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ING1,Inhibitor of growth protein 1,27012,192,0.95 [0.71-1.26],0.7147838214603761
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INHBB,Inhibin beta B chain,23677,173,1.02 [0.76-1.35],0.9098009728280754
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INHBC,Inhibin beta C chain,27746,198,0.92 [0.69-1.23],0.5578506339645138
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INPP1,Inositol polyphosphate 1-phosphatase,27620,196,1.06 [0.84-1.33],0.6178531060417711
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",23566,168,1.03 [0.80-1.34],0.8012904612417113
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24149,177,1.13 [0.83-1.52],0.4432420000519143
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",27620,196,0.99 [0.87-1.13],0.9195338190393928
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INSL3,Insulin-like 3,24131,176,0.94 [0.74-1.18],0.5798884947419959
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INSL4,Early placenta insulin-like peptide,24051,179,0.94 [0.72-1.24],0.6670489332759202
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INSL5,Insulin-like peptide INSL5,24062,176,1.02 [0.88-1.19],0.7718835444966886
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INSR,Insulin receptor,23501,175,1.10 [0.46-2.62],0.8227274807244348
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IPCEF1,Interactor protein for cytohesin exchange factors 1,27507,196,1.07 [0.93-1.24],0.3302806049442834
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IQGAP2,Ras GTPase-activating-like protein IQGAP2,27620,196,0.96 [0.76-1.20],0.6992028357867123
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",27233,194,1.00 [0.87-1.15],0.9988744481735689
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IRAK1,Interleukin-1 receptor-associated kinase 1,27187,191,0.97 [0.81-1.17],0.7607116504956264
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IRAK4,Interleukin-1 receptor-associated kinase 4,27699,197,1.05 [0.93-1.19],0.4108814848120707
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,26681,190,1.06 [0.75-1.50],0.7296266943201397
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ISM1,Isthmin-1,27699,197,1.16 [0.84-1.59],0.3649130640182891
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ISM2,Isthmin-2,24186,178,0.91 [0.65-1.27],0.5690142204013213
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IST1,IST1 homolog,23893,175,1.04 [0.90-1.20],0.6088932680539625
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGA11,Integrin alpha-11,27699,197,1.20 [0.84-1.72],0.3217272259140316
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGA2,Integrin alpha-2,23677,173,1.21 [0.78-1.89],0.3863527222239357
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGA5,Integrin alpha-5,27746,198,1.01 [0.61-1.67],0.9772508610891708
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGA6,Integrin alpha-6,27699,197,0.96 [0.76-1.22],0.7556575275865548
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGAL,Integrin alpha-L,23501,175,0.92 [0.66-1.27],0.6015414211772376
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGAM,Integrin alpha-M,27746,198,0.88 [0.59-1.31],0.5395512327248703
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGAV,Integrin alpha-V,27975,194,1.30 [0.61-2.81],0.4985213023852607
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGAX,Integrin alpha-X,23735,176,0.88 [0.67-1.17],0.3916627615093579
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGB1,Integrin beta-1,27699,194,0.95 [0.53-1.70],0.8609558575810871
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGB1BP1,Integrin beta-1-binding protein 1,27092,194,1.13 [0.83-1.53],0.432958954974897
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGB1BP2,Integrin beta-1-binding protein 2,27233,194,0.98 [0.88-1.10],0.7794172685438084
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGB2,Integrin beta-2,27567,199,0.95 [0.61-1.47],0.8122076292234361
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGB5,Integrin beta-5,27840,197,1.02 [0.73-1.42],0.9089766960044524
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGB6,Integrin beta-6,27187,191,1.08 [0.70-1.66],0.7374568765134997
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGB7,Integrin beta-7,27975,194,1.08 [0.82-1.42],0.5938834783164986
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGBL1,Integrin beta-like protein 1,24186,178,0.71 [0.47-1.09],0.1209062277372592
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24235,177,0.83 [0.39-1.78],0.6311933798435572
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,27837,194,1.00 [0.71-1.39],0.98944667003535
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24235,177,1.36 [0.83-2.24],0.2216143889690089
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24051,179,1.05 [0.78-1.42],0.7597739215564201
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITM2A,Integral membrane protein 2A,27699,197,0.92 [0.74-1.14],0.4429557506380358
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITPA,Inosine triphosphate pyrophosphatase,23421,172,1.03 [0.83-1.27],0.8169089804888693
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",23566,168,1.04 [0.85-1.28],0.6908630121228546
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",23404,170,1.14 [0.86-1.51],0.3717226361115165
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",27063,192,0.79 [0.60-1.04],0.096345571754778
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IZUMO1,Izumo sperm-egg fusion protein 1,23311,173,1.05 [0.79-1.39],0.7244538533831855
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",JAM2,Junctional adhesion molecule B,27981,197,1.37 [0.85-2.21],0.193247246168402
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",JAM3,Junctional adhesion molecule C,23677,173,0.99 [0.75-1.33],0.9728085547520297
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",JCHAIN,Immunoglobulin J chain,27187,191,0.95 [0.77-1.18],0.6493759458446269
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,23311,173,1.05 [0.82-1.36],0.6872755468873177
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",JPT2,Jupiter microtubule associated homolog 2,24062,176,1.13 [0.96-1.33],0.1553256719338245
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",JUN,Transcription factor AP-1,27187,191,1.10 [0.88-1.37],0.3896627065037035
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,27620,196,0.84 [0.65-1.10],0.2004884539037421
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KAZN,Kazrin,24062,176,1.03 [0.89-1.18],0.7033787935934649
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KCNC4,Potassium voltage-gated channel subfamily C member 4,23404,170,0.90 [0.68-1.19],0.4666801095820834
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KCNH2,Potassium voltage-gated channel subfamily H member 2,23510,172,0.88 [0.71-1.09],0.2593457271179754
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KCNIP4,Kv channel-interacting protein 4,27063,192,1.07 [0.85-1.35],0.5500717887687534
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KCTD5,BTB/POZ domain-containing protein KCTD5,23681,175,1.04 [0.75-1.44],0.8025665561481571
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KDM3A,Lysine-specific demethylase 3A,23501,175,1.12 [0.99-1.28],0.0742661919121557
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KDR,Vascular endothelial growth factor receptor 2,27840,197,1.16 [0.71-1.89],0.5526637796582841
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KEL,Kell blood group glycoprotein,27063,192,0.98 [0.68-1.40],0.8947599197824094
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KHDC3L,KH domain-containing protein 3,23311,173,1.25 [1.07-1.46],0.0059129375016048
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KHK,Ketohexokinase,23566,168,1.10 [0.87-1.38],0.4292941913544771
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIAA0319,Dyslexia-associated protein KIAA0319,24131,176,0.83 [0.52-1.33],0.4409597191349433
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIAA1549,UPF0606 protein KIAA1549,23735,176,1.06 [0.87-1.30],0.5485532739907082
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIAA1549L,UPF0606 protein KIAA1549L,23735,176,0.82 [0.48-1.37],0.4426208299875649
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIAA2013,Uncharacterized protein KIAA2013,24051,179,0.96 [0.74-1.24],0.7373518936638999
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIF1C,Kinesin-like protein KIF1C,23421,172,1.15 [0.81-1.64],0.4296736271993538
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIF20B,Kinesin-like protein KIF20B,23404,170,1.05 [0.88-1.26],0.5850601584443114
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIF22,Kinesin-like protein KIF22,23421,172,1.02 [0.90-1.15],0.7384683543454855
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIFBP,KIF-binding protein,27620,196,0.98 [0.85-1.15],0.834190514817835
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24051,179,0.93 [0.79-1.10],0.4211862024071359
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,27092,194,0.96 [0.81-1.14],0.651538770088075
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24062,176,0.93 [0.85-1.02],0.1078082228523335
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,27092,194,1.02 [0.92-1.14],0.6836292368665708
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,23311,173,1.02 [0.86-1.20],0.8460459254331392
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIRREL1,Kin of IRRE-like protein 1,23404,170,0.97 [0.75-1.24],0.7817340457136255
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIRREL2,Kin of IRRE-like protein 2,27063,192,0.98 [0.71-1.35],0.8961106081337619
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIT,Mast/stem cell growth factor receptor Kit,27789,194,1.17 [0.77-1.80],0.4618943082468787
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KITLG,Kit ligand,27743,197,0.78 [0.56-1.09],0.1488208597216041
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLB,Beta-klotho,27063,192,0.95 [0.80-1.14],0.5923968340908214
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLF4,Krueppel-like factor 4,23404,170,1.34 [0.97-1.86],0.0761010087791396
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLHL41,Kelch-like protein 41,24149,177,1.30 [1.02-1.66],0.0316273606238169
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK1,Kallikrein-1,27465,195,1.01 [0.92-1.12],0.7675762905311755
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK10,Kallikrein-10,27747,196,1.08 [0.79-1.48],0.6289828926361458
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK11,Kallikrein-11,27575,196,1.17 [0.78-1.77],0.4460284255250062
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK12,Kallikrein-12,27092,194,1.01 [0.92-1.10],0.8401707120318512
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK13,Kallikrein-13,27140,189,1.20 [0.90-1.61],0.2181363366233929
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK14,Kallikrein-14,27975,194,1.29 [0.99-1.69],0.0582437951345131
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK15,Kallikrein-15,24012,179,1.05 [0.80-1.39],0.7130430352249271
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK3,Prostate-specific antigen,24186,178,0.96 [0.75-1.24],0.7561540381157202
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK4,Kallikrein-4,27975,194,0.82 [0.66-1.02],0.0721738019323577
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK6,Kallikrein-6,27800,197,1.09 [0.72-1.65],0.6885326836472683
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK7,Kallikrein-7,23043,167,1.28 [0.89-1.86],0.1844361137461725
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK8,Kallikrein-8,26822,190,1.19 [0.83-1.71],0.3480113853894147
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLKB1,Plasma kallikrein,23745,174,2.26 [1.30-3.95],0.0040211715450927
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLRB1,Killer cell lectin-like receptor subfamily B member 1,28030,197,0.99 [0.70-1.39],0.9369044692973862
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,23404,170,0.91 [0.70-1.18],0.4596383788592152
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLRD1,Natural killer cells antigen CD94,28030,197,1.08 [0.82-1.42],0.575040437114769
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLRF1,Killer cell lectin-like receptor subfamily F member 1,23501,175,1.03 [0.74-1.44],0.8512348229685042
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLRK1,NKG2-D type II integral membrane protein,24131,176,0.88 [0.64-1.20],0.4131637277541046
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KRT14,"Keratin, type I cytoskeletal 14",26186,189,1.12 [0.72-1.73],0.6230476634308005
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KRT17,"Keratin, type I cytoskeletal 17",23421,172,0.84 [0.56-1.25],0.3921108127024889
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KRT18,"Keratin, type I cytoskeletal 18",27620,196,1.01 [0.86-1.18],0.9462916724453118
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KRT19,"Keratin, type I cytoskeletal 19",27657,196,1.03 [0.85-1.24],0.7928936598659394
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KRT5,"Keratin, type II cytoskeletal 5",27063,192,1.09 [0.84-1.41],0.5298389027203798
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KRT6C,"Keratin, type II cytoskeletal 6C",23421,172,1.10 [0.79-1.52],0.5871717620810792
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KRT8,"Keratin, type II cytoskeletal 8",23404,170,0.84 [0.63-1.12],0.2448168132137257
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KYAT1,Kynurenine--oxoglutarate transaminase 1,27696,197,1.14 [0.92-1.42],0.2179579506552188
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KYNU,Kynureninase,28030,197,1.33 [1.02-1.73],0.0322772427886846
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",L1CAM,Neural cell adhesion molecule L1,27840,197,1.05 [0.68-1.63],0.8256452207871094
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24188,179,1.08 [0.92-1.26],0.3459944794623836
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LACRT,Extracellular glycoprotein lacritin,24006,179,0.90 [0.67-1.21],0.5002098345246708
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LACTB2,Endoribonuclease LACTB2,27743,197,1.04 [0.86-1.26],0.6646686351160507
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAG3,Lymphocyte activation gene 3 protein,27620,196,0.79 [0.58-1.09],0.1594979802904043
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,27745,195,1.24 [0.90-1.71],0.1905859371498731
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,27549,196,1.06 [0.93-1.20],0.3767660192623455
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAMA1,Laminin subunit alpha-1,23421,172,0.89 [0.66-1.19],0.4282623543654219
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAMA4,Laminin subunit alpha-4,27880,196,1.16 [0.80-1.69],0.4352145274033766
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAMB1,Laminin subunit beta-1,23566,168,1.07 [0.65-1.76],0.789964180449271
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAMP1,Lysosome-associated membrane glycoprotein 1,23505,176,1.04 [0.63-1.72],0.8732648830130842
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAMP2,Lysosome-associated membrane glycoprotein 2,26899,189,1.37 [0.68-2.78],0.3810146516649718
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAMP3,Lysosome-associated membrane glycoprotein 3,27984,196,0.99 [0.78-1.26],0.9362587976551474
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAMTOR5,Ragulator complex protein LAMTOR5,24051,179,1.33 [1.00-1.77],0.0488519368894292
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAP3,Cytosol aminopeptidase,27187,191,0.88 [0.67-1.15],0.3462857292320729
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LARP1,La-related protein 1,24051,179,1.08 [0.88-1.33],0.4595965789279173
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAT,Linker for activation of T-cells family member 1,28030,197,1.04 [0.88-1.22],0.6654707172469707
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAT2,Linker for activation of T-cells family member 2,27620,196,1.01 [0.91-1.12],0.8059156656315658
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LATS1,Serine/threonine-protein kinase LATS1,23501,175,1.05 [0.88-1.25],0.5837085386093561
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAYN,Layilin,27498,196,0.98 [0.67-1.44],0.9266482390827404
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LBP,Lipopolysaccharide-binding protein,27837,194,1.03 [0.83-1.27],0.8191639075251466
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LBR,Delta(14)-sterol reductase LBR,27981,197,1.06 [0.89-1.26],0.538721707438937
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LCAT,Phosphatidylcholine-sterol acyltransferase,24199,176,1.74 [0.90-3.37],0.1021671515700752
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LCN15,Lipocalin-15,24149,177,1.04 [0.84-1.30],0.698571222226873
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LCN2,Neutrophil gelatinase-associated lipocalin,26897,182,1.09 [0.77-1.53],0.6433017137494196
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LCP1,Plastin-2,24186,178,1.01 [0.75-1.36],0.9580888715529678
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LDLR,Low-density lipoprotein receptor,27810,199,1.30 [1.03-1.64],0.0263978811463936
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LDLRAP1,Low density lipoprotein receptor adapter protein 1,24149,177,1.05 [0.90-1.22],0.5228998462789533
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LECT2,Leukocyte cell-derived chemotaxin-2,24188,179,1.07 [0.86-1.32],0.5650975813894503
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LEFTY2,Left-right determination factor 2,27926,194,0.86 [0.68-1.09],0.2032675362705801
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LEG1,Protein LEG1 homolog,22847,170,0.86 [0.68-1.07],0.1720159568466064
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LELP1,Late cornified envelope-like proline-rich protein 1,23404,170,0.91 [0.74-1.13],0.3866367749115854
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LEO1,RNA polymerase-associated protein LEO1,24149,177,1.14 [0.75-1.74],0.5350762310510804
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LEP,Leptin,27743,197,1.10 [0.90-1.34],0.3633553993639312
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LEPR,Leptin receptor,27743,197,1.06 [0.71-1.59],0.7806257818366756
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LETM1,Mitochondrial proton/calcium exchanger protein,24149,177,1.14 [0.88-1.48],0.330072979843436
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LGALS1,Galectin-1,27743,197,1.28 [0.89-1.85],0.1795039680692439
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LGALS3,Galectin-3,27804,200,1.79 [1.19-2.69],0.0053391100458366
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LGALS3BP,Galectin-3-binding protein,24235,177,0.80 [0.49-1.32],0.3890036130078411
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LGALS4,Galectin-4,27745,195,1.03 [0.81-1.31],0.7909938019680132
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LGALS7_LGALS7B,Galectin-7,27658,193,1.26 [0.95-1.68],0.1073962515625688
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LGALS8,Galectin-8,27981,197,1.03 [0.84-1.27],0.7601514914806521
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LGALS9,Galectin-9,27742,196,1.10 [0.75-1.62],0.6225331409967441
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LGMN,Legumain,27880,196,1.02 [0.72-1.45],0.8985652020833934
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LHB,Lutropin subunit beta,27092,194,1.03 [0.89-1.19],0.6825878728120627
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,27792,195,1.04 [0.84-1.28],0.7418025347034518
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LIF,Leukemia inhibitory factor,27063,192,1.11 [0.88-1.39],0.3725989429563371
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LIFR,Leukemia inhibitory factor receptor,27699,197,0.83 [0.50-1.39],0.4806894925129569
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,27746,198,1.15 [0.81-1.64],0.4381500255769393
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24186,178,1.08 [0.95-1.22],0.2241689303181272
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,23421,172,0.98 [0.74-1.30],0.8939685213893056
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,27698,197,1.37 [0.92-2.04],0.1169073396254796
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24188,179,1.00 [0.82-1.22],0.9985193372549808
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,28081,200,1.49 [0.94-2.35],0.08684150036883
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,27945,200,1.16 [0.80-1.67],0.4394038133823654
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,27187,191,1.15 [0.85-1.54],0.357910514993064
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,28081,200,1.10 [0.92-1.32],0.2893534105819602
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LIPF,Gastric triacylglycerol lipase,23566,168,1.17 [0.92-1.48],0.2061763122354555
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LMNB1,Lamin-B1,24015,176,1.06 [0.85-1.33],0.5830614915206536
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LMNB2,Lamin-B2,24131,176,1.50 [0.95-2.37],0.0841870551169396
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LMOD1,Leiomodin-1,24149,177,1.15 [0.80-1.67],0.4444450385789822
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LMOD2,Leiomodin-2,23404,170,1.12 [0.91-1.38],0.2761001682408782
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LONP1,"Lon protease homolog, mitochondrial",23566,168,1.02 [0.86-1.20],0.864208786764898
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LPA,Apolipoprotein(a),23636,173,0.95 [0.88-1.04],0.2701951695430562
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LPCAT2,Lysophosphatidylcholine acyltransferase 2,27620,196,1.09 [0.84-1.43],0.509062615196598
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LPL,Lipoprotein lipase,27743,197,1.10 [0.84-1.46],0.4803749117178852
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LPO,Lactoperoxidase,26881,188,0.80 [0.64-0.99],0.0435664551879207
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LPP,Lipoma-preferred partner,23421,172,1.11 [0.89-1.38],0.3564579566343658
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,23421,172,0.94 [0.76-1.17],0.5878078639526259
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,23510,172,0.90 [0.65-1.23],0.494285961801249
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRG1,Leucine-rich alpha-2-glycoprotein,24235,177,0.70 [0.41-1.21],0.2047501468969975
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,27888,194,1.29 [0.89-1.85],0.1770771779408924
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,23410,174,1.33 [0.88-2.03],0.175191277433839
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRP1,Prolow-density lipoprotein receptor-related protein 1,27620,196,1.59 [1.01-2.49],0.0439050468592073
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRP11,Low-density lipoprotein receptor-related protein 11,27743,197,1.01 [0.70-1.45],0.9497030533268536
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRP2,Low-density lipoprotein receptor-related protein 2,23510,172,0.97 [0.65-1.45],0.87161655309835
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRP2BP,LRP2-binding protein,23510,172,1.02 [0.86-1.20],0.8513426284953546
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,27981,197,1.29 [1.07-1.54],0.0061256680419664
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRRC25,Leucine-rich repeat-containing protein 25,27620,196,1.09 [0.79-1.49],0.6105559925492681
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRRC37A2,Leucine-rich repeat-containing protein 37A2,24062,176,0.89 [0.63-1.26],0.5120506286368367
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRRC38,Leucine-rich repeat-containing protein 38,23510,172,1.06 [0.80-1.41],0.6981739524166667
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRRC59,Leucine-rich repeat-containing protein 59,24188,179,1.08 [0.80-1.45],0.6273948065553595
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24051,179,1.02 [0.76-1.37],0.9084816092421696
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRRN1,Leucine-rich repeat neuronal protein 1,27187,191,1.09 [0.78-1.53],0.5957299282960158
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,23510,172,1.17 [0.85-1.60],0.3385480081007569
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24149,177,1.27 [0.79-2.04],0.3225756034216116
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LSM1,U6 snRNA-associated Sm-like protein LSm1,27092,194,0.79 [0.61-1.03],0.0767556796609156
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LSM8,U6 snRNA-associated Sm-like protein LSm8,23735,176,1.10 [0.95-1.26],0.1943760808291711
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LSP1,Lymphocyte-specific protein 1,27699,197,0.99 [0.73-1.35],0.9424198186406304
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LTA,Lymphotoxin-alpha,27699,197,0.89 [0.65-1.22],0.4731842194006354
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LTA4H,Leukotriene A-4 hydrolase,27975,194,1.10 [0.89-1.36],0.3720247252575952
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LTB,Lymphotoxin-beta,24051,179,1.29 [0.92-1.80],0.1417804091296436
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LTBP2,Latent-transforming growth factor beta-binding protein 2,28081,200,1.05 [0.71-1.55],0.8110758175190815
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LTBP3,Latent-transforming growth factor beta-binding protein 3,27092,194,1.13 [0.92-1.39],0.2504058035936802
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LTBR,Tumor necrosis factor receptor superfamily member 3,27615,195,0.91 [0.57-1.45],0.682169963372024
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LTO1,Protein LTO1 homolog,27187,191,1.11 [0.84-1.48],0.4641455097880143
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LUZP2,Leucine zipper protein 2,24051,179,1.15 [0.86-1.55],0.3466231079851382
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LXN,Latexin,27423,194,0.87 [0.72-1.07],0.1894475936475111
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LY6D,Lymphocyte antigen 6D,27610,195,1.22 [0.88-1.71],0.2361404393918453
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LY75,Lymphocyte antigen 75,27699,197,1.17 [0.84-1.62],0.3542387930081476
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LY9,T-lymphocyte surface antigen Ly-9,27444,193,0.74 [0.47-1.16],0.188211637930548
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LY96,Lymphocyte antigen 96,27549,196,1.29 [0.91-1.81],0.1494845458726875
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYAR,Cell growth-regulating nucleolar protein,27092,194,1.27 [1.07-1.51],0.006710118579178
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYN,Tyrosine-protein kinase Lyn,27620,196,0.99 [0.85-1.15],0.8733251672788922
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYPD1,Ly6/PLAUR domain-containing protein 1,27063,192,1.09 [0.92-1.30],0.3301774513203731
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYPD3,Ly6/PLAUR domain-containing protein 3,27612,195,1.00 [0.70-1.43],0.9939638485942236
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYPD8,Ly6/PLAUR domain-containing protein 8,27092,194,0.97 [0.76-1.25],0.8412203254478303
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYPLA2,Acyl-protein thioesterase 2,23404,170,1.04 [0.91-1.18],0.5518514350753354
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,23510,172,1.06 [0.92-1.21],0.4278560361385367
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24235,177,1.30 [0.63-2.69],0.4780495893085711
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYZL2,Lysozyme-like protein 2,23311,173,1.45 [1.06-1.98],0.0193233545220956
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LZTFL1,Leucine zipper transcription factor-like protein 1,23677,173,1.09 [0.89-1.33],0.4283439333938852
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",M6PR,Cation-dependent mannose-6-phosphate receptor,23566,168,0.83 [0.56-1.24],0.3642080601714265
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,27454,196,1.10 [0.87-1.39],0.4230103379950681
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAEA,E3 ubiquitin-protein transferase MAEA,27092,194,0.76 [0.53-1.07],0.1138467523282245
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAG,Myelin-associated glycoprotein,23510,172,1.28 [0.93-1.74],0.126191870054425
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAGEA3,Melanoma-associated antigen 3,23735,176,1.02 [0.86-1.21],0.8510133592821905
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAGED1,Melanoma-associated antigen D1,27092,194,0.95 [0.73-1.25],0.7248891742834253
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAMDC2,MAM domain-containing protein 2,24188,179,0.69 [0.45-1.07],0.0973453274572102
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAMDC4,Apical endosomal glycoprotein,24051,179,1.08 [0.84-1.39],0.540922357101576
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",23566,168,1.08 [0.61-1.90],0.800256902666735
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAN2B2,Epididymis-specific alpha-mannosidase,24188,179,1.03 [0.81-1.31],0.8020657891796422
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",23311,173,0.93 [0.70-1.25],0.6337091926305514
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MANF,Mesencephalic astrocyte-derived neurotrophic factor,27880,196,0.98 [0.89-1.09],0.7421635986333404
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MANSC1,MANSC domain-containing protein 1,27840,197,1.12 [0.71-1.76],0.6309683331233393
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MANSC4,MANSC domain-containing protein 4,23421,172,0.98 [0.78-1.24],0.8924842163433481
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,23404,170,0.80 [0.50-1.28],0.3532395833622197
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,23421,172,0.89 [0.69-1.14],0.3500084736819212
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAP2,Microtubule-associated protein 2,24131,176,1.14 [0.84-1.54],0.3923939599757601
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24062,176,1.08 [0.87-1.35],0.4796043679694567
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,27699,197,0.98 [0.86-1.11],0.7169418486986261
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,27092,194,1.01 [0.89-1.15],0.8544908352103042
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,27498,196,1.00 [0.89-1.12],0.980095472068214
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAPK13,Mitogen-activated protein kinase 13,23311,173,1.13 [0.84-1.52],0.4317685037164928
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAPK9,Mitogen-activated protein kinase 9,27699,197,1.05 [0.78-1.40],0.7607832112065324
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAPKAPK2,MAP kinase-activated protein kinase 2,23735,176,1.07 [0.88-1.30],0.4689945040382892
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAPRE3,Microtubule-associated protein RP/EB family member 3,23311,173,1.03 [0.93-1.13],0.5950853874799767
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAPT,Microtubule-associated protein tau,27063,192,1.02 [0.80-1.30],0.8740170747458857
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MARCO,Macrophage receptor MARCO,27743,197,1.37 [0.85-2.21],0.1935009771525648
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MARS1,"Methionine--tRNA ligase, cytoplasmic",23629,173,1.05 [0.89-1.25],0.540998282867263
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MASP1,Mannan-binding lectin serine protease 1,27498,196,0.84 [0.49-1.42],0.5062074106303361
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MATN2,Matrilin-2,27794,196,1.19 [0.78-1.80],0.4189856251041016
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MATN3,Matrilin-3,27507,196,0.87 [0.58-1.30],0.4938267429819112
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAVS,Mitochondrial antiviral-signaling protein,27092,194,0.97 [0.84-1.11],0.6593325958239529
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAX,Protein max,27063,192,1.04 [0.92-1.17],0.544596368285333
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MB,Myoglobin,28081,200,0.93 [0.72-1.21],0.6071102652149292
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MBL2,Mannose-binding protein C,23879,173,1.01 [0.89-1.16],0.8361592054267006
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MCAM,Cell surface glycoprotein MUC18,27837,194,1.26 [0.88-1.81],0.2104179381667141
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24149,177,0.90 [0.63-1.27],0.5416943956648176
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MCEMP1,Mast cell-expressed membrane protein 1,23501,175,1.14 [0.98-1.33],0.0816275460497339
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MCFD2,Multiple coagulation factor deficiency protein 2,27626,197,0.98 [0.74-1.31],0.9066374651810346
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MCTS1,Malignant T-cell-amplified sequence 1,24062,176,1.13 [0.67-1.90],0.6382341961575508
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,27549,196,1.05 [0.88-1.25],0.5973260437672898
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MDH1,"Malate dehydrogenase, cytoplasmic",24055,175,1.18 [0.84-1.65],0.3407167346884283
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MDK,Midkine,27761,197,1.11 [0.87-1.40],0.4020136571823809
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MDM1,Nuclear protein MDM1,23510,172,1.07 [0.67-1.71],0.7741637730180545
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",23566,168,1.03 [0.88-1.21],0.6894990640475478
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MED18,Mediator of RNA polymerase II transcription subunit 18,27092,194,1.01 [0.86-1.20],0.8702668603253454
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MED21,Mediator of RNA polymerase II transcription subunit 21,23421,172,1.02 [0.77-1.35],0.880561128125581
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MEGF10,Multiple epidermal growth factor-like domains protein 10,27745,195,1.04 [0.75-1.43],0.8332617622626136
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MEGF11,Multiple epidermal growth factor-like domains protein 11,23421,172,0.80 [0.49-1.30],0.3618517038278027
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MEGF9,Multiple epidermal growth factor-like domains protein 9,27991,200,2.08 [1.20-3.58],0.008506015344203
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MELTF,Melanotransferrin,24188,179,1.22 [0.75-1.99],0.4245845856548105
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MENT,Protein MENT,23677,173,1.04 [0.53-2.04],0.9134769216911772
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MEP1A,Meprin A subunit alpha,24062,176,1.19 [0.97-1.45],0.096634064728734
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MEP1B,Meprin A subunit beta,27743,197,0.95 [0.86-1.06],0.3812713042024066
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MEPE,Matrix extracellular phosphoglycoprotein,27745,195,1.10 [0.68-1.79],0.6887644856255397
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MERTK,Tyrosine-protein kinase Mer,28030,197,1.43 [0.89-2.28],0.1359532682158737
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MESD,LRP chaperone MESD,27746,198,1.01 [0.91-1.12],0.9152061990358497
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MET,Hepatocyte growth factor receptor,27816,198,1.68 [0.90-3.14],0.1013513271173925
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",METAP1,Methionine aminopeptidase 1,27063,192,1.23 [0.83-1.84],0.3056407130020921
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",27699,197,1.07 [0.92-1.25],0.3620668093476077
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",METAP2,Methionine aminopeptidase 2,27926,194,1.05 [0.85-1.31],0.6310371898208877
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MFAP3,Microfibril-associated glycoprotein 3,27233,194,1.16 [0.92-1.46],0.2114955823231008
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MFAP3L,Microfibrillar-associated protein 3-like,23510,172,0.91 [0.72-1.16],0.4491987630855589
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MFAP4,Microfibril-associated glycoprotein 4,23677,173,0.89 [0.56-1.41],0.6138018620574871
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MFAP5,Microfibrillar-associated protein 5,28081,200,0.92 [0.68-1.25],0.6031383795021081
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MFGE8,Lactadherin,27746,198,1.34 [1.01-1.78],0.0452663153691526
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MGLL,Monoglyceride lipase,27832,196,0.97 [0.84-1.12],0.7060535375119961
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MGMT,Methylated-DNA--protein-cysteine methyltransferase,27699,197,0.96 [0.87-1.06],0.3993057935568981
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MIA,Melanoma-derived growth regulatory protein,27840,197,0.94 [0.67-1.32],0.7001655428655076
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MICALL2,MICAL-like protein 2,23510,172,1.13 [0.92-1.38],0.2437744144899448
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,27699,197,0.98 [0.90-1.07],0.6769283398042318
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MIF,Macrophage migration inhibitory factor,27707,198,1.06 [0.88-1.27],0.5624578561084104
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MILR1,Allergin-1,27187,191,1.06 [0.82-1.37],0.6699743935529088
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24051,179,1.01 [0.89-1.16],0.8609444116888749
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MINK1,Misshapen-like kinase 1,24131,176,1.01 [0.86-1.18],0.9004132964850647
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MITD1,MIT domain-containing protein 1,27549,196,1.02 [0.89-1.16],0.7835417527993989
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MKI67,Proliferation marker protein Ki-67,23501,175,1.24 [0.92-1.69],0.159667870350724
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MLLT1,Protein ENL,23311,173,1.05 [0.87-1.28],0.6198157179084294
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MLN,Promotilin,27699,197,1.03 [0.89-1.18],0.7271567008233797
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MME,Neprilysin,27620,196,1.19 [1.02-1.37],0.0226140932923089
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP1,Interstitial collagenase,26672,183,1.08 [0.93-1.24],0.310130213962978
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP10,Stromelysin-2,27704,195,0.84 [0.68-1.04],0.1177102078531259
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP12,Macrophage metalloelastase,27751,193,1.07 [0.84-1.37],0.5925321464052544
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP13,Collagenase 3,27063,192,0.91 [0.62-1.36],0.659373032941708
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP15,Matrix metalloproteinase-15,24188,179,0.78 [0.54-1.12],0.1847185888386057
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP3,Stromelysin-1,27746,198,1.15 [0.89-1.48],0.2833091871364428
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP7,Matrilysin,27186,194,1.20 [0.91-1.57],0.1981997266635961
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP8,Neutrophil collagenase,27934,197,1.04 [0.88-1.23],0.6466444019220303
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP9,Matrix metalloproteinase-9,27697,197,0.98 [0.80-1.20],0.8308196932182069
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",23421,172,0.97 [0.72-1.31],0.8664472477840711
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MN1,Transcriptional activator MN1,23510,172,1.02 [0.80-1.30],0.8714346830762008
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MNAT1,CDK-activating kinase assembly factor MAT1,23735,176,1.30 [0.99-1.71],0.0619555102212886
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MNDA,Myeloid cell nuclear differentiation antigen,27702,197,1.01 [0.89-1.14],0.9160750794923738
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MOCS2,Molybdopterin synthase catalytic subunit,23677,173,1.16 [0.94-1.43],0.1769280436492067
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MOG,Myelin-oligodendrocyte glycoprotein,27975,194,1.16 [0.79-1.72],0.4485551204552891
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MORC3,MORC family CW-type zinc finger protein 3,24131,176,1.28 [0.83-1.98],0.2577728409972281
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MORF4L1,Mortality factor 4-like protein 1,23735,176,1.01 [0.72-1.43],0.9400811979352164
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MORF4L2,Mortality factor 4-like protein 2,23311,173,0.95 [0.64-1.42],0.8137136200140794
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MORN4,MORN repeat-containing protein 4,23311,173,0.92 [0.75-1.13],0.4275734690777788
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MPHOSPH8,M-phase phosphoprotein 8,27233,194,1.08 [0.92-1.28],0.340805368394951
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MPI,Mannose-6-phosphate isomerase,27620,196,1.05 [0.91-1.22],0.485267387205413
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,27832,196,0.96 [0.82-1.13],0.6503734531733827
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MPO,Myeloperoxidase,27746,198,0.97 [0.74-1.26],0.8018763285212459
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MPRIP,Myosin phosphatase Rho-interacting protein,24001,178,0.98 [0.71-1.36],0.9261900457702174
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MRC1,Macrophage mannose receptor 1,24199,176,1.37 [0.83-2.26],0.2151117846439599
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MRI1,Methylthioribose-1-phosphate isomerase,23510,172,1.23 [0.99-1.52],0.0587013852599592
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MRPL24,"39S ribosomal protein L24, mitochondrial",23421,172,1.33 [1.02-1.73],0.0335790868638373
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MRPL28,"39S ribosomal protein L28, mitochondrial",24149,177,1.18 [0.87-1.59],0.2870088548405476
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MRPL46,"39S ribosomal protein L46, mitochondrial",27063,192,0.91 [0.57-1.47],0.7046727590585576
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MRPL52,"39S ribosomal protein L52, mitochondrial",23271,173,1.61 [0.96-2.71],0.073116391539166
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24149,177,0.93 [0.76-1.14],0.4769969469038806
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MRPS16,"28S ribosomal protein S16, mitochondrial",23501,175,1.17 [0.77-1.80],0.4612674387317789
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MSLN,Mesothelin,27577,196,1.07 [0.85-1.34],0.5714013773030279
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MSLNL,Mesothelin-like protein,23510,172,0.68 [0.44-1.03],0.0712502904239239
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MSMB,Beta-microseminoprotein,27649,199,1.11 [0.93-1.33],0.2584864557135801
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MSR1,Macrophage scavenger receptor types I and II,27981,197,1.26 [0.95-1.67],0.102324336448553
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MSRA,Mitochondrial peptide methionine sulfoxide reductase,27840,197,1.05 [0.88-1.24],0.5910067939243497
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MST1,Hepatocyte growth factor-like protein,23822,175,1.24 [0.92-1.65],0.1534208609099047
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MSTN,Growth/differentiation factor 8,27233,194,1.01 [0.79-1.30],0.9434393756250904
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTDH,Protein LYRIC,23501,175,1.13 [0.97-1.33],0.1217399380588113
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24131,176,0.85 [0.48-1.51],0.5768025968956818
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,23735,176,1.00 [0.88-1.14],0.9797971268007974
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTIF3,"Translation initiation factor IF-3, mitochondrial",24062,176,1.08 [0.92-1.27],0.363710403249211
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTPN,Myotrophin,27233,194,0.72 [0.47-1.12],0.1487935784179992
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTR,Methionine synthase,23421,172,1.24 [1.04-1.48],0.0163277743384193
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTSS1,Protein MTSS 1,24062,176,1.02 [0.90-1.17],0.7190564609062644
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTSS2,Protein MTSS 2,24051,179,1.02 [0.89-1.18],0.742397183868041
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTUS1,Microtubule-associated tumor suppressor 1,23735,176,1.01 [0.78-1.30],0.9557722204502812
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MUC13,Mucin-13,27063,192,0.89 [0.68-1.15],0.3601109629328719
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MUC16,Mucin-16,27620,196,0.98 [0.92-1.04],0.505278513094088
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MUC2,Mucin-2,24186,178,1.13 [0.97-1.32],0.129850072047182
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MUCL3,Mucin-like protein 3,23311,173,0.93 [0.66-1.30],0.6756555302759732
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MVK,Mevalonate kinase,27187,191,1.06 [0.90-1.25],0.5068707519633296
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MXRA8,Matrix remodeling-associated protein 8,23677,173,0.90 [0.56-1.46],0.6750737788146101
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYBPC1,"Myosin-binding protein C, slow-type",24188,179,1.07 [0.85-1.33],0.572880526336585
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYBPC2,"Myosin-binding protein C, fast-type",23566,168,0.99 [0.83-1.19],0.9330344517541
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24149,177,0.97 [0.78-1.20],0.7818664262316917
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYDGF,Myeloid-derived growth factor,24188,179,1.04 [0.90-1.19],0.6162142652643472
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYH4,Myosin-4,23421,172,0.87 [0.62-1.23],0.4356261085624071
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYH7B,Myosin-7B,23311,173,1.10 [0.82-1.49],0.5175848895952134
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYH9,Myosin-9,24186,178,1.05 [0.93-1.20],0.4137756309364326
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",23421,172,1.14 [0.84-1.56],0.4057558521839096
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYL3,Myosin light chain 3,23566,168,1.00 [0.81-1.25],0.9875658264950888
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYL4,Myosin light chain 4,23566,168,1.03 [0.79-1.36],0.8054186445123743
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYL6B,Myosin light chain 6B,23510,172,1.13 [0.98-1.29],0.0863804401397159
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",23510,172,1.09 [0.80-1.49],0.5843042200549025
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYO6,Unconventional myosin-VI,24149,177,0.94 [0.63-1.40],0.7563765647329306
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYO9B,Unconventional myosin-IXb,27187,191,0.92 [0.76-1.13],0.4417151833280524
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYOC,Myocilin,27746,198,1.00 [0.76-1.31],0.999808065427364
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYOM1,Myomesin-1,23404,170,0.95 [0.68-1.31],0.7404121273736151
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYOM2,Myomesin-2,23421,172,0.85 [0.61-1.20],0.3578435727441792
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYOM3,Myomesin-3,23677,173,1.04 [0.88-1.22],0.6435418925677202
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MZB1,Marginal zone B- and B1-cell-specific protein,27842,196,0.83 [0.64-1.07],0.1470182379404806
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MZT1,Mitotic-spindle organizing protein 1,27092,194,0.97 [0.76-1.24],0.8227154439149795
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAA10,N-alpha-acetyltransferase 10,23421,172,1.02 [0.76-1.36],0.9062517540751072
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAA80,N-alpha-acetyltransferase 80,23510,172,1.09 [0.96-1.23],0.189232787119877
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAAA,N-acylethanolamine-hydrolyzing acid amidase,27418,195,0.97 [0.78-1.20],0.7873605826756265
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NACC1,Nucleus accumbens-associated protein 1,24051,179,1.02 [0.79-1.32],0.8742497841909854
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NADK,NAD kinase,27743,197,1.00 [0.80-1.26],0.9663271039881612
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAGA,Alpha-N-acetylgalactosaminidase,23451,173,1.24 [1.03-1.50],0.0211815178518044
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAGK,N-acetyl-D-glucosamine kinase,23520,168,1.05 [0.81-1.35],0.7302627961232562
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,23677,173,2.44 [1.23-4.86],0.0109979775681414
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAMPT,Nicotinamide phosphoribosyltransferase,27092,194,1.01 [0.81-1.27],0.9202029021230178
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAP1L4,Nucleosome assembly protein 1-like 4,24021,176,1.01 [0.72-1.43],0.9422172336779407
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAPRT,Nicotinate phosphoribosyltransferase,24131,176,1.18 [0.78-1.78],0.4328520263331878
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NARS1,"Asparagine--tRNA ligase, cytoplasmic",24149,177,1.13 [0.83-1.53],0.4338659612200501
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NBL1,Neuroblastoma suppressor of tumorigenicity 1,27840,197,0.71 [0.44-1.15],0.1639473942361535
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NBN,Nibrin,27187,191,1.03 [0.81-1.30],0.8230706200023606
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCAM1,Neural cell adhesion molecule 1,27837,194,1.27 [0.81-1.99],0.300194766981566
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCAM2,Neural cell adhesion molecule 2,27746,198,1.37 [0.86-2.19],0.1820704702666223
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCAN,Neurocan core protein,27981,197,1.04 [0.74-1.46],0.8261828003662612
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCF2,Neutrophil cytosol factor 2,27661,197,0.95 [0.81-1.10],0.4716179731372174
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCK2,Cytoplasmic protein NCK2,27880,196,0.99 [0.88-1.12],0.8666373540489946
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCLN,Nicalin,27187,191,1.17 [0.97-1.42],0.10027540914383
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCR1,Natural cytotoxicity triggering receptor 1,27658,197,0.93 [0.65-1.32],0.6677645000075461
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24062,176,1.15 [0.75-1.78],0.5166970768948227
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCS1,Neuronal calcium sensor 1,27975,194,1.89 [1.23-2.92],0.0039424487933717
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NDRG1,Protein NDRG1,27063,192,1.12 [0.96-1.30],0.1567265230306707
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24051,179,1.11 [0.92-1.35],0.2638282814960729
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,23460,174,1.18 [0.79-1.77],0.4183789087614412
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24062,176,1.07 [0.91-1.25],0.4358337987968583
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",27092,194,0.92 [0.77-1.09],0.3276711319521119
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NEB,Nebulin,23421,172,0.89 [0.59-1.36],0.6001956107170993
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NECAP2,Adaptin ear-binding coat-associated protein 2,23421,172,0.96 [0.77-1.20],0.7351248484013213
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NECTIN1,Nectin-1,23501,175,0.76 [0.47-1.23],0.2588036732829565
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NECTIN2,Nectin-2,27698,197,0.93 [0.59-1.45],0.7402655326358487
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NECTIN4,Nectin-4,27840,197,0.86 [0.56-1.32],0.4890042779301594
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,23501,175,1.27 [0.93-1.73],0.1391138897607648
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NEDD9,Enhancer of filamentation 1,23501,175,0.99 [0.64-1.52],0.947717051732402
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NEFL,Neurofilament light polypeptide,26974,190,1.12 [0.83-1.51],0.4721837724273674
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NEK7,Serine/threonine-protein kinase Nek7,23735,176,0.95 [0.77-1.16],0.61293949707391
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NELL1,Protein kinase C-binding protein NELL1,27840,197,1.00 [0.74-1.35],0.9848153874668588
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NELL2,Protein kinase C-binding protein NELL2,27880,196,0.78 [0.50-1.23],0.2875834106816225
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NENF,Neudesin,24051,179,1.05 [0.93-1.18],0.42306889952056
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NEO1,Neogenin,24149,177,1.34 [0.72-2.50],0.3542223746012347
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NEXN,Nexilin,24199,176,0.92 [0.74-1.14],0.4630908947799029
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFASC,Neurofascin,28030,197,0.90 [0.57-1.43],0.6556352917692614
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFAT5,Nuclear factor of activated T-cells 5,23501,175,1.04 [0.89-1.23],0.6226129146174544
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",27699,197,1.01 [0.89-1.16],0.8498035370838436
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",27187,191,1.06 [0.85-1.31],0.6172003234535326
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFE2,Transcription factor NF-E2 45 kDa subunit,23566,168,0.97 [0.79-1.18],0.7541952737719073
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFIC,Nuclear factor 1 C-type,24149,177,1.07 [0.79-1.44],0.6817160772617274
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFKB1,Nuclear factor NF-kappa-B p105 subunit,23421,172,1.01 [0.83-1.24],0.8928850247660003
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFKB2,Nuclear factor NF-kappa-B p100 subunit,23735,176,0.81 [0.59-1.11],0.1860923395251199
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFKBIE,NF-kappa-B inhibitor epsilon,27092,194,1.02 [0.79-1.32],0.8772716559661354
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24062,176,1.06 [0.92-1.22],0.435789267495717
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFX1,Transcriptional repressor NF-X1,23421,172,1.13 [0.92-1.40],0.2425913959087778
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFYA,Nuclear transcription factor Y subunit alpha,23421,172,0.96 [0.66-1.40],0.8343776407900118
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NGF,Beta-nerve growth factor,27549,196,0.71 [0.25-2.02],0.5168910430434672
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NGFR,Tumor necrosis factor receptor superfamily member 16,24188,179,0.77 [0.45-1.30],0.3204097821829693
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NGRN,Neugrin,24131,176,1.17 [0.63-2.18],0.6186632999476758
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NHLRC3,NHL repeat-containing protein 3,23094,170,1.44 [0.90-2.29],0.1274784208570894
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NID1,Nidogen-1,27742,194,0.97 [0.71-1.34],0.8558010235450052
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NID2,Nidogen-2,27746,198,1.05 [0.89-1.24],0.5524184154856815
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NINJ1,Ninjurin-1,27092,194,1.25 [1.05-1.48],0.0112683773155568
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NIT1,Deaminated glutathione amidase,23566,168,1.12 [0.82-1.53],0.4690839249646722
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NIT2,Omega-amidase NIT2,24102,177,1.04 [0.86-1.26],0.6615725145893083
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NLGN1,Neuroligin-1,23510,172,1.09 [0.90-1.32],0.3716838842912621
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NLGN2,Neuroligin-2,23404,170,0.74 [0.52-1.07],0.1081116846570398
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NME1,Nucleoside diphosphate kinase A,23501,175,1.26 [0.67-2.39],0.4740510978329945
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NME3,Nucleoside diphosphate kinase 3,27794,196,0.89 [0.52-1.54],0.6811984448648969
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NMI,N-myc-interactor,23966,179,1.11 [0.92-1.35],0.2757740386147209
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,27549,196,1.01 [0.85-1.19],0.919045405958782
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NMRK2,Nicotinamide riboside kinase 2,23311,173,1.11 [0.82-1.51],0.5031015425406173
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24149,177,1.00 [0.81-1.24],0.996802188870218
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NOMO1,Nodal modulator 1,27746,198,1.33 [0.80-2.22],0.2729151039476303
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NOP56,Nucleolar protein 56,23421,172,1.08 [0.96-1.22],0.1872244675682899
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NOS1,"Nitric oxide synthase, brain",27063,192,1.04 [0.81-1.34],0.7652927034754446
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NOS2,"Nitric oxide synthase, inducible",23421,172,1.12 [0.79-1.60],0.5250477304424286
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NOS3,"Nitric oxide synthase, endothelial",27063,192,0.97 [0.76-1.23],0.7936972565662769
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NOTCH1,Neurogenic locus notch homolog protein 1,28081,200,1.91 [0.87-4.19],0.1084521734466231
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NOTCH2,Neurogenic locus notch homolog protein 2,24186,178,1.61 [0.84-3.08],0.1489864025682796
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NOTCH3,Neurogenic locus notch homolog protein 3,28081,200,0.81 [0.56-1.15],0.2367447423941414
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPC2,NPC intracellular cholesterol transporter 2,23778,176,1.21 [0.78-1.89],0.3973448386081126
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPDC1,Neural proliferation differentiation and control protein 1,27743,197,1.11 [0.74-1.68],0.6103972188540587
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPHS1,Nephrin,23501,175,1.47 [1.03-2.09],0.0329997095435495
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPHS2,Podocin,23501,175,0.99 [0.86-1.14],0.9020641917659066
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPL,N-acetylneuraminate lyase,24188,179,1.47 [1.08-2.01],0.0142432886361082
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPPB,Natriuretic peptides B,27233,194,0.95 [0.86-1.05],0.3048294362431097
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPPC,C-type natriuretic peptide,27699,197,1.06 [0.79-1.41],0.7164888720920167
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPR1,Atrial natriuretic peptide receptor 1,23421,172,1.22 [0.88-1.67],0.2317670815549113
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPTN,Neuroplastin,27092,194,1.06 [0.92-1.22],0.4347158566571847
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPTX1,Neuronal pentraxin-1,27746,198,1.25 [0.92-1.69],0.1510911488358879
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPTX2,Neuronal pentraxin-2,24186,178,0.90 [0.59-1.39],0.645878716830248
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPTXR,Neuronal pentraxin receptor,27743,197,0.95 [0.66-1.38],0.8047719335048384
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPY,Pro-neuropeptide Y,27975,194,1.12 [0.93-1.35],0.2440431133806361
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NRCAM,Neuronal cell adhesion molecule,27743,197,1.08 [0.69-1.69],0.7234689966184318
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NRGN,Neurogranin,24199,176,1.04 [0.89-1.22],0.5968581414114889
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NRN1,Neuritin,24149,177,0.92 [0.60-1.41],0.7014459259281325
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NRP1,Neuropilin-1,27884,194,1.14 [0.73-1.78],0.5662304451253053
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NRP2,Neuropilin-2,27746,198,1.03 [0.67-1.59],0.875474041518115
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NRTN,Neurturin,27187,191,0.95 [0.73-1.23],0.6901875364888828
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NRXN3,Neurexin-3,23510,172,1.11 [0.75-1.64],0.6014388379278897
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NSFL1C,NSFL1 cofactor p47,27981,197,1.04 [0.86-1.25],0.6919103801000437
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24188,179,1.09 [0.90-1.32],0.396033481934238
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NT5C1A,Cytosolic 5'-nucleotidase 1A,24131,176,1.56 [1.12-2.19],0.0093869013449769
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NT5C3A,Cytosolic 5'-nucleotidase 3A,27661,197,1.06 [0.92-1.23],0.3914493581518451
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NT5E,5'-nucleotidase,27840,197,1.10 [0.89-1.37],0.3661812345480587
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NTF3,Neurotrophin-3,27699,197,1.05 [0.74-1.50],0.7864318791566379
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NTF4,Neurotrophin-4,27092,194,0.86 [0.60-1.23],0.4068930127760627
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NTRK2,BDNF/NT-3 growth factors receptor,27743,197,1.26 [0.77-2.06],0.3498179367422933
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NTRK3,NT-3 growth factor receptor,27981,197,1.04 [0.59-1.85],0.8909059738471525
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NTproBNP,N-terminal prohormone of brain natriuretic peptide,27743,197,0.95 [0.83-1.08],0.4214611611573872
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUB1,NEDD8 ultimate buster 1,27699,197,1.05 [0.90-1.22],0.5272172836941289
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24051,179,1.03 [0.89-1.19],0.6815748409115994
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUCB2,Nucleobindin-2,27925,192,1.11 [0.79-1.55],0.559631567084627
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUDC,Nuclear migration protein nudC,28030,197,0.98 [0.80-1.19],0.8060750162629235
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,23566,168,0.97 [0.56-1.71],0.9292946369065715
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,23421,172,0.92 [0.68-1.24],0.5679961875272617
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUDT16,U8 snoRNA-decapping enzyme,24020,176,1.10 [0.94-1.29],0.2477195004448005
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],27620,196,1.00 [0.80-1.24],0.9732966388938962
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUDT5,ADP-sugar pyrophosphatase,27746,198,1.11 [0.88-1.41],0.3676965297844948
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUMB,Protein numb homolog,23501,175,1.09 [0.91-1.30],0.3495963286382886
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUP50,Nuclear pore complex protein Nup50,23421,172,1.14 [0.79-1.66],0.4809562866734579
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NXPE4,NXPE family member 4,23421,172,0.71 [0.43-1.15],0.1644913374288479
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NXPH1,Neurexophilin-1,27063,192,0.83 [0.58-1.18],0.3018770604044937
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NXPH3,Neurexophilin-3,23501,175,1.41 [0.86-2.29],0.1719636860419779
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OBP2B,Odorant-binding protein 2b,27463,196,0.92 [0.76-1.11],0.3751300559528018
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OCLN,Occludin,24149,177,1.19 [0.87-1.64],0.2670458941120608
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ODAM,Odontogenic ameloblast-associated protein,27021,191,1.13 [0.90-1.41],0.2908852396894265
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OFD1,Oral-facial-digital syndrome 1 protein,23735,176,0.94 [0.75-1.17],0.5640306893640326
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OGA,Protein O-GlcNAcase,24062,176,1.12 [0.92-1.38],0.2594432805233508
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OGFR,Opioid growth factor receptor,27620,196,1.16 [0.80-1.69],0.4280975164430579
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OGN,Mimecan,27746,198,0.83 [0.60-1.14],0.2470926148175369
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,23735,176,1.11 [0.90-1.37],0.3113810113509554
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OLFM4,Olfactomedin-4,22791,169,1.10 [0.97-1.24],0.1239318601001511
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OLR1,Oxidized low-density lipoprotein receptor 1,27477,194,1.11 [0.91-1.36],0.3144238904777002
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OMD,Osteomodulin,27880,196,1.03 [0.78-1.37],0.8203674895324192
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OMG,Oligodendrocyte-myelin glycoprotein,27620,196,0.95 [0.78-1.16],0.5976637168246454
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OMP,Olfactory marker protein,23404,170,1.03 [0.77-1.37],0.8609865395016054
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OPHN1,Oligophrenin-1,24131,176,1.02 [0.89-1.16],0.802738462517464
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OPLAH,5-oxoprolinase,23566,168,1.06 [0.85-1.31],0.6140884491612715
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OPTC,Opticin,27620,196,1.19 [0.92-1.54],0.1773695719363476
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ORM1,Alpha-1-acid glycoprotein 1,24152,176,1.75 [0.88-3.50],0.1135569740512009
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OSBPL2,Oxysterol-binding protein-related protein 2,24131,176,0.92 [0.64-1.33],0.6729243630799164
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OSCAR,Osteoclast-associated immunoglobulin-like receptor,27794,196,1.15 [0.79-1.69],0.4653935028690178
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OSM,Oncostatin-M,27571,197,1.00 [0.84-1.18],0.9548159309145337
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OSMR,Oncostatin-M-specific receptor subunit beta,27884,194,1.88 [1.04-3.37],0.0356852528110185
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OSTN,Osteocrin,23510,172,0.83 [0.57-1.23],0.3592418452476514
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OTOA,Otoancorin,23404,170,1.06 [0.82-1.38],0.6346697413013822
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OTUD6B,Deubiquitinase OTUD6B,24062,176,1.13 [0.89-1.43],0.3282788079642206
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OTUD7B,OTU domain-containing protein 7B,24149,177,1.08 [0.87-1.35],0.4934965862978608
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",23566,168,1.20 [0.97-1.48],0.0879336608098071
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OXT,Oxytocin-neurophysin 1,27981,197,0.98 [0.89-1.07],0.6183746950162885
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",P4HB,Protein disulfide-isomerase,27618,195,1.13 [0.82-1.57],0.4476637470696314
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PACS2,Phosphofurin acidic cluster sorting protein 2,23421,172,1.16 [0.92-1.46],0.207371834253726
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PADI2,Protein-arginine deiminase type-2,27187,191,1.28 [1.08-1.52],0.004242557698132
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PADI4,Protein-arginine deiminase type-4,27021,191,1.01 [0.86-1.20],0.8722119525087794
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAEP,Glycodelin,27549,196,0.79 [0.72-0.87],3.1710991661098853e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24149,177,1.00 [0.88-1.13],0.973054806540576
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",23735,176,1.25 [0.95-1.64],0.1120653102319731
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,27233,194,0.95 [0.76-1.20],0.6686790197195966
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAGR1,PAXIP1-associated glutamate-rich protein 1,23566,168,1.05 [0.76-1.45],0.7649726085660665
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23269,173,1.19 [0.92-1.54],0.1790180542733042
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAK4,Serine/threonine-protein kinase PAK 4,27063,192,1.07 [0.87-1.31],0.520068878865037
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PALLD,Palladin,23501,175,1.13 [0.82-1.56],0.4386811714552616
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PALM,Paralemmin-1,23937,176,1.51 [0.94-2.41],0.0850373637086258
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PALM2,Paralemmin-2,24131,176,1.38 [0.97-1.98],0.0755368892215614
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PALM3,Paralemmin-3,23421,172,1.08 [0.92-1.29],0.3460501915330085
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAM,Peptidyl-glycine alpha-amidating monooxygenase,27932,200,1.23 [0.78-1.94],0.3773971745820067
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAMR1,Inactive serine protease PAMR1,27746,198,1.41 [0.90-2.22],0.1297046845004994
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAPPA,Pappalysin-1,27187,191,0.87 [0.66-1.15],0.3356464946076795
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PARD3,Partitioning defective 3 homolog,23735,176,1.11 [0.92-1.33],0.2707546755649668
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PARK7,Parkinson disease protein 7,27746,198,1.10 [0.87-1.39],0.4120034945855396
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PARP1,Poly [ADP-ribose] polymerase 1,27699,197,1.08 [0.88-1.33],0.4697827222704361
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAXX,Protein PAXX,23677,173,1.06 [0.77-1.45],0.7182776903732964
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PBK,Lymphokine-activated killer T-cell-originated protein kinase,23311,173,1.59 [1.02-2.50],0.0421336455068488
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PBLD,Phenazine biosynthesis-like domain-containing protein,27063,192,1.07 [0.84-1.38],0.5835526824581787
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24062,176,0.95 [0.59-1.53],0.8272228672732771
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCARE,Photoreceptor cilium actin regulator,23404,170,1.10 [0.95-1.27],0.1861096280682688
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,23633,173,1.10 [0.81-1.50],0.5276452811346679
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCBP2,Poly(rC)-binding protein 2,24149,177,1.10 [0.90-1.34],0.3564617885917893
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCDH1,Protocadherin-1,27941,196,1.34 [0.78-2.28],0.2856473135708002
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCDH12,Protocadherin-12,24149,177,1.38 [0.82-2.32],0.223011239967417
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCDH17,Protocadherin-17,27743,197,0.90 [0.63-1.30],0.5917380199699773
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCDH7,Protocadherin-7,24062,176,1.37 [0.98-1.91],0.0664587007038802
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCDH9,Protocadherin-9,24062,176,1.19 [0.78-1.81],0.4318012152557848
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCDHB15,Protocadherin beta-15,24051,179,0.80 [0.56-1.16],0.2420890961581073
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCNA,Proliferating cell nuclear antigen,23311,173,1.02 [0.82-1.28],0.8311848540295639
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCSK7,Proprotein convertase subtilisin/kexin type 7,24051,179,1.43 [1.12-1.83],0.0040304658868296
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCSK9,Proprotein convertase subtilisin/kexin type 9,28081,200,1.10 [0.80-1.51],0.5648594776548203
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCYT2,Ethanolamine-phosphate cytidylyltransferase,24062,176,1.05 [0.87-1.26],0.6168189520628247
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDAP1,28 kDa heat- and acid-stable phosphoprotein,24188,179,1.06 [0.92-1.23],0.4300746406831368
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDCD1,Programmed cell death protein 1,27934,194,0.88 [0.65-1.19],0.4079061851338178
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDCD1LG2,Programmed cell death 1 ligand 2,27620,196,0.86 [0.58-1.29],0.4763267015556279
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDCD5,Programmed cell death protein 5,27981,197,1.04 [0.84-1.28],0.7404337542212435
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDCD6,Programmed cell death protein 6,27743,197,1.04 [0.86-1.25],0.6945823747676945
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDCL2,Phosducin-like protein 2,23311,173,1.08 [0.84-1.38],0.5519387720662225
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",23311,173,1.10 [0.87-1.38],0.4226794447620954
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",23421,172,1.01 [0.80-1.27],0.9648278118908306
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",23677,173,1.02 [0.88-1.17],0.8035476381467883
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDGFA,Platelet-derived growth factor subunit A,28081,200,1.05 [0.89-1.25],0.5522457527538184
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDGFB,Platelet-derived growth factor subunit B,27880,196,1.04 [0.90-1.21],0.5840727893448372
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDGFC,Platelet-derived growth factor C,27092,194,1.03 [0.67-1.58],0.9023074912439676
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDGFRA,Platelet-derived growth factor receptor alpha,27743,197,1.05 [0.68-1.63],0.8270192216363603
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDGFRB,Platelet-derived growth factor receptor beta,28081,200,0.86 [0.60-1.22],0.3958757915973159
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDIA2,Protein disulfide-isomerase A2,23311,173,0.69 [0.46-1.05],0.0805067590141459
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDIA3,Protein disulfide-isomerase A3,23677,173,1.03 [0.59-1.82],0.9089053175924072
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDIA4,Protein disulfide-isomerase A4,24186,178,1.07 [0.85-1.35],0.5789959439498095
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDIA5,Protein disulfide-isomerase A5,23311,173,0.97 [0.76-1.24],0.8354497457110532
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDLIM5,PDZ and LIM domain protein 5,24149,177,1.02 [0.90-1.15],0.750099080514641
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDLIM7,PDZ and LIM domain protein 7,27880,196,0.96 [0.87-1.06],0.439823200522239
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",27092,194,1.19 [0.97-1.46],0.0885728424570617
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDRG1,p53 and DNA damage-regulated protein 1,23510,172,1.25 [1.01-1.55],0.038862808066634
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,23311,173,1.02 [0.81-1.29],0.8709924363253391
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDZD2,PDZ domain-containing protein 2,23421,172,0.92 [0.71-1.18],0.4956411111386805
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,23501,175,1.29 [0.96-1.72],0.0871634206356066
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PEAR1,Platelet endothelial aggregation receptor 1,28081,200,1.24 [0.71-2.15],0.4529541034185532
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PEBP1,Phosphatidylethanolamine-binding protein 1,27746,198,1.07 [0.87-1.32],0.4995189331421882
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PECAM1,Platelet endothelial cell adhesion molecule,27746,198,0.97 [0.64-1.47],0.8823321637082739
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PECR,Peroxisomal trans-2-enoyl-CoA reductase,23566,168,1.79 [1.28-2.51],0.0006735270854881
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PENK,Proenkephalin-A,23677,173,1.02 [0.63-1.64],0.9473087688345968
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PEPD,Xaa-Pro dipeptidase,24199,176,1.21 [0.69-2.11],0.5131484927066938
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PER3,Period circadian protein homolog 3,23501,175,0.98 [0.87-1.12],0.8033466970527627
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PF4,Platelet factor 4,24059,173,1.01 [0.87-1.17],0.8637158595768866
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PFDN2,Prefoldin subunit 2,27063,192,1.03 [0.82-1.30],0.7891537106733241
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PFDN4,Prefoldin subunit 4,23311,173,1.11 [0.87-1.41],0.397281645373611
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PFDN6,Prefoldin subunit 6,23510,172,1.03 [0.83-1.27],0.7856076520480292
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",27572,196,1.02 [0.87-1.20],0.7968057961540979
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PGA4,Pepsin A-4,24199,176,0.98 [0.79-1.21],0.8454488259257975
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24188,179,1.12 [0.87-1.45],0.376975332073341
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PGF,Placenta growth factor,28030,197,1.08 [0.69-1.70],0.726842676486458
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PGLYRP1,Peptidoglycan recognition protein 1,27945,200,1.03 [0.77-1.37],0.8665993561322068
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,23923,173,1.18 [0.74-1.88],0.4810170247006123
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PGLYRP4,Peptidoglycan recognition protein 4,23421,172,0.93 [0.73-1.18],0.5478149865362416
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PGM2,Phosphoglucomutase-2,23510,172,1.16 [0.95-1.41],0.1365670412495353
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PGR,Progesterone receptor,23501,175,1.16 [1.04-1.29],0.006988217460568
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PHACTR2,Phosphatase and actin regulator 2,24149,177,1.05 [0.92-1.19],0.4602522307588249
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PHLDB1,Pleckstrin homology-like domain family B member 1,24062,176,0.97 [0.74-1.27],0.7993234368767832
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PHLDB2,Pleckstrin homology-like domain family B member 2,23311,173,1.06 [0.91-1.22],0.4533357801574963
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,27549,196,0.90 [0.58-1.38],0.6160437943212874
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,23677,173,1.19 [0.84-1.69],0.3325438596205337
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PI16,Peptidase inhibitor 16,24199,176,1.60 [0.89-2.87],0.1145772475331491
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PI3,Elafin,27371,198,1.10 [0.87-1.38],0.4309237118636267
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24149,177,1.06 [0.88-1.27],0.5526728201858344
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PIGR,Polymeric immunoglobulin receptor,27386,196,1.13 [0.80-1.59],0.5027434027344899
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,27699,197,1.10 [0.90-1.34],0.3754718708950356
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,27746,198,1.01 [0.62-1.65],0.9540297012190928
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,23501,175,1.02 [0.80-1.31],0.8731379993780786
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PILRA,Paired immunoglobulin-like type 2 receptor alpha,27746,198,1.22 [0.90-1.65],0.2017098933439336
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PILRB,Paired immunoglobulin-like type 2 receptor beta,27743,197,1.24 [0.98-1.56],0.0671888731992304
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,23677,173,0.93 [0.75-1.16],0.5174543576513421
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PITHD1,PITH domain-containing protein 1,23269,173,1.09 [0.93-1.28],0.2776763011256068
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PKD1,Polycystin-1,24188,179,1.43 [0.83-2.48],0.1993618128676734
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PKD2,Polycystin-2,23421,172,0.97 [0.76-1.25],0.8131510338503714
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PKLR,Pyruvate kinase PKLR,27792,196,1.03 [0.86-1.24],0.7550099036543267
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PKN3,Serine/threonine-protein kinase N3,23735,176,1.00 [0.83-1.20],0.962628890064829
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLA2G10,Group 10 secretory phospholipase A2,27549,196,0.94 [0.76-1.16],0.5549013712243218
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLA2G15,Phospholipase A2 group XV,27840,197,0.96 [0.60-1.56],0.8842592137895358
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLA2G1B,Phospholipase A2,28031,199,0.89 [0.66-1.20],0.4604313033866909
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLA2G2A,"Phospholipase A2, membrane associated",27659,199,1.05 [0.85-1.29],0.6476127714591815
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLA2G4A,Cytosolic phospholipase A2,27880,196,0.96 [0.83-1.11],0.5590761313313943
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLA2G7,Platelet-activating factor acetylhydrolase,27746,198,0.97 [0.65-1.45],0.8746373023819356
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLAT,Tissue-type plasminogen activator,27991,200,0.95 [0.74-1.22],0.6918518824174789
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLAU,Urokinase-type plasminogen activator,27746,198,1.18 [0.80-1.75],0.3992217231810839
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLAUR,Urokinase plasminogen activator surface receptor,27567,194,1.37 [0.86-2.17],0.1816156186060191
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLB1,"Phospholipase B1, membrane-associated",24131,176,1.15 [0.90-1.46],0.2680161093301072
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",23501,175,1.05 [0.78-1.41],0.745493515066104
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24131,176,1.06 [0.92-1.23],0.4139472977091416
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLEKHO1,Pleckstrin homology domain-containing family O member 1,24131,176,1.09 [0.88-1.34],0.4332732589101417
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLG,Plasminogen,23603,172,1.89 [1.07-3.34],0.0279467452805084
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLIN1,Perilipin-1,27063,192,1.39 [1.02-1.90],0.0349177807939563
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLIN3,Perilipin-3,27743,197,1.06 [0.79-1.41],0.69901956139047
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLPBP,Pyridoxal phosphate homeostasis protein,27743,197,1.06 [0.89-1.28],0.5010476547679064
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLSCR3,Phospholipid scramblase 3,24091,175,1.04 [0.82-1.32],0.7637190262478399
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLTP,Phospholipid transfer protein,27984,200,1.03 [0.72-1.47],0.8922899929360486
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLXDC1,Plexin domain-containing protein 1,27092,194,1.28 [0.95-1.73],0.1101783734211866
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLXDC2,Plexin domain-containing protein 2,24131,176,1.30 [0.79-2.11],0.2986908535408423
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLXNA4,Plexin-A4,27699,197,1.01 [0.87-1.18],0.8619341755530089
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLXNB2,Plexin-B2,27947,200,1.06 [0.62-1.79],0.8401133399907386
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLXNB3,Plexin-B3,27653,197,1.21 [0.93-1.57],0.1622242380927123
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,27602,197,0.96 [0.90-1.03],0.2861775252476747
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PMCH,Pro-MCH,23421,172,1.15 [1.00-1.33],0.0522878948703818
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PMM2,Phosphomannomutase 2,23421,172,1.19 [0.94-1.51],0.1398984659776356
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PMS1,PMS1 protein homolog 1,23510,172,1.04 [0.78-1.37],0.7996297271794592
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PMVK,Phosphomevalonate kinase,27018,192,0.98 [0.88-1.10],0.7634280656448269
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PNLIP,Pancreatic triacylglycerol lipase,24199,176,1.00 [0.79-1.27],0.9973361880189728
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PNLIPRP1,Inactive pancreatic lipase-related protein 1,24131,176,0.99 [0.82-1.20],0.9421237257619194
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PNLIPRP2,Pancreatic lipase-related protein 2,27745,195,1.05 [1.00-1.10],0.0589275642307503
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PNMA1,Paraneoplastic antigen Ma1,23566,168,1.12 [0.87-1.46],0.3759738967151826
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PNMA2,Paraneoplastic antigen Ma2,23404,170,1.04 [0.75-1.45],0.8017192712138878
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",27187,191,1.05 [0.95-1.16],0.3257755468407202
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PODXL,Podocalyxin,27620,196,0.72 [0.32-1.63],0.4320964774872131
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PODXL2,Podocalyxin-like protein 2,27840,197,1.22 [0.77-1.93],0.3928492168935489
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",POF1B,Protein POF1B,23501,175,1.23 [0.92-1.62],0.1571665385891363
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",POLR2A,DNA-directed RNA polymerase II subunit RPB1,23501,175,1.11 [0.69-1.80],0.6631539053715764
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",27620,196,1.17 [0.84-1.63],0.3511612102773752
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",POMC,Pro-opiomelanocortin,23566,168,0.94 [0.75-1.17],0.5903807556220625
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PON1,Serum paraoxonase/arylesterase 1,24199,176,0.71 [0.42-1.19],0.1888046519731357
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PON2,Serum paraoxonase/arylesterase 2,27233,194,1.19 [0.82-1.72],0.3532615069122634
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PON3,Serum paraoxonase/lactonase 3,27880,196,1.48 [0.90-2.45],0.1252630475345139
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",POSTN,Periostin,24186,178,0.98 [0.67-1.43],0.9122343490161852
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPBP,Platelet basic protein,24058,175,1.10 [0.93-1.31],0.2585498064777509
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPCDC,Phosphopantothenoylcysteine decarboxylase,27981,197,0.94 [0.72-1.22],0.6209770114703053
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPIB,Peptidyl-prolyl cis-trans isomerase B,27760,200,1.03 [0.90-1.18],0.6496468365020199
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPIE,Peptidyl-prolyl cis-trans isomerase E,23735,176,0.91 [0.71-1.17],0.4633570426290502
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24186,178,1.15 [0.92-1.42],0.2136478642830851
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPL,Periplakin,23501,175,1.19 [0.78-1.79],0.4190545510499434
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPM1A,Protein phosphatase 1A,27092,194,0.71 [0.45-1.11],0.1350670918935132
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPM1B,Protein phosphatase 1B,23501,175,1.22 [1.02-1.45],0.0283400305503658
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPM1F,Protein phosphatase 1F,24188,179,1.02 [0.78-1.34],0.8963136981894877
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPME1,Protein phosphatase methylesterase 1,27620,196,1.02 [0.83-1.24],0.8824446338424938
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24051,179,1.06 [0.89-1.26],0.4919145135530725
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,27840,197,0.95 [0.83-1.08],0.4357095624944542
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,23735,176,1.06 [0.88-1.28],0.5226383256020604
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24149,177,1.03 [0.86-1.23],0.7369650196529967
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24149,177,1.01 [0.70-1.48],0.9404086314358412
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP1R2,Protein phosphatase inhibitor 2,27743,197,1.05 [0.90-1.23],0.5119167974669644
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP1R9B,Neurabin-2,28030,197,0.94 [0.82-1.07],0.3384737125908595
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24062,176,1.06 [0.94-1.20],0.3408667739776666
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP3R1,Calcineurin subunit B type 1,27549,196,1.02 [0.75-1.37],0.913668158428866
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPT1,Palmitoyl-protein thioesterase 1,23510,172,1.10 [0.93-1.30],0.2584427932275762
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPY,Pancreatic prohormone,27732,196,1.01 [0.89-1.14],0.9275763362844486
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PQBP1,Polyglutamine-binding protein 1,27092,194,1.03 [0.83-1.28],0.7974410674051744
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRAME,Melanoma antigen preferentially expressed in tumors,23311,173,1.55 [0.94-2.55],0.0854494347839819
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRAP1,Proline-rich acidic protein 1,24186,178,0.94 [0.67-1.33],0.7371122492923444
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRC1,Protein regulator of cytokinesis 1,24051,179,1.07 [0.82-1.41],0.6049167668287918
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRCP,Lysosomal Pro-X carboxypeptidase,27909,198,1.00 [0.67-1.50],0.9967101362880691
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRDX1,Peroxiredoxin-1,26986,189,0.89 [0.76-1.03],0.1276411506158452
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRDX2,Peroxiredoxin-2,23790,174,1.04 [0.83-1.30],0.7332234714332353
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",27187,191,1.06 [0.89-1.26],0.5181274888829582
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRDX5,"Peroxiredoxin-5, mitochondrial",28030,197,0.99 [0.83-1.19],0.9426411434599928
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRDX6,Peroxiredoxin-6,27975,194,0.96 [0.78-1.19],0.7096659754498511
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PREB,Prolactin regulatory element-binding protein,27187,191,0.75 [0.47-1.19],0.2220930986815313
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRELP,Prolargin,27745,195,0.88 [0.52-1.51],0.6530078896038904
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRG2,Bone marrow proteoglycan,24186,178,0.89 [0.68-1.18],0.4266427960818487
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRG3,Proteoglycan 3,24186,178,0.80 [0.60-1.06],0.1250275838055963
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,27187,191,1.11 [0.89-1.40],0.3536468418967017
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,23510,172,1.06 [0.68-1.64],0.7992935280892074
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,27743,197,1.02 [0.88-1.18],0.8049357013079104
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24090,176,1.04 [0.88-1.23],0.6412168007062564
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRKCQ,Protein kinase C theta type,27187,191,1.07 [0.82-1.41],0.6117698709496651
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRKD2,Serine/threonine-protein kinase D2,23421,172,1.12 [0.86-1.47],0.3960917598851994
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRKG1,cGMP-dependent protein kinase 1,23677,173,0.96 [0.86-1.08],0.519257603524838
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,27092,194,1.14 [0.95-1.38],0.1634996935947954
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRL,Prolactin,27981,197,0.93 [0.79-1.10],0.3977703340942523
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRND,Prion-like protein doppel,24131,176,1.16 [0.89-1.50],0.2648519867939527
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PROC,Vitamin K-dependent protein C,27789,194,1.32 [0.80-2.17],0.2808549881794816
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PROCR,Endothelial protein C receptor,23421,172,0.54 [0.32-0.91],0.0211864391160117
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PROK1,Prokineticin-1,27699,197,0.73 [0.60-0.88],0.0011823846239126
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PROS1,Vitamin K-dependent protein S,24235,177,1.73 [1.03-2.92],0.0392173332477213
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRR4,Proline-rich protein 4,23508,173,0.93 [0.75-1.16],0.5279350891196347
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRR5,Proline-rich protein 5,23501,175,1.12 [0.85-1.49],0.4202402857821269
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRRT3,Proline-rich transmembrane protein 3,23566,168,1.10 [0.74-1.64],0.6317937525003459
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRSS2,Trypsin-2,27837,194,1.23 [0.97-1.57],0.0892795514441093
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRSS22,Brain-specific serine protease 4,23501,175,1.27 [0.89-1.80],0.1902079224876447
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRSS27,Serine protease 27,27654,197,1.14 [0.84-1.55],0.4010503355907353
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRSS53,Serine protease 53,24131,176,1.39 [0.96-2.01],0.080617717643022
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRSS8,Prostasin,27653,194,1.11 [0.82-1.52],0.4916199247946216
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,27063,192,0.99 [0.88-1.11],0.8119321284879889
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRTG,Protogenin,27975,194,1.19 [0.73-1.95],0.4891521971121574
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRTN3,Myeloblastin,27024,193,0.99 [0.75-1.29],0.9158007863881814
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRUNE2,Protein prune homolog 2,23735,176,1.22 [0.78-1.92],0.3878806200298307
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSAP,Prosaposin,23955,177,1.38 [0.87-2.18],0.1673299679180284
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSAPL1,Proactivator polypeptide-like 1,24062,176,1.05 [0.79-1.40],0.7286744739593373
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSCA,Prostate stem cell antigen,24062,176,1.06 [1.00-1.12],0.0637731275142925
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSG1,Pregnancy-specific beta-1-glycoprotein 1,27549,196,1.09 [0.97-1.23],0.1380339856804406
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSIP1,PC4 and SFRS1-interacting protein,27699,197,1.10 [0.92-1.32],0.2845843458105291
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSMA1,Proteasome subunit alpha type-1,27092,194,0.95 [0.72-1.26],0.7287128599070212
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSMC3,26S proteasome regulatory subunit 6A,23311,173,1.12 [0.70-1.80],0.6311959328090878
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSMD1,26S proteasome non-ATPase regulatory subunit 1,24149,177,1.03 [0.78-1.37],0.8115903060277007
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSMD5,26S proteasome non-ATPase regulatory subunit 5,23510,172,1.14 [0.91-1.42],0.2537250532385549
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSMD9,26S proteasome non-ATPase regulatory subunit 9,27620,196,1.01 [0.81-1.26],0.9485293451355576
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSME1,Proteasome activator complex subunit 1,27510,196,0.97 [0.70-1.35],0.8591083739162746
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSME2,Proteasome activator complex subunit 2,27418,196,1.02 [0.73-1.43],0.9012782871803418
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSMG3,Proteasome assembly chaperone 3,27699,197,1.06 [0.84-1.35],0.6145943919841703
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSMG4,Proteasome assembly chaperone 4,23501,175,1.12 [0.88-1.42],0.3683891561814104
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSPN,Persephin,27699,197,0.98 [0.87-1.11],0.7597132317207822
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSRC1,Proline/serine-rich coiled-coil protein 1,27092,194,1.18 [0.96-1.44],0.1140362861677517
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,22814,169,1.02 [0.88-1.17],0.8193545739869781
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",27063,192,0.88 [0.57-1.34],0.5462692060810455
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTGDS,Prostaglandin-H2 D-isomerase,27516,193,0.93 [0.59-1.45],0.7382286455269251
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTGES2,Prostaglandin E synthase 2,23308,173,1.19 [0.91-1.54],0.197054566032655
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTGR1,Prostaglandin reductase 1,24188,179,0.98 [0.82-1.17],0.7935757806346393
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTH,Parathyroid hormone,23510,172,1.18 [0.99-1.42],0.0691940558660496
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,27699,197,1.15 [0.86-1.53],0.3397471607677942
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTK7,Inactive tyrosine-protein kinase 7,27063,192,1.12 [0.81-1.56],0.4907612895894357
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTN,Pleiotrophin,27233,194,1.07 [0.84-1.38],0.5729421608726828
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTP4A3,Protein tyrosine phosphatase type IVA 3,23501,175,0.99 [0.75-1.31],0.9505238328139128
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,27549,196,1.00 [0.85-1.17],0.9862675037123816
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,27832,196,0.96 [0.84-1.10],0.580065598289995
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,23455,175,1.18 [0.83-1.66],0.354885286068794
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRB,Receptor-type tyrosine-protein phosphatase beta,24188,179,1.20 [0.74-1.95],0.4615824249669134
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRC,Receptor-type tyrosine-protein phosphatase C,24186,178,0.94 [0.50-1.77],0.8409086614519059
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRF,Receptor-type tyrosine-protein phosphatase F,28081,200,1.05 [0.69-1.62],0.8138408532823675
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRH,Receptor-type tyrosine-protein phosphatase H,24062,176,1.27 [0.95-1.70],0.1023506923367768
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24062,176,0.92 [0.47-1.78],0.7999318985589143
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRM,Receptor-type tyrosine-protein phosphatase mu,27655,197,1.15 [0.69-1.92],0.587033144835454
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,27457,196,1.08 [0.73-1.61],0.6976013325623646
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRR,Receptor-type tyrosine-protein phosphatase R,24131,176,1.07 [0.72-1.60],0.7313732992520281
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRS,Receptor-type tyrosine-protein phosphatase S,28081,200,1.10 [0.66-1.82],0.7258090888981032
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24188,179,1.07 [0.69-1.66],0.7491560109177351
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,23677,173,1.14 [0.90-1.44],0.2871782483857839
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTS,6-pyruvoyl tetrahydrobiopterin synthase,26942,190,1.15 [0.92-1.43],0.2175606223749735
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTTG1,Securin,23735,176,1.21 [0.89-1.64],0.2247796336608539
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTX3,Pentraxin-related protein PTX3,27699,197,0.84 [0.66-1.07],0.1507659032099635
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PVALB,Parvalbumin alpha,27840,194,0.97 [0.87-1.08],0.6030781479845155
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PVR,Poliovirus receptor,27981,197,1.12 [0.80-1.57],0.4929245459056453
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PXDNL,Peroxidasin-like protein,24051,179,1.09 [0.87-1.36],0.4439402895348107
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PXN,Paxillin,27063,192,1.21 [0.98-1.50],0.0794719827944638
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PYDC1,Pyrin domain-containing protein 1,23566,168,1.04 [0.74-1.46],0.8303148400123643
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PYY,Peptide YY,23421,172,1.07 [0.92-1.25],0.3959211612716786
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PZP,Pregnancy zone protein,24235,177,1.01 [0.82-1.25],0.9179943964617564
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",QDPR,Dihydropteridine reductase,27613,197,1.05 [0.79-1.39],0.755958197340334
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",QPCT,Glutaminyl-peptide cyclotransferase,27781,198,0.97 [0.61-1.57],0.9125331509366296
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",QSOX1,Sulfhydryl oxidase 1,23739,174,0.97 [0.68-1.38],0.8643390597825844
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB10,Ras-related protein Rab-10,24188,179,1.13 [0.87-1.46],0.3578404686212227
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB11FIP3,Rab11 family-interacting protein 3,24188,179,1.02 [0.89-1.17],0.7517041199073383
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB27B,Ras-related protein Rab-27B,24188,179,1.03 [0.86-1.22],0.7750126367352455
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB2B,Ras-related protein Rab-2B,24051,179,1.11 [0.89-1.40],0.35150788437309
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB33A,Ras-related protein Rab-33A,23421,172,0.97 [0.78-1.21],0.7936123762252124
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB37,Ras-related protein Rab-37,27187,191,1.15 [1.01-1.32],0.0381245767058115
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB39B,Ras-related protein Rab-39B,23421,172,0.97 [0.82-1.15],0.7580061380651011
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,23404,170,1.03 [0.80-1.32],0.8316860824202696
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB44,Ras-related protein Rab-44,24051,179,0.87 [0.61-1.24],0.4424032433436372
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB6A,Ras-related protein Rab-6A,27699,197,1.09 [0.85-1.40],0.508622190572918
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB6B,Ras-related protein Rab-6B,27063,192,1.19 [0.94-1.50],0.1412710993872213
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RABEP1,Rab GTPase-binding effector protein 1,23677,173,1.02 [0.85-1.23],0.827253565162085
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RABEPK,Rab9 effector protein with kelch motifs,27092,194,1.14 [0.95-1.38],0.1634101293790977
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RABGAP1L,Rab GTPase-activating protein 1-like,27187,191,1.08 [0.87-1.33],0.4832150389489382
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAC3,Ras-related C3 botulinum toxin substrate 3,23510,172,0.62 [0.45-0.85],0.0030362519100985
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAD23B,UV excision repair protein RAD23 homolog B,27092,194,1.11 [0.85-1.45],0.432190645649224
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAD51,DNA repair protein RAD51 homolog 1,23735,176,1.13 [0.91-1.42],0.2736903414202633
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RALB,Ras-related protein Ral-B,23501,175,1.33 [0.84-2.12],0.2242691002681879
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RALY,RNA-binding protein Raly,24051,179,0.95 [0.71-1.28],0.7539202705284352
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RANBP1,Ran-specific GTPase-activating protein,23566,168,1.21 [0.92-1.59],0.169090783870632
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RANBP2,E3 SUMO-protein ligase RanBP2,23404,170,0.89 [0.57-1.39],0.6139931430457666
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RANGAP1,Ran GTPase-activating protein 1,27092,194,1.11 [0.88-1.40],0.3675137714556407
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAP1A,Ras-related protein Rap-1A,23501,175,1.02 [0.83-1.25],0.8520671983811035
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAPGEF2,Rap guanine nucleotide exchange factor 2,23735,176,1.12 [0.86-1.46],0.4095157540596315
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RARRES1,Retinoic acid receptor responder protein 1,27092,194,0.95 [0.64-1.39],0.7775538739865997
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RARRES2,Retinoic acid receptor responder protein 2,27884,194,1.03 [0.79-1.35],0.8344754913583161
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RASA1,Ras GTPase-activating protein 1,27063,192,0.57 [0.38-0.85],0.0064262915020133
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,23311,173,1.26 [0.93-1.72],0.1361688625553763
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RASSF2,Ras association domain-containing protein 2,27092,194,1.06 [0.86-1.31],0.5632186936674156
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBFOX3,RNA binding protein fox-1 homolog 3,24149,177,1.32 [0.94-1.85],0.1104122422867006
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBKS,Ribokinase,27096,195,1.03 [0.80-1.31],0.8385536465230307
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBM17,Splicing factor 45,24149,177,1.02 [0.85-1.22],0.8545573880812318
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBM19,Probable RNA-binding protein 19,23421,172,0.84 [0.60-1.18],0.3112116565738383
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBM25,RNA-binding protein 25,23311,173,1.09 [0.80-1.48],0.592323102905312
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBP1,Retinol-binding protein 1,23510,172,1.04 [0.86-1.27],0.6815652431367567
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBP2,Retinol-binding protein 2,27620,196,0.98 [0.83-1.16],0.8057104844845233
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBP5,Retinol-binding protein 5,27620,196,1.21 [0.98-1.50],0.0790108531572196
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBP7,Retinoid-binding protein 7,24062,176,1.06 [0.85-1.33],0.6043430860329859
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBPMS,RNA-binding protein with multiple splicing,23501,175,1.15 [0.96-1.38],0.1167963714353783
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBPMS2,RNA-binding protein with multiple splicing 2,23566,168,0.99 [0.86-1.15],0.9100116887187648
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RCC1,Regulator of chromosome condensation,24051,179,0.99 [0.75-1.31],0.9460092642757048
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RCOR1,REST corepressor 1,27233,194,1.19 [0.95-1.49],0.1359484877126814
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,23566,168,0.67 [0.32-1.40],0.2870958093922807
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REEP4,Receptor expression-enhancing protein 4,24149,177,1.01 [0.80-1.27],0.9339154082680314
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REG1A,Lithostathine-1-alpha,27566,193,1.27 [1.00-1.61],0.0501410500389377
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REG1B,Lithostathine-1-beta,28081,200,1.20 [0.98-1.47],0.0810633422400725
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REG3A,Regenerating islet-derived protein 3-alpha,28081,200,1.07 [0.87-1.30],0.5339016999020698
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REG3G,Regenerating islet-derived protein 3-gamma,24051,179,1.07 [0.75-1.52],0.7124885257058267
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REG4,Regenerating islet-derived protein 4,27794,196,1.26 [0.98-1.64],0.0755479071289627
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RELB,Transcription factor RelB,23501,175,1.18 [0.93-1.49],0.1655185034588027
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RELT,Tumor necrosis factor receptor superfamily member 19L,27746,198,1.10 [0.69-1.75],0.6971679336116667
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REN,Renin,27743,197,0.98 [0.82-1.17],0.8175479195116666
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REPS1,RalBP1-associated Eps domain-containing protein 1,23501,175,1.08 [0.75-1.56],0.6603946116966783
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REST,RE1-silencing transcription factor,23311,173,1.07 [0.73-1.58],0.7205746735579502
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,27620,196,1.07 [0.79-1.43],0.6748938439223361
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RETN,Resistin,27676,199,1.06 [0.79-1.44],0.6946400274934199
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REXO2,"Oligoribonuclease, mitochondrial",23421,172,1.14 [0.88-1.47],0.310725934507203
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RFC4,Replication factor C subunit 4,24051,179,1.20 [0.63-2.28],0.5889666814075729
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RGCC,Regulator of cell cycle RGCC,24149,177,1.07 [0.89-1.30],0.465616809242763
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,23735,176,1.10 [0.90-1.34],0.3643597584034888
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RGMA,Repulsive guidance molecule A,27981,197,1.08 [0.72-1.62],0.7165028684766346
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RGMB,RGM domain family member B,27981,197,1.40 [0.86-2.27],0.175930662408541
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RGS10,Regulator of G-protein signaling 10,24149,177,1.11 [0.88-1.40],0.3795889292922744
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RGS8,Regulator of G-protein signaling 8,27187,191,0.95 [0.77-1.17],0.6240309053918781
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RHOC,Rho-related GTP-binding protein RhoC,27368,195,1.00 [0.89-1.11],0.9330705574506064
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RICTOR,Rapamycin-insensitive companion of mTOR,23501,175,1.08 [0.83-1.42],0.5542145827557682
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,23677,173,0.98 [0.73-1.33],0.9185372179361144
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RILP,Rab-interacting lysosomal protein,27888,194,1.05 [0.85-1.29],0.6419652044763839
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RILPL2,RILP-like protein 2,24188,179,1.00 [0.86-1.16],0.9864668031168508
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,23421,172,0.94 [0.75-1.18],0.6038630734784951
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RLN1,Prorelaxin H1,24149,177,0.84 [0.69-1.01],0.0700846389227256
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RLN2,Prorelaxin H2,23633,172,0.88 [0.79-0.98],0.0238317172012325
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNASE1,Ribonuclease pancreatic,24199,176,0.96 [0.53-1.76],0.9072056374488616
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNASE10,Inactive ribonuclease-like protein 10,23566,168,1.00 [0.74-1.36],0.980246148017699
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNASE3,Eosinophil cationic protein,27613,197,1.05 [0.94-1.17],0.3637569155092781
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNASE4,Ribonuclease 4,23382,173,1.48 [0.90-2.45],0.123799286230706
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNASE6,Ribonuclease K6,24015,175,1.09 [0.66-1.78],0.7449925939481437
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNASEH2A,Ribonuclease H2 subunit A,24149,177,1.18 [0.92-1.50],0.1983747304728448
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNASET2,Ribonuclease T2,27948,198,1.08 [0.67-1.74],0.7488105667445634
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNF149,E3 ubiquitin-protein ligase RNF149,23566,168,1.20 [0.74-1.94],0.4580499001052245
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNF168,E3 ubiquitin-protein ligase RNF168,23501,175,1.34 [1.02-1.77],0.036434326534704
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNF31,E3 ubiquitin-protein ligase RNF31,23501,175,1.34 [0.99-1.82],0.0560159950021491
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNF4,E3 ubiquitin-protein ligase RNF4,23735,176,0.99 [0.80-1.23],0.9335661591897232
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNF41,E3 ubiquitin-protein ligase NRDP1,27092,194,1.08 [0.89-1.30],0.439744778990053
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNF43,E3 ubiquitin-protein ligase RNF43,23735,176,0.86 [0.65-1.14],0.2849500393580155
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNF5,E3 ubiquitin-protein ligase RNF5,23566,168,1.07 [0.87-1.31],0.5170743514816529
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ROBO1,Roundabout homolog 1,27794,196,1.10 [0.65-1.84],0.7259916651331311
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ROBO2,Roundabout homolog 2,27981,197,1.76 [1.04-3.00],0.0355540367665667
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ROBO4,Roundabout homolog 4,23566,168,0.89 [0.39-2.05],0.7822801580619891
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,27743,197,1.00 [0.66-1.49],0.982441804945644
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RP2,Protein XRP2,27620,196,1.21 [0.91-1.61],0.1894782307184781
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RPA2,Replication protein A 32 kDa subunit,23501,175,1.15 [0.75-1.77],0.5105099945532008
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RPE,Ribulose-phosphate 3-epimerase,23735,176,1.10 [0.90-1.33],0.348626229641055
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RPGR,X-linked retinitis pigmentosa GTPase regulator,23510,172,0.81 [0.55-1.19],0.284873493512
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RPL14,60S ribosomal protein L14,23566,168,0.99 [0.70-1.41],0.9713752478787973
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RPS10,40S ribosomal protein S10,23421,172,1.09 [0.78-1.50],0.6203571495479245
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RRAS,Ras-related protein R-Ras,23510,172,1.02 [0.91-1.14],0.7644744980451667
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RRM2,Ribonucleoside-diphosphate reductase subunit M2,27092,194,0.88 [0.67-1.15],0.345602881614634
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,27092,194,1.06 [0.88-1.28],0.5683477589698823
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RRP15,RRP15-like protein,23404,170,1.03 [0.88-1.20],0.7538421712459746
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RSPO1,R-spondin-1,27549,196,0.77 [0.54-1.11],0.1605898782715211
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RSPO3,R-spondin-3,27975,194,0.78 [0.50-1.23],0.2807531782921405
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RTBDN,Retbindin,27620,196,1.17 [0.77-1.79],0.4548337720704308
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RTKN2,Rhotekin-2,23421,172,0.94 [0.70-1.25],0.663090196661967
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24149,177,1.07 [0.92-1.25],0.3864621427754008
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RTN4R,Reticulon-4 receptor,27975,194,0.85 [0.58-1.24],0.3917873880175275
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RUVBL1,RuvB-like 1,27092,194,1.11 [0.99-1.24],0.0666000826671254
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RWDD1,RWD domain-containing protein 1,27981,197,1.01 [0.83-1.23],0.8961465916484245
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RYR1,Ryanodine receptor 1,23421,172,1.14 [0.77-1.69],0.4993486820242095
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100A11,Protein S100-A11,27517,196,1.01 [0.78-1.32],0.9281802479073336
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100A12,Protein S100-A12,27374,194,1.04 [0.88-1.22],0.6583119107900506
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100A13,Protein S100-A13,23501,175,1.23 [0.84-1.82],0.2889854821884345
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100A14,Protein S100-A14,24149,177,0.87 [0.65-1.15],0.3203168831316456
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100A16,Protein S100-A16,27021,191,0.94 [0.76-1.16],0.5356904217646037
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100A3,Protein S100-A3,24051,179,0.73 [0.49-1.10],0.1349268481492682
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100A4,Protein S100-A4,27840,197,1.04 [0.83-1.29],0.7400995514241899
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100G,Protein S100-G,24149,177,0.77 [0.54-1.08],0.1304451485668363
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100P,Protein S100-P,27233,194,1.09 [0.87-1.35],0.4556369996686794
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SAA4,Serum amyloid A-4 protein,24235,177,1.06 [0.69-1.61],0.8021799507683396
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SAFB2,Scaffold attachment factor B2,24149,177,1.33 [0.85-2.10],0.215458987955628
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SAG,S-arrestin,23404,170,0.92 [0.69-1.23],0.5746181509500405
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SAMD9L,Sterile alpha motif domain-containing protein 9-like,27699,197,0.98 [0.82-1.17],0.8276300071649157
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SAP18,Histone deacetylase complex subunit SAP18,23735,176,0.91 [0.74-1.13],0.4061616513301078
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SARG,Specifically androgen-regulated gene protein,24091,177,1.03 [0.91-1.18],0.6119976217691292
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SART1,U4/U6.U5 tri-snRNP-associated protein 1,23421,172,0.98 [0.66-1.45],0.9129062281828288
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SAT1,Diamine acetyltransferase 1,23421,172,1.08 [0.83-1.41],0.575871341521288
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SAT2,Thialysine N-epsilon-acetyltransferase,23735,176,0.87 [0.69-1.10],0.2503057345601088
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SATB1,DNA-binding protein SATB1,24149,177,1.37 [0.95-1.98],0.0924315973009454
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SBSN,Suprabasin,24139,178,1.11 [0.73-1.69],0.6364645089876879
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCAMP3,Secretory carrier-associated membrane protein 3,27620,196,1.02 [0.88-1.18],0.8418799611419592
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCARA5,Scavenger receptor class A member 5,27981,197,1.22 [0.79-1.87],0.368042744253891
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCARB1,Scavenger receptor class B member 1,27063,192,1.17 [0.98-1.40],0.0747531096113903
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCARB2,Lysosome membrane protein 2,27039,192,0.96 [0.62-1.49],0.8615821033549225
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCARF1,Scavenger receptor class F member 1,28081,200,1.08 [0.81-1.44],0.5992422341857206
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCARF2,Scavenger receptor class F member 2,27981,197,1.28 [0.83-1.97],0.2669887975397864
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCG2,Secretogranin-2,27838,192,1.17 [0.79-1.75],0.429459329436171
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCG3,Secretogranin-3,27794,196,0.96 [0.65-1.40],0.8166986664414485
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCGB1A1,Uteroglobin,27790,195,0.84 [0.68-1.05],0.1196970303733309
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCGB2A2,Mammaglobin-A,23421,172,0.97 [0.61-1.55],0.9050224152702524
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCGB3A1,Secretoglobin family 3A member 1,23677,173,0.56 [0.31-1.01],0.0546038995730764
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCGB3A2,Secretoglobin family 3A member 2,27832,196,0.96 [0.82-1.12],0.586665743474361
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCGN,Secretagogin,27187,191,1.12 [0.84-1.50],0.4254811702887231
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCIN,Adseverin,23404,170,0.92 [0.75-1.14],0.4377685305937981
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCLY,Selenocysteine lyase,27888,194,1.16 [0.90-1.49],0.2616512121109688
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCN2A,Sodium channel protein type 2 subunit alpha,23404,170,0.91 [0.66-1.25],0.5537600201712272
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCN2B,Sodium channel subunit beta-2,23510,172,1.03 [0.62-1.68],0.9214596572130128
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCN3A,Sodium channel protein type 3 subunit alpha,23510,172,0.97 [0.66-1.43],0.8795014518094807
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCN3B,Sodium channel subunit beta-3,23404,170,0.98 [0.71-1.34],0.8827678366731067
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCN4B,Sodium channel subunit beta-4,23566,168,1.20 [0.85-1.71],0.3023958885614366
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCP2,Non-specific lipid-transfer protein,27092,194,1.16 [1.01-1.33],0.0403263570136249
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCPEP1,Retinoid-inducible serine carboxypeptidase,23470,168,1.15 [0.86-1.54],0.3412573965871288
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCRG1,Scrapie-responsive protein 1,24188,179,1.00 [0.59-1.69],0.9979355276424636
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCRIB,Protein scribble homolog,23566,168,1.00 [0.86-1.17],0.9550767554294076
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCRN1,Secernin-1,27699,197,1.05 [0.84-1.31],0.6658365542167476
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCT,Secretin,23510,172,1.02 [0.74-1.42],0.8911934314002063
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SDC1,Syndecan-1,27743,197,0.92 [0.67-1.27],0.6316668671716336
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SDC4,Syndecan-4,27743,197,1.27 [0.96-1.69],0.0891341629747336
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SDCCAG8,Serologically defined colon cancer antigen 8,24051,179,1.00 [0.88-1.13],0.9831794210764604
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SDHB,Succinate dehydrogenase,24062,176,1.12 [0.93-1.36],0.2387622276644456
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SDK2,Protein sidekick-2,23677,173,0.80 [0.54-1.19],0.2749925006632907
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEC31A,Protein transport protein Sec31A,23566,168,1.06 [0.87-1.29],0.5446880066395908
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEL1L,Protein sel-1 homolog 1,23566,168,1.31 [0.92-1.85],0.1342952188720131
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SELE,E-selectin,28081,200,1.05 [0.82-1.34],0.7017489132410842
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SELENOP,Selenoprotein P,24235,177,1.15 [0.61-2.17],0.6647115035722421
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SELL,L-selectin,24235,177,0.58 [0.31-1.06],0.0770265824219165
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SELP,P-selectin,27837,194,1.07 [0.86-1.32],0.5528817491426632
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SELPLG,P-selectin glycoprotein ligand 1,27699,197,1.24 [0.78-1.97],0.3631999752260005
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEMA3F,Semaphorin-3F,27743,197,1.60 [0.99-2.58],0.0566513532831006
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEMA3G,Semaphorin-3G,23677,173,1.01 [0.72-1.42],0.941886209040729
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEMA4C,Semaphorin-4C,27620,196,1.28 [0.86-1.91],0.2252541987870344
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEMA4D,Semaphorin-4D,27981,197,0.99 [0.65-1.52],0.9781403539541016
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEMA6C,Semaphorin-6C,23501,175,1.21 [0.73-2.01],0.4556345311677596
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEMA7A,Semaphorin-7A,27991,200,0.93 [0.59-1.49],0.7688099336867847
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEPTIN3,Neuronal-specific septin-3,24149,177,0.90 [0.73-1.10],0.2955096930345939
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEPTIN7,Septin-7,23735,176,0.99 [0.76-1.30],0.9623538207605288
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEPTIN8,Septin-8,24084,176,1.30 [0.86-1.95],0.2081399292545799
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEPTIN9,Septin-9,27620,196,1.06 [0.69-1.63],0.7961703405554814
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA1,Alpha-1-antitrypsin,23768,176,1.50 [0.25-8.82],0.6555056528550499
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA11,Serpin A11,28081,200,0.93 [0.69-1.26],0.650124211823645
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA12,Serpin A12,26938,195,1.05 [0.94-1.17],0.3654261399950823
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA3,Alpha-1-antichymotrypsin,24135,176,1.94 [0.77-4.89],0.1613240615842267
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA4,Kallistatin,23779,175,1.82 [1.00-3.31],0.0508856432694407
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA5,Plasma serine protease inhibitor,23877,175,1.25 [0.83-1.88],0.2820828359948149
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA6,Corticosteroid-binding globulin,24235,177,1.33 [0.65-2.75],0.435817142457427
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA7,Thyroxine-binding globulin,24235,177,0.97 [0.45-2.07],0.9299168034315112
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA9,Serpin A9,27475,194,1.01 [0.85-1.20],0.9112027034624188
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINB1,Leukocyte elastase inhibitor,27658,197,1.02 [0.89-1.18],0.7453778921741105
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINB5,Serpin B5,27233,194,1.29 [0.99-1.67],0.0607024045143114
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINB6,Serpin B6,27893,196,1.08 [0.88-1.32],0.4856544850291464
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINB8,Serpin B8,28030,197,1.06 [0.87-1.31],0.5589706536590557
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINB9,Serpin B9,27549,196,1.01 [0.70-1.47],0.9548346175618934
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINC1,Antithrombin-III,24183,177,3.26 [1.23-8.64],0.0173012885034887
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPIND1,Heparin cofactor 2,24183,177,1.93 [1.16-3.22],0.0118307152093613
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINE1,Plasminogen activator inhibitor 1,28081,200,1.07 [0.89-1.29],0.4741563107171078
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINE2,Glia-derived nexin,24188,179,1.08 [0.87-1.34],0.4810554499410857
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINF1,Pigment epithelium-derived factor,23869,176,1.49 [0.86-2.58],0.1502392447058886
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINF2,Alpha-2-antiplasmin,23776,174,3.55 [1.28-9.84],0.0147428200897797
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPING1,Plasma protease C1 inhibitor,24183,177,2.79 [1.31-5.94],0.0076409894772107
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINH1,Serpin H1,23735,176,1.03 [0.92-1.15],0.6198558402978906
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINI1,Neuroserpin,23629,173,1.01 [0.64-1.59],0.9687529926696506
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINI2,Serpin I2,24062,176,0.99 [0.76-1.28],0.925278279316642
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,27063,192,1.20 [0.99-1.45],0.0647276633042557
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SETMAR,Histone-lysine N-methyltransferase SETMAR,27467,196,1.34 [0.91-2.00],0.1419589063559961
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEZ6,Seizure protein 6 homolog,23510,172,1.16 [0.73-1.86],0.532288528072923
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEZ6L,Seizure 6-like protein,27840,197,1.10 [0.70-1.75],0.6801408548240413
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEZ6L2,Seizure 6-like protein 2,27620,196,0.80 [0.47-1.36],0.4136978036481875
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SF3B4,Splicing factor 3B subunit 4,27620,196,0.95 [0.80-1.13],0.5530064896534335
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SFRP1,Secreted frizzled-related protein 1,27466,196,1.10 [0.82-1.46],0.5269213655431116
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SFRP4,Secreted frizzled-related protein 4,23677,173,0.68 [0.49-0.96],0.028209009081777
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SFTPA1,Pulmonary surfactant-associated protein A1,27092,194,1.08 [0.88-1.32],0.4865800802177645
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SFTPA2,Pulmonary surfactant-associated protein A2,27092,194,1.23 [0.97-1.56],0.0827754919835449
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SFTPD,Pulmonary surfactant-associated protein D,27743,197,0.91 [0.75-1.11],0.3541890196588899
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SGSH,N-sulphoglucosamine sulphohydrolase,23768,178,1.16 [0.91-1.48],0.2367120626901447
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SH2B3,SH2B adapter protein 3,27092,194,1.05 [0.92-1.20],0.471321879390547
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SH2D1A,SH2 domain-containing protein 1A,27699,197,0.90 [0.71-1.14],0.3842233424754901
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,23404,170,0.93 [0.72-1.19],0.5551279532207423
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SH3BP1,SH3 domain-binding protein 1,24062,176,1.15 [0.89-1.50],0.2855476596904767
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SH3GL3,Endophilin-A3,23606,176,0.98 [0.83-1.17],0.8521421794884005
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SH3GLB2,Endophilin-B2,24131,176,1.07 [0.86-1.32],0.5503295525070939
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SHBG,Sex hormone-binding globulin,24199,176,0.86 [0.66-1.11],0.2430014024338711
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SHC1,SHC-transforming protein 1,23311,173,0.95 [0.84-1.08],0.4611924303811935
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SHD,SH2 domain-containing adapter protein D,23371,170,0.99 [0.84-1.18],0.944888024173394
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SHH,Sonic hedgehog protein,23501,175,0.81 [0.56-1.15],0.2359944724732007
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SHISA5,Protein shisa-5,24186,178,1.12 [0.64-1.97],0.6858585466753253
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SHMT1,"Serine hydroxymethyltransferase, cytosolic",27832,196,1.07 [0.93-1.24],0.3334454569875895
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SHPK,Sedoheptulokinase,23735,176,1.01 [0.72-1.41],0.9590623816408992
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIAE,Sialate O-acetylesterase,27796,197,1.04 [0.80-1.36],0.7540928899553222
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIGLEC1,Sialoadhesin,27880,196,0.94 [0.70-1.26],0.676499470443138
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIGLEC10,Sialic acid-binding Ig-like lectin 10,27699,197,1.05 [0.72-1.53],0.8057904892371514
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIGLEC15,Sialic acid-binding Ig-like lectin 15,27063,192,0.95 [0.80-1.12],0.5113714298252083
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIGLEC5,Sialic acid-binding Ig-like lectin 5,27746,198,1.10 [0.98-1.24],0.1194670338287832
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIGLEC6,Sialic acid-binding Ig-like lectin 6,27975,194,0.74 [0.51-1.08],0.1220799765127491
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIGLEC7,Sialic acid-binding Ig-like lectin 7,27743,197,1.28 [0.82-2.00],0.2812237426879378
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIGLEC8,Sialic acid-binding Ig-like lectin 8,23566,168,1.14 [0.82-1.57],0.4433733212884455
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIGLEC9,Sialic acid-binding Ig-like lectin 9,27937,194,1.03 [0.67-1.58],0.8789104774666672
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIL1,Nucleotide exchange factor SIL1,23566,168,1.19 [0.80-1.76],0.3925181728392302
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,27811,200,1.28 [1.01-1.62],0.0386950974662181
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIRPB1,Signal-regulatory protein beta-1,27705,195,1.19 [0.90-1.58],0.2290932092673722
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIRT1,NAD-dependent protein deacetylase sirtuin-1,23501,175,1.11 [0.97-1.27],0.1357744720798069
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIRT2,NAD-dependent protein deacetylase sirtuin-2,27620,196,1.00 [0.87-1.15],0.98729235497483
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",27063,192,0.95 [0.75-1.21],0.6762096504128436
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIT1,Signaling threshold-regulating transmembrane adapter 1,27187,191,0.96 [0.76-1.20],0.7016649900010761
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SKAP1,Src kinase-associated phosphoprotein 1,27498,196,1.01 [0.85-1.20],0.91746378059306
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SKAP2,Src kinase-associated phosphoprotein 2,27880,196,0.95 [0.84-1.07],0.3753981876993332
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SKIV2L,Helicase SKI2W,23421,172,1.07 [0.76-1.50],0.7123705031626673
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLA2,Src-like-adapter 2,24149,177,1.03 [0.90-1.18],0.6747253786851224
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLAMF1,Signaling lymphocytic activation molecule,27187,191,1.07 [0.86-1.33],0.5731568284457096
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLAMF6,SLAM family member 6,27092,194,0.83 [0.59-1.17],0.2938676973200149
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLAMF7,SLAM family member 7,27699,197,0.83 [0.67-1.04],0.1051468560083118
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLAMF8,SLAM family member 8,27092,194,0.84 [0.67-1.07],0.153208635244076
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC12A2,Solute carrier family 12 member 2,23421,172,0.72 [0.41-1.28],0.2673960154058328
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC13A1,Solute carrier family 13 member 1,24051,179,0.89 [0.68-1.16],0.3863590014377839
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC16A1,Monocarboxylate transporter 1,27063,192,1.10 [0.91-1.34],0.3192685633498262
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC1A4,Neutral amino acid transporter A,23510,172,1.10 [0.85-1.42],0.4808166453324083
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC27A4,Long-chain fatty acid transport protein 4,27063,192,0.98 [0.81-1.19],0.8507821523970758
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC28A1,Sodium/nucleoside cotransporter 1,23311,173,0.98 [0.77-1.25],0.8880250803263315
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC34A3,Sodium-dependent phosphate transport protein 2C,23311,173,1.09 [0.83-1.43],0.5372313702603035
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC39A14,Zinc transporter ZIP14,27063,192,0.96 [0.64-1.42],0.8271754961031466
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC39A5,Zinc transporter ZIP5,27699,197,0.81 [0.63-1.03],0.0905295158186744
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC44A4,Choline transporter-like protein 4,23510,172,1.00 [0.81-1.23],0.9942764130643484
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC4A1,Band 3 anion transport protein,24186,178,1.00 [0.74-1.35],0.9798739994602444
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC51B,Organic solute transporter subunit beta,23421,172,1.07 [0.89-1.28],0.4534138613191076
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,23677,173,1.09 [0.92-1.29],0.3258751815574356
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24062,176,1.06 [0.82-1.38],0.64348122659257
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",23311,173,0.85 [0.64-1.12],0.2478307510144216
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLIT2,Slit homolog 2 protein,27063,192,0.96 [0.75-1.24],0.7546855779253505
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLITRK1,SLIT and NTRK-like protein 1,23501,175,1.60 [1.03-2.48],0.0370891117335597
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLITRK2,SLIT and NTRK-like protein 2,27975,194,1.33 [0.95-1.85],0.0934407369287171
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLITRK6,SLIT and NTRK-like protein 6,27233,194,1.44 [1.02-2.03],0.0379392278879268
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLK,STE20-like serine/threonine-protein kinase,23735,176,1.20 [1.04-1.37],0.0117810467192072
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLMAP,Sarcolemmal membrane-associated protein,24062,176,0.99 [0.83-1.18],0.9331038225298128
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLURP1,Secreted Ly-6/uPAR-related protein 1,24000,178,1.22 [0.88-1.69],0.2396927178598175
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMAD1,Mothers against decapentaplegic homolog 1,27092,194,1.03 [0.88-1.21],0.6754460306273125
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMAD2,Mothers against decapentaplegic homolog 2,24051,179,1.19 [0.97-1.45],0.0933712375329296
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMAD3,Mothers against decapentaplegic homolog 3,24051,179,1.03 [0.78-1.37],0.8168883010475957
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMAD5,Mothers against decapentaplegic homolog 5,27620,196,1.27 [0.69-2.35],0.4388554056290209
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMARCA2,Probable global transcription activator SNF2L2,27063,192,1.12 [0.95-1.32],0.1922208767525575
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMC3,Structural maintenance of chromosomes protein 3,23311,173,1.07 [0.83-1.36],0.6161833799397162
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMNDC1,Survival of motor neuron-related-splicing factor 30,24062,176,1.07 [0.87-1.33],0.5047447712537829
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMOC1,SPARC-related modular calcium-binding protein 1,27975,194,1.06 [0.72-1.55],0.7699971567962817
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMOC2,SPARC-related modular calcium-binding protein 2,27880,196,1.00 [0.72-1.39],0.9905098371736716
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMPD1,Sphingomyelin phosphodiesterase,27846,197,1.03 [0.79-1.34],0.8148248260250983
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMPD3,Sphingomyelin phosphodiesterase 3,23501,175,1.26 [1.05-1.50],0.0126508282559752
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,27840,196,0.93 [0.77-1.13],0.4591447138860854
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24051,179,1.06 [0.89-1.25],0.5341144675680592
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMS,Spermine synthase,23404,170,1.13 [0.92-1.39],0.2505995409481778
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMTN,Smoothelin,24088,175,0.95 [0.81-1.10],0.4730561725660388
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNAP23,Synaptosomal-associated protein 23,27743,197,1.03 [0.89-1.19],0.719765746502868
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNAP25,Synaptosomal-associated protein 25,23404,170,1.20 [0.88-1.63],0.2464623849875278
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNAP29,Synaptosomal-associated protein 29,27840,197,1.01 [0.88-1.16],0.8864247859445907
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNAPIN,SNARE-associated protein Snapin,24149,177,1.13 [0.89-1.44],0.3255806141679609
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNCA,Alpha-synuclein,23677,173,1.04 [0.91-1.18],0.5505995134221727
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNCG,Gamma-synuclein,27549,196,0.91 [0.76-1.10],0.3543382752909335
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",23566,168,1.03 [0.67-1.59],0.8927731605752625
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNRPB2,U2 small nuclear ribonucleoprotein B'',24131,176,1.20 [0.95-1.53],0.1302920766742795
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNU13,NHP2-like protein 1,23421,172,1.17 [0.96-1.41],0.1127250859353699
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNX15,Sorting nexin-15,23677,173,1.02 [0.78-1.33],0.8695197098820855
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNX18,Sorting nexin-18,24062,176,1.02 [0.75-1.39],0.8806987929256802
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNX2,Sorting nexin-2,24051,179,1.05 [0.88-1.25],0.6172693411572322
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNX5,Sorting nexin-5,23566,168,1.29 [0.82-2.03],0.2718477550111267
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNX9,Sorting nexin-9,27743,197,1.01 [0.85-1.22],0.8818748956317266
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SOD1,Superoxide dismutase [Cu-Zn],27166,190,0.98 [0.75-1.27],0.8550181695208225
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SOD2,"Superoxide dismutase [Mn], mitochondrial",27746,198,1.23 [0.90-1.69],0.1997210277728406
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SOD3,Extracellular superoxide dismutase,24199,176,0.87 [0.65-1.16],0.333481242532657
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SORBS1,Sorbin and SH3 domain-containing protein 1,24149,177,1.12 [0.80-1.56],0.5187618101454259
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SORCS2,VPS10 domain-containing receptor SorCS2,27092,194,1.03 [0.72-1.47],0.8814436451469297
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SORD,Sorbitol dehydrogenase,27844,194,1.12 [0.93-1.36],0.226788370131347
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SORT1,Sortilin,27698,197,1.26 [0.90-1.76],0.1800837726761831
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SOST,Sclerostin,27698,197,1.70 [1.24-2.34],0.0010038746800493
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,23510,172,0.97 [0.72-1.31],0.8477703420707743
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SOX2,Transcription factor SOX-2,24109,177,1.09 [0.59-2.00],0.7790974883760698
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SOX9,Transcription factor SOX-9,23510,172,1.01 [0.58-1.74],0.978613430784582
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24149,177,1.02 [0.63-1.66],0.9292202884913544
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPAG1,Sperm-associated antigen 1,24149,177,1.14 [0.91-1.42],0.2454741128955393
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPARC,SPARC,27840,197,1.07 [0.89-1.28],0.4686870419998735
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPARCL1,SPARC-like protein 1,27749,191,1.07 [0.68-1.70],0.7653280656244146
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPART,Spartin,23677,173,1.00 [0.83-1.20],0.9729912064121616
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPESP1,Sperm equatorial segment protein 1,24188,179,0.85 [0.50-1.44],0.5542850275993896
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINK1,Serine protease inhibitor Kazal-type 1,27746,198,1.05 [0.79-1.39],0.7380086209500787
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINK2,Serine protease inhibitor Kazal-type 2,23677,173,1.20 [0.82-1.77],0.3391156877483573
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINK4,Serine protease inhibitor Kazal-type 4,27699,197,1.28 [1.06-1.53],0.0096284397361211
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINK5,Serine protease inhibitor Kazal-type 5,27746,198,0.97 [0.66-1.43],0.8901460184400838
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINK6,Serine protease inhibitor Kazal-type 6,27975,194,1.15 [0.91-1.45],0.237446597515416
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINK8,Serine protease inhibitor Kazal-type 8,23421,172,0.93 [0.62-1.39],0.7077272544516542
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINT1,Kunitz-type protease inhibitor 1,27665,197,1.07 [0.66-1.73],0.7846909665272516
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINT2,Kunitz-type protease inhibitor 2,27880,196,1.19 [0.88-1.60],0.2665453293652844
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINT3,Kunitz-type protease inhibitor 3,24062,176,1.04 [0.92-1.16],0.5487513636794322
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPOCK1,Testican-1,27549,196,1.20 [0.73-1.98],0.4766487893994845
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPON1,Spondin-1,27794,196,1.09 [0.74-1.59],0.6652091633212027
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPON2,Spondin-2,27611,197,0.96 [0.66-1.39],0.8245663770472492
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPP1,Osteopontin,28035,200,1.19 [0.91-1.54],0.1991673185320799
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",23501,175,1.15 [0.85-1.56],0.3607146107017278
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPRING1,SREBP regulating gene protein,23311,173,1.11 [0.89-1.38],0.3694402054014107
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPRR1B,Cornifin-B,23735,176,0.97 [0.82-1.15],0.7178925378215224
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPRR3,Small proline-rich protein 3,24131,176,1.32 [1.09-1.60],0.0042498456239653
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPRY2,Protein sprouty homolog 2,27187,191,1.00 [0.87-1.15],0.9717106442488184
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",23404,170,0.83 [0.51-1.34],0.4488015224801874
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPTLC1,Serine palmitoyltransferase 1,24131,176,1.29 [0.95-1.76],0.1053066006692154
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SRC,Proto-oncogene tyrosine-protein kinase Src,27793,197,0.98 [0.88-1.09],0.7042812065497983
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SRP14,Signal recognition particle 14 kDa protein,27620,196,1.22 [1.01-1.48],0.0441741175148097
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SRPK2,SRSF protein kinase 2,27699,197,1.03 [0.89-1.20],0.6661153612670205
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SRPX,Sushi repeat-containing protein SRPX,24188,179,1.05 [0.68-1.62],0.831378994240477
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SSB,Lupus La protein,27063,192,0.87 [0.68-1.10],0.2432226634494844
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",23501,175,1.10 [0.75-1.61],0.6324081914998512
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,27698,197,0.96 [0.85-1.08],0.5293442042295533
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,27837,194,0.92 [0.68-1.24],0.5950157204593067
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SSH3,Protein phosphatase Slingshot homolog 3,23311,173,1.58 [1.04-2.40],0.0329057006393852
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SSNA1,Sjoegren syndrome nuclear autoantigen 1,24062,176,1.11 [0.85-1.45],0.451664572355852
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ST13,Hsc70-interacting protein,23677,173,1.07 [0.83-1.38],0.6111213689590684
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",27620,196,1.16 [0.88-1.53],0.298384375030979
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",28081,200,1.72 [1.13-2.61],0.0106428661268494
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",23501,175,1.34 [1.09-1.64],0.0053763009633247
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STAB2,Stabilin-2,24186,178,1.40 [0.85-2.31],0.1834608264987682
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STAM,Signal transducing adapter molecule 1,24051,179,0.94 [0.64-1.37],0.7391458966545414
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STAMBP,STAM-binding protein,27498,196,1.01 [0.83-1.22],0.9424106889896152
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STAT2,Signal transducer and activator of transcription 2,23501,175,1.04 [0.87-1.26],0.65061228940825
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STAT5B,Signal transducer and activator of transcription 5B,27620,196,1.02 [0.93-1.12],0.6880107644686664
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,23311,173,1.02 [0.83-1.27],0.8251507637748253
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STC1,Stanniocalcin-1,27981,197,1.05 [0.78-1.43],0.7298787576187694
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STC2,Stanniocalcin-2,27707,198,0.98 [0.62-1.52],0.9114007323527946
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STEAP4,Metalloreductase STEAP4,23404,170,0.94 [0.77-1.16],0.5784641642715831
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STIP1,Stress-induced-phosphoprotein 1,27707,198,1.02 [0.84-1.23],0.8393711637611214
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STK11,Serine/threonine-protein kinase STK11,27233,194,1.09 [0.92-1.30],0.3282307074898033
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STK24,Serine/threonine-protein kinase 24,27063,192,1.08 [0.88-1.33],0.4623348850583794
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STK4,Serine/threonine-protein kinase 4,27743,197,0.99 [0.86-1.15],0.9360091914510722
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STOML2,"Stomatin-like protein 2, mitochondrial",23311,173,0.94 [0.80-1.11],0.467536904326807
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STX16,Syntaxin-16,27092,194,0.89 [0.71-1.13],0.3416757913195609
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STX1B,Syntaxin-1B,23510,172,1.11 [0.82-1.50],0.5120441086632379
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STX3,Syntaxin-3,24131,176,0.96 [0.66-1.39],0.8122173730255732
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STX4,Syntaxin-4,27620,196,0.96 [0.78-1.19],0.696802863058123
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STX5,Syntaxin-5,23501,175,1.18 [0.87-1.60],0.2955737402908649
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STX6,Syntaxin-6,27092,194,1.10 [0.93-1.31],0.2531443130951676
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STX7,Syntaxin-7,23501,175,1.08 [0.81-1.43],0.6188191830554133
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STX8,Syntaxin-8,27699,197,1.08 [0.84-1.38],0.5658964904019503
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STXBP1,Syntaxin-binding protein 1,24149,177,1.11 [0.92-1.34],0.2709064564960282
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STXBP3,Syntaxin-binding protein 3,27092,194,1.05 [0.79-1.40],0.735479960042652
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUGP1,SURP and G-patch domain-containing protein 1,24062,176,1.22 [0.88-1.69],0.2397842806895941
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUGT1,Protein SGT1 homolog,27092,194,1.03 [0.88-1.21],0.7162285631172107
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SULT1A1,Sulfotransferase 1A1,27981,197,1.01 [0.91-1.11],0.8867360506734763
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SULT2A1,Bile salt sulfotransferase,27699,197,0.99 [0.78-1.24],0.9059765237997132
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUMF1,Formylglycine-generating enzyme,23501,175,1.09 [0.91-1.31],0.3264434919446094
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,27981,197,1.22 [0.96-1.56],0.1031256137343353
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUOX,"Sulfite oxidase, mitochondrial",24149,177,1.10 [0.88-1.36],0.4033718831777878
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUSD1,Sushi domain-containing protein 1,27233,194,1.10 [0.84-1.43],0.4866079171070845
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUSD2,Sushi domain-containing protein 2,27746,198,1.10 [0.72-1.68],0.6557608681630831
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUSD4,Sushi domain-containing protein 4,24051,179,1.11 [0.82-1.50],0.4840296860875095
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUSD5,Sushi domain-containing protein 5,23534,172,1.17 [0.77-1.80],0.461040798645972
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SV2A,Synaptic vesicle glycoprotein 2A,23510,172,1.09 [0.88-1.37],0.4270082664309561
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SWAP70,Switch-associated protein 70,24062,176,1.10 [0.76-1.61],0.6165039693213539
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SYAP1,Synapse-associated protein 1,23677,173,1.07 [0.83-1.38],0.6173374117662649
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,23404,170,0.84 [0.63-1.12],0.2464260663988926
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SYT1,Synaptotagmin-1,24131,176,1.09 [0.77-1.54],0.630337164423461
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SYTL4,Synaptotagmin-like protein 4,24188,179,0.99 [0.81-1.20],0.9107810327068216
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,23735,176,0.97 [0.85-1.11],0.6589704489798838
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TACC3,Transforming acidic coiled-coil-containing protein 3,27620,196,1.02 [0.91-1.14],0.7201410218263614
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TACSTD2,Tumor-associated calcium signal transducer 2,24591,167,1.00 [0.62-1.59],0.9944534191830828
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TADA3,Transcriptional adapter 3,24051,179,1.24 [0.87-1.76],0.2409518366591065
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TAFA5,Chemokine-like protein TAFA-5,27620,196,1.01 [0.70-1.44],0.9659581351140158
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TAGLN3,Transgelin-3,23311,173,0.98 [0.77-1.24],0.8612947242798463
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TALDO1,Transaldolase,24089,177,1.14 [0.84-1.54],0.4148481537281187
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TANK,TRAF family member-associated NF-kappa-B activator,27187,191,1.01 [0.84-1.21],0.9220076121506544
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TAP1,Antigen peptide transporter 1,23735,176,1.13 [0.92-1.38],0.245806416248705
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TARBP2,RISC-loading complex subunit TARBP2,27063,192,1.00 [0.85-1.18],0.9583477185194996
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",23510,172,0.93 [0.76-1.13],0.4573792352817741
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24051,179,0.96 [0.65-1.42],0.8500479702487842
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TAX1BP1,Tax1-binding protein 1,24131,176,1.00 [0.80-1.25],0.971517049211718
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TBC1D17,TBC1 domain family member 17,27063,192,0.99 [0.75-1.31],0.9481744929083082
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TBC1D23,TBC1 domain family member 23,27620,196,0.96 [0.84-1.11],0.6056187205398516
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TBC1D5,TBC1 domain family member 5,27699,197,0.97 [0.83-1.14],0.6931930539295297
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TBCA,Tubulin-specific chaperone A,23677,173,1.03 [0.88-1.22],0.6878798578765675
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TBCB,Tubulin-folding cofactor B,27549,196,1.02 [0.90-1.16],0.7192004027406713
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TBCC,Tubulin-specific chaperone C,27549,196,1.02 [0.87-1.19],0.7970975790107778
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TBL1X,F-box-like/WD repeat-containing protein TBL1X,27092,194,1.05 [0.90-1.22],0.5258773684509495
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TBR1,T-box brain protein 1,23510,172,1.08 [0.81-1.43],0.6056031619354144
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TCL1A,T-cell leukemia/lymphoma protein 1A,27503,195,1.07 [0.94-1.23],0.2994572773090508
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TCL1B,T-cell leukemia/lymphoma protein 1B,27233,194,0.88 [0.74-1.06],0.1875726686551567
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TCN1,Transcobalamin-1,23695,173,1.06 [0.69-1.64],0.78483453495202
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TCN2,Transcobalamin-2,28035,200,1.22 [0.81-1.83],0.3371681683214619
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TCOF1,Treacle protein,24188,179,1.22 [0.80-1.86],0.363599491693522
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TCP11,T-complex protein 11 homolog,23735,176,0.90 [0.69-1.17],0.429027360375263
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TCTN3,Tectonic-3,24188,179,1.20 [0.74-1.95],0.4681032143429589
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TDGF1,Teratocarcinoma-derived growth factor 1,27063,192,0.99 [0.91-1.09],0.8966706938936414
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TDO2,"Tryptophan 2,3-dioxygenase",23510,172,0.91 [0.61-1.36],0.6605388099389491
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TDP1,Tyrosyl-DNA phosphodiesterase 1,24051,179,1.14 [0.95-1.35],0.1517697320296898
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TDRKH,Tudor and KH domain-containing protein,27063,192,0.97 [0.84-1.14],0.7376986439677953
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TEF,Thyrotroph embryonic factor,23421,172,1.05 [0.75-1.46],0.768862143069889
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TEK,Angiopoietin-1 receptor,27840,197,1.17 [0.66-2.08],0.5989586111765183
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TERF1,Telomeric repeat-binding factor 1,23501,175,1.34 [0.86-2.08],0.1910057651223645
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TET2,Methylcytosine dioxygenase TET2,23689,175,0.98 [0.85-1.14],0.8214386109069691
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TEX101,Testis-expressed protein 101,23510,172,1.31 [0.92-1.87],0.1380002056041721
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TEX33,Testis-expressed protein 33,23735,176,1.03 [0.73-1.45],0.8666033297129736
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TF,Serotransferrin,24235,177,1.04 [0.55-1.98],0.8972910408861215
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TFAP2A,Transcription factor AP-2-alpha,23404,170,1.11 [0.89-1.38],0.3563095283837717
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TFF1,Trefoil factor 1,27606,197,0.96 [0.81-1.14],0.634265083425855
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TFF2,Trefoil factor 2,27832,196,0.92 [0.74-1.15],0.4646645285704923
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TFF3,Trefoil factor 3,27701,189,0.83 [0.64-1.08],0.1728702329128472
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TFPI,Tissue factor pathway inhibitor,27652,194,1.29 [0.88-1.88],0.1935019762703693
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TFPI2,Tissue factor pathway inhibitor 2,27749,197,1.18 [0.91-1.52],0.2103887757796378
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TFRC,Transferrin receptor protein 1,27844,194,1.01 [0.75-1.38],0.9252801841249378
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TG,Thyroglobulin,24051,179,1.02 [0.91-1.15],0.7333711280665173
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGFA,Protransforming growth factor alpha,27699,197,1.04 [0.80-1.35],0.7709338597082988
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGFB1,Transforming growth factor beta-1 proprotein,27984,196,1.12 [0.81-1.55],0.4991144974605441
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGFB2,Transforming growth factor beta-2 proprotein,24051,179,1.06 [0.82-1.38],0.6369439720483416
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGFBI,Transforming growth factor-beta-induced protein ig-h3,27562,194,0.89 [0.56-1.42],0.6303485668984917
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGFBR1,TGF-beta receptor type-1,23501,175,1.11 [0.59-2.09],0.7459774138249198
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGFBR2,TGF-beta receptor type-2,27840,197,1.06 [0.71-1.59],0.7688909875388611
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGFBR3,Transforming growth factor beta receptor type 3,28081,200,1.19 [0.82-1.75],0.3617538554217107
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGM2,Protein-glutamine gamma-glutamyltransferase 2,27700,197,1.01 [0.86-1.20],0.8611486403208829
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGOLN2,Trans-Golgi network integral membrane protein 2,24199,176,1.24 [0.71-2.17],0.4565685034433488
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THAP12,52 kDa repressor of the inhibitor of the protein kinase,23269,173,0.97 [0.82-1.14],0.6940985688557717
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THBD,Thrombomodulin,27743,197,1.16 [0.73-1.82],0.5320600793054131
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THBS2,Thrombospondin-2,27746,198,0.99 [0.70-1.40],0.960730333065841
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THBS4,Thrombospondin-4,27742,194,0.98 [0.74-1.29],0.8681910431022527
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THOP1,Thimet oligopeptidase,27611,197,1.40 [0.95-2.06],0.0909828629203639
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THPO,Thrombopoietin,27233,194,1.26 [0.91-1.75],0.1632307966217989
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THRAP3,Thyroid hormone receptor-associated protein 3,23421,172,1.02 [0.91-1.15],0.7034624282507059
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THSD1,Thrombospondin type-1 domain-containing protein 1,23313,173,1.46 [1.00-2.12],0.0475133761786526
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THTPA,Thiamine-triphosphatase,24014,179,1.07 [0.91-1.25],0.4276726020436506
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THY1,Thy-1 membrane glycoprotein,27981,197,0.80 [0.50-1.27],0.342807882070736
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIA1,Nucleolysin TIA-1 isoform p40,26923,192,1.03 [0.92-1.14],0.6447085428805606
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIE1,Tyrosine-protein kinase receptor Tie-1,28081,200,1.03 [0.76-1.40],0.828950103873185
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",27012,192,1.21 [0.94-1.56],0.1420044774309991
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,23735,176,0.88 [0.58-1.34],0.5495226127090168
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,27837,194,1.27 [0.96-1.68],0.0968225621304514
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24188,179,1.08 [0.76-1.53],0.6838419260717479
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24131,176,1.07 [0.90-1.26],0.4539135521159936
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIMP1,Metalloproteinase inhibitor 1,27420,188,1.13 [0.72-1.78],0.5968120682228122
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIMP2,Metalloproteinase inhibitor 2,24188,179,0.53 [0.27-1.07],0.0750161891866779
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIMP3,Metalloproteinase inhibitor 3,27880,196,0.99 [0.91-1.09],0.9150957841244944
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIMP4,Metalloproteinase inhibitor 4,27746,198,1.05 [0.77-1.43],0.7708449277105445
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TINAGL1,Tubulointerstitial nephritis antigen-like,27649,197,0.90 [0.51-1.57],0.700906275376538
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TJAP1,Tight junction-associated protein 1,27840,197,0.99 [0.85-1.16],0.9488177701316126
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TJP3,Tight junction protein ZO-3,23404,170,0.74 [0.50-1.10],0.1410879489322395
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TK1,"Thymidine kinase, cytosolic",23735,176,1.09 [0.81-1.47],0.577423926242387
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TLR1,Toll-like receptor 1,23501,175,1.50 [0.90-2.51],0.1223393526052519
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TLR2,Toll-like receptor 2,23735,176,0.93 [0.50-1.74],0.8158447503787176
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TLR3,Toll-like receptor 3,28030,197,1.08 [0.88-1.32],0.472253337156639
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TLR4,Toll-like receptor 4,23501,175,1.17 [0.70-1.94],0.5526527029665177
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,23510,172,1.11 [0.85-1.44],0.4384696642690581
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMED1,Transmembrane emp24 domain-containing protein 1,23735,176,0.79 [0.59-1.06],0.1186079895565323
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMED10,Transmembrane emp24 domain-containing protein 10,23421,172,0.72 [0.49-1.07],0.108119062018552
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMED4,Transmembrane emp24 domain-containing protein 4,23421,172,1.00 [0.77-1.29],0.9873761308730274
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMED8,Protein TMED8,24062,176,1.06 [0.92-1.22],0.4425739011992179
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMEM106A,Transmembrane protein 106A,24051,179,1.00 [0.82-1.23],0.9621904374783316
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMEM132A,Transmembrane protein 132A,23566,168,0.94 [0.74-1.19],0.6243467148861069
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMEM25,Transmembrane protein 25,24149,177,1.25 [0.94-1.65],0.1215186610604193
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMOD4,Tropomodulin-4,23311,173,1.07 [0.76-1.51],0.6955685918357174
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMPRSS11B,Transmembrane protease serine 11B,23404,170,0.96 [0.79-1.16],0.6590620350418663
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMPRSS11D,Transmembrane protease serine 11D,24084,176,1.55 [1.13-2.14],0.0070420069998124
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMPRSS15,Enteropeptidase,27620,196,1.11 [0.96-1.27],0.150320125715835
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMPRSS5,Transmembrane protease serine 5,27419,195,0.98 [0.70-1.37],0.8949592710898843
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMSB10,Thymosin beta-10,27746,198,1.09 [0.93-1.28],0.2978493042894603
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNC,Tenascin,27837,194,1.00 [0.76-1.30],0.9746146968491232
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNF,Tumor necrosis factor,27187,194,0.81 [0.56-1.16],0.2515315907391621
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24062,176,1.18 [0.89-1.55],0.2468991051571923
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,27187,191,0.89 [0.62-1.28],0.5390711922543843
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,23677,173,1.07 [0.86-1.34],0.5498127613685059
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,27549,196,0.98 [0.66-1.46],0.9342638882311216
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,27549,196,0.94 [0.66-1.34],0.7386005718248859
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,27801,200,0.79 [0.62-1.00],0.0513240561047987
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,28030,197,1.11 [0.79-1.54],0.5486333900945983
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,27745,195,1.35 [0.90-2.03],0.1413314274249121
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,27840,197,1.02 [0.70-1.47],0.9284594388563124
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,27794,196,0.79 [0.53-1.18],0.2472554933113226
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,27187,191,1.10 [0.81-1.50],0.52783371069604
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,27794,196,1.23 [0.81-1.87],0.3290514035730953
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,23677,173,0.85 [0.59-1.23],0.3796628661972907
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,27975,194,1.36 [0.91-2.02],0.1312527875350247
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,27746,198,1.03 [0.66-1.61],0.895078134607045
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,27746,198,0.99 [0.69-1.41],0.948545098237027
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,27981,197,1.18 [0.74-1.87],0.4881543692093893
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,27984,196,1.14 [0.82-1.58],0.4424760894989117
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,27549,196,1.30 [1.05-1.61],0.0145421015463907
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,27981,197,0.79 [0.59-1.06],0.1149340104733826
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,27549,196,1.02 [0.74-1.41],0.8959310978237809
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFSF10,Tumor necrosis factor ligand superfamily member 10,28030,197,0.97 [0.61-1.55],0.8967650579250266
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFSF11,Tumor necrosis factor ligand superfamily member 11,27699,197,0.88 [0.72-1.07],0.2028556965655614
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFSF12,Tumor necrosis factor ligand superfamily member 12,28030,197,1.14 [0.75-1.74],0.5264611868221064
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFSF13,Tumor necrosis factor ligand superfamily member 13,27880,196,1.46 [0.91-2.33],0.1123518596594956
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,28034,200,1.15 [0.74-1.79],0.5425777545231364
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFSF14,Tumor necrosis factor ligand superfamily member 14,27549,196,0.96 [0.77-1.20],0.7415966121189476
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFSF8,Tumor necrosis factor ligand superfamily member 8,24186,178,1.18 [0.79-1.74],0.418386686336933
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNIP1,TNFAIP3-interacting protein 1,24131,176,1.00 [0.85-1.17],0.9521827548002032
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNN,Tenascin-N,24186,178,1.14 [0.82-1.58],0.4268649946199392
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNNI3,"Troponin I, cardiac muscle",27233,194,0.93 [0.81-1.07],0.315622257564753
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNPO1,Transportin-1,23735,176,1.19 [0.81-1.75],0.3808091945978977
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNR,Tenascin-R,27549,196,1.11 [0.82-1.49],0.5090647724932011
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNXB,Tenascin-X,27746,198,1.42 [0.87-2.30],0.1602581975928872
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24188,179,1.09 [0.91-1.31],0.3571979229888936
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TOP1,DNA topoisomerase 1,24062,176,0.99 [0.87-1.14],0.9401967682457192
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TOP1MT,"DNA topoisomerase I, mitochondrial",23311,173,0.95 [0.70-1.29],0.748243469199712
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TOP2B,DNA topoisomerase 2-beta,23501,175,1.11 [0.93-1.33],0.2586674984194621
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TOR1AIP1,Torsin-1A-interacting protein 1,23566,168,1.00 [0.76-1.32],0.983316466907227
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TP53,Cellular tumor antigen p53,27092,194,1.13 [0.85-1.52],0.4023028493777193
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TP53BP1,TP53-binding protein 1,23501,175,1.07 [0.91-1.26],0.3806046102060513
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TP53I3,Quinone oxidoreductase PIG3,23160,171,1.17 [0.90-1.54],0.2473682208501847
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TP53INP1,Tumor protein p53-inducible nuclear protein 1,27233,194,1.14 [0.81-1.62],0.4467848830235319
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TP73,Tumor protein p73,23510,172,1.00 [0.66-1.53],0.9949767049225604
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPBGL,Trophoblast glycoprotein-like,23510,172,1.12 [0.81-1.55],0.4820030881295829
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPD52L2,Tumor protein D54,23677,173,1.03 [0.90-1.17],0.7090709828234367
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPK1,Thiamin pyrophosphokinase 1,24188,179,1.10 [0.65-1.85],0.7201076058598039
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPM3,Tropomyosin alpha-3 chain,23421,172,1.20 [0.88-1.62],0.2425051597668055
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPMT,Thiopurine S-methyltransferase,27092,194,1.10 [0.93-1.30],0.2749477888961985
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPP1,Tripeptidyl-peptidase 1,27562,194,0.99 [0.74-1.31],0.9331996180037078
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPPP2,Tubulin polymerization-promoting protein family member 2,23735,176,0.97 [0.81-1.15],0.6994972203254117
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPPP3,Tubulin polymerization-promoting protein family member 3,27063,192,1.06 [0.78-1.44],0.7054105796216863
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPR,Nucleoprotein TPR,23421,172,1.05 [0.80-1.38],0.7361786228471314
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPRKB,EKC/KEOPS complex subunit TPRKB,23311,173,1.18 [0.98-1.42],0.0810684128159311
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPSAB1,Tryptase alpha/beta-1,27983,197,1.28 [1.01-1.63],0.0409219054067233
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPSD1,Tryptase delta,24149,177,1.28 [0.94-1.75],0.1167143029299714
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPSG1,Tryptase gamma,23501,175,0.85 [0.49-1.49],0.5736773711315006
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPT1,Translationally-controlled tumor protein,27187,191,1.06 [0.88-1.26],0.5515812057549024
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRAF2,TNF receptor-associated factor 2,27699,197,0.98 [0.82-1.16],0.7805089810256347
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRAF3,"TNF receptor-associated factor 3, Isoform 2",23501,175,1.05 [0.72-1.54],0.8047176565282279
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,23421,172,0.97 [0.71-1.33],0.8673251806694604
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,23735,176,1.17 [1.00-1.36],0.0441073904824884
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TREH,Trehalase,24186,178,0.95 [0.78-1.14],0.5596065106842341
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TREM2,Triggering receptor expressed on myeloid cells 2,27745,195,1.25 [0.98-1.58],0.0735769418226383
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TREML1,Trem-like transcript 1 protein,24199,176,0.98 [0.75-1.29],0.8989247472644338
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TREML2,Trem-like transcript 2 protein,27746,198,0.95 [0.65-1.39],0.8107183438437249
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRIAP1,TP53-regulated inhibitor of apoptosis 1,27975,194,1.10 [0.91-1.34],0.3295814001302294
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRIM21,E3 ubiquitin-protein ligase TRIM21,27699,197,1.13 [0.96-1.33],0.1416719013866207
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRIM24,Transcription intermediary factor 1-alpha,23688,176,1.25 [1.03-1.52],0.0237886471983524
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24062,176,1.03 [0.90-1.18],0.6626130746992223
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRIM26,Tripartite motif-containing protein 26,23311,173,1.11 [0.88-1.41],0.3644191512194112
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRIM40,E3 ubiquitin ligase TRIM40,23510,172,1.14 [0.94-1.38],0.1904414687254508
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRIM5,Tripartite motif-containing protein 5,27699,197,0.98 [0.84-1.13],0.7573761996383328
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRIM58,E3 ubiquitin-protein ligase TRIM58,24051,179,1.02 [0.87-1.21],0.7854944202571471
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRPV3,Transient receptor potential cation channel subfamily V member 3,23421,172,0.98 [0.73-1.32],0.9068947227911922
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSC1,Hamartin,23501,175,1.08 [0.92-1.29],0.3471675210746314
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSC22D1,TSC22 domain family protein 1,24149,177,1.10 [0.90-1.35],0.3338366095172378
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSHB,Thyrotropin subunit beta,27743,197,0.88 [0.75-1.02],0.0860527020338226
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSLP,Thymic stromal lymphopoietin,27233,194,0.92 [0.74-1.15],0.470124348326317
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSNAX,Translin-associated protein X,23421,172,1.05 [0.73-1.51],0.8022149948950441
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSPAN1,Tetraspanin-1,27233,194,0.80 [0.52-1.25],0.3327101887670001
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSPAN15,Tetraspanin-15,23421,172,0.83 [0.60-1.15],0.2570729008660424
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSPAN7,Tetraspanin-7,23404,170,1.09 [0.94-1.25],0.2599432484725162
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSPAN8,Tetraspanin-8,24062,176,0.97 [0.84-1.11],0.6268623826661975
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSPYL1,Testis-specific Y-encoded-like protein 1,23501,175,1.13 [0.80-1.60],0.488051095507325
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TST,Thiosulfate sulfurtransferase,27016,192,1.08 [0.92-1.28],0.3488429401365979
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TTF2,Transcription termination factor 2,23510,172,1.16 [0.87-1.55],0.3223990385455998
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TTN,Titin,23421,172,1.12 [0.92-1.35],0.2502908908588159
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TTR,Transthyretin,23965,174,1.45 [0.82-2.57],0.1998397509870662
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TUBB3,Tubulin beta-3 chain,23404,170,0.81 [0.47-1.37],0.4308595735682637
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TWF2,Twinfilin-2,24186,178,1.05 [0.88-1.24],0.6102724205473957
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TXK,Tyrosine-protein kinase TXK,23735,176,0.94 [0.78-1.15],0.5750589184649733
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TXLNA,Alpha-taxilin,27549,196,1.03 [0.90-1.19],0.6509247609167483
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TXN,Thioredoxin,23791,174,1.00 [0.72-1.38],0.9957232215372432
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TXNDC15,Thioredoxin domain-containing protein 15,27840,197,0.76 [0.48-1.21],0.2440533461549375
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TXNDC5,Thioredoxin domain-containing protein 5,27981,197,1.05 [0.87-1.26],0.6298361921210451
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TXNDC9,Thioredoxin domain-containing protein 9,24131,176,1.19 [0.92-1.53],0.1809485752335188
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TXNL1,Thioredoxin-like protein 1,23355,170,1.05 [0.91-1.21],0.5142282117319374
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",27746,198,1.17 [0.90-1.52],0.2478850353327005
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TYMP,Thymidine phosphorylase,27561,195,1.01 [0.84-1.22],0.8857418991434947
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TYRO3,Tyrosine-protein kinase receptor TYRO3,27743,197,1.57 [1.01-2.45],0.0456663250504879
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",23501,175,1.25 [0.98-1.60],0.0709018847477382
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UBAC1,Ubiquitin-associated domain-containing protein 1,27620,196,0.95 [0.67-1.35],0.7816361941970442
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UBE2B,Ubiquitin-conjugating enzyme E2 B,24051,179,0.87 [0.53-1.43],0.5717354731697584
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24188,179,1.04 [0.83-1.31],0.7211946555550298
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,23501,175,1.29 [1.05-1.57],0.012890596989758
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UBQLN3,Ubiquilin-3,23421,172,0.97 [0.69-1.36],0.8585868216757185
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UBXN1,UBX domain-containing protein 1,23677,173,1.09 [0.88-1.34],0.4250727441151989
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24062,176,1.07 [0.96-1.18],0.210361816134499
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UGDH,UDP-glucose 6-dehydrogenase,23421,172,1.09 [0.96-1.24],0.1778785069438421
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UHRF2,E3 ubiquitin-protein ligase UHRF2,23421,172,0.86 [0.55-1.34],0.5094749824823412
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ULBP2,UL16-binding protein 2,27549,196,1.09 [0.78-1.54],0.6031978542763734
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UMOD,Uromodulin,28000,200,0.87 [0.70-1.10],0.2448755371626175
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UNC5D,Netrin receptor UNC5D,23501,175,1.39 [0.85-2.25],0.1861972854599525
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UNC79,Protein unc-79 homolog,23311,173,0.95 [0.73-1.23],0.6817503479596694
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UNG,Uracil-DNA glycosylase,24051,179,0.81 [0.52-1.25],0.331733981237639
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UPB1,Beta-ureidopropionase,24188,179,1.07 [0.92-1.25],0.3688116611946689
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UPK3A,Uroplakin-3a,23404,170,1.29 [1.00-1.67],0.0503230950233046
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UPK3BL1,Uroplakin-3b-like protein 1,23694,176,1.13 [0.91-1.41],0.2682913856199866
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UROD,Uroporphyrinogen decarboxylase,23677,173,1.04 [0.85-1.28],0.7119751000363803
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UROS,Uroporphyrinogen-III synthase,23510,172,1.06 [0.87-1.29],0.5663397583873265
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",USO1,General vesicular transport factor p115,27620,196,0.97 [0.85-1.12],0.7146820665783102
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",USP25,Ubiquitin carboxyl-terminal hydrolase 25,24051,179,1.09 [0.90-1.33],0.3759761998612561
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",USP28,Ubiquitin carboxyl-terminal hydrolase 28,24131,176,0.94 [0.64-1.38],0.7615704366962213
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",USP47,Ubiquitin carboxyl-terminal hydrolase 47,23421,172,0.95 [0.79-1.13],0.5582876373698111
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",USP8,Ubiquitin carboxyl-terminal hydrolase 8,27233,194,1.05 [0.92-1.20],0.4423878887975312
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UXS1,UDP-glucuronic acid decarboxylase 1,27092,194,0.82 [0.64-1.06],0.1251228132944583
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VAMP5,Vesicle-associated membrane protein 5,27233,194,1.06 [0.85-1.33],0.5811925240958664
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VAMP8,Vesicle-associated membrane protein 8,23501,175,1.02 [0.86-1.20],0.8527508825724689
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VASH1,Tubulinyl-Tyr carboxypeptidase 1,27699,197,1.04 [0.89-1.21],0.6404562127150757
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VASN,Vasorin,27294,190,1.38 [0.87-2.19],0.1767165092431234
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VASP,Vasodilator-stimulated phosphoprotein,24199,176,1.03 [0.84-1.25],0.7835109175487898
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,27620,196,0.89 [0.48-1.67],0.7224583564446493
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VAV3,Guanine nucleotide exchange factor VAV3,23404,170,1.02 [0.88-1.18],0.7983050109518932
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VCAM1,Vascular cell adhesion protein 1,27789,194,0.82 [0.51-1.33],0.427623446851945
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VCAN,Versican core protein,27981,197,0.90 [0.59-1.38],0.6336553823242694
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VCPKMT,Protein-lysine methyltransferase METTL21D,23311,173,1.10 [0.95-1.27],0.1835298004232594
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VEGFA,Vascular endothelial growth factor A,27936,197,1.20 [0.97-1.47],0.086028779031794
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VEGFB,Vascular endothelial growth factor B,23501,175,1.19 [0.72-1.99],0.4924922356716453
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VEGFC,Vascular endothelial growth factor C,27840,197,1.07 [0.86-1.34],0.537628475106682
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VEGFD,Vascular endothelial growth factor D,27979,197,0.99 [0.69-1.44],0.9685372144753456
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VGF,Neurosecretory protein VGF,24149,177,1.00 [0.62-1.61],0.9968460131497826
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VIM,Vimentin,27233,194,1.00 [0.90-1.11],0.9951428229968334
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VIPR1,Vasoactive intestinal polypeptide receptor 1,23566,168,0.99 [0.56-1.76],0.9849586510985032
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VIT,Vitrin,24188,179,1.25 [0.85-1.84],0.2545661941225485
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VMO1,Vitelline membrane outer layer protein 1 homolog,27620,196,1.09 [0.90-1.33],0.3607675628944482
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VNN1,Pantetheinase,24199,176,1.25 [1.02-1.53],0.0332147119142478
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VNN2,Vascular non-inflammatory molecule 2,27620,196,0.90 [0.69-1.18],0.4512970597030192
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VPS28,Vacuolar protein sorting-associated protein 28 homolog,23735,176,1.10 [0.89-1.36],0.3706343303786302
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VPS37A,Vacuolar protein sorting-associated protein 37A,27620,196,0.98 [0.83-1.15],0.7688770248298262
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VPS4B,Vacuolar protein sorting-associated protein 4B,24051,179,1.08 [0.93-1.25],0.3151533635344514
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VPS53,Vacuolar protein sorting-associated protein 53 homolog,27620,196,0.99 [0.84-1.17],0.8807847234421278
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSIG10,V-set and immunoglobulin domain-containing protein 10,24051,179,1.04 [0.71-1.51],0.8554913846471794
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,23421,172,0.99 [0.64-1.54],0.9644128127895872
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSIG2,V-set and immunoglobulin domain-containing protein 2,24051,179,1.26 [1.00-1.60],0.053306593523865
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSIG4,V-set and immunoglobulin domain-containing protein 4,27707,198,1.12 [0.81-1.55],0.5054866427575225
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,27702,197,1.05 [0.86-1.28],0.622308367957705
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSNL1,Visinin-like protein 1,24131,176,1.52 [1.08-2.14],0.0170379826081101
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSTM1,V-set and transmembrane domain-containing protein 1,27063,192,0.84 [0.64-1.10],0.1960957186475524
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSTM2B,V-set and transmembrane domain-containing protein 2B,23735,176,1.04 [0.75-1.45],0.7973462393595023
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,27233,194,0.90 [0.71-1.14],0.3737984294369993
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,27981,197,1.00 [0.84-1.19],0.9808985285010215
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VTCN1,V-set domain-containing T-cell activation inhibitor 1,27092,194,0.89 [0.60-1.32],0.5582296052828668
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,23677,173,1.00 [0.78-1.28],0.9890701570184902
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VWA1,von Willebrand factor A domain-containing protein 1,27926,194,1.13 [0.84-1.52],0.408441727511278
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VWA5A,von Willebrand factor A domain-containing protein 5A,23311,173,1.09 [0.93-1.27],0.2762611096005415
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VWC2,Brorin,27456,196,1.13 [0.81-1.57],0.4686316274647302
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VWC2L,von Willebrand factor C domain-containing protein 2-like,24149,177,0.87 [0.62-1.21],0.4011339077498691
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VWF,von Willebrand factor,28081,200,0.99 [0.84-1.18],0.9263119859135855
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WARS,"Tryptophan--tRNA ligase, cytoplasmic",27746,198,1.26 [0.91-1.76],0.1700085194446835
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WAS,Wiskott-Aldrich syndrome protein,27187,191,0.96 [0.79-1.16],0.6657912156709691
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WASF1,Wiskott-Aldrich syndrome protein family member 1,27233,194,1.00 [0.87-1.15],0.9776259214948916
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WASF3,Wiskott-Aldrich syndrome protein family member 3,27063,192,1.01 [0.87-1.18],0.898693296584766
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WASHC3,WASH complex subunit 3,24131,176,1.01 [0.83-1.21],0.9524759933697656
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WASL,Neural Wiskott-Aldrich syndrome protein,23501,175,1.05 [0.84-1.31],0.6989323166528392
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WDR46,WD repeat-containing protein 46,24051,179,0.94 [0.63-1.39],0.748594434505861
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WFDC1,WAP four-disulfide core domain protein 1,23575,178,1.04 [0.81-1.34],0.7481956641520787
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WFDC12,WAP four-disulfide core domain protein 12,27938,194,0.99 [0.81-1.20],0.886257068492146
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WFDC2,WAP four-disulfide core domain protein 2,26322,188,0.80 [0.56-1.15],0.2280942920592016
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",27467,196,0.91 [0.66-1.24],0.5435694840603817
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",27794,196,0.91 [0.63-1.32],0.619947289123467
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WIF1,Wnt inhibitory factor 1,27975,194,1.11 [0.77-1.60],0.5857295881059955
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WNT9A,Protein Wnt-9a,27187,191,1.16 [0.75-1.80],0.5096492709271866
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,27549,196,1.05 [0.84-1.32],0.6694427370186438
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",XCL1,Lymphotactin,27975,194,0.92 [0.73-1.17],0.492724794334595
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",XG,Glycoprotein Xg,27939,199,1.18 [0.77-1.79],0.4454196638683183
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",XIAP,E3 ubiquitin-protein ligase XIAP,23501,175,1.01 [0.79-1.30],0.9091858816816412
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",XPNPEP2,Xaa-Pro aminopeptidase 2,27840,197,1.02 [0.89-1.18],0.75625384879644
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",XRCC4,DNA repair protein XRCC4,27063,192,1.18 [0.85-1.63],0.3302378179950941
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",YAP1,Transcriptional coactivator YAP1,24131,176,1.27 [0.75-2.16],0.3753173749999886
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24062,176,1.02 [0.93-1.13],0.6703705657581587
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",YES1,Tyrosine-protein kinase Yes,27620,196,1.00 [0.89-1.12],0.9892141786489868
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",YJU2,Splicing factor YJU2,24051,179,1.08 [0.70-1.66],0.7173964415866392
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",YOD1,Ubiquitin thioesterase OTU1,23421,172,1.04 [0.83-1.31],0.7450165511032814
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",YTHDF3,YTH domain-containing family protein 3,27187,191,1.08 [0.93-1.26],0.2962632383416014
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",YWHAQ,14-3-3 protein theta,23677,173,1.04 [0.85-1.27],0.6898466802626355
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",YY1,Transcriptional repressor protein YY1,23501,175,1.30 [0.79-2.13],0.3010958770742263
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZBP1,Z-DNA-binding protein 1,23501,175,1.26 [0.94-1.69],0.1248088802936321
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZBTB16,Zinc finger and BTB domain-containing protein 16,27092,194,1.03 [0.86-1.24],0.7219122911012277
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZBTB17,Zinc finger and BTB domain-containing protein 17,27233,194,1.24 [0.95-1.62],0.106606114944805
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZCCHC8,Zinc finger CCHC domain-containing protein 8,23421,172,0.94 [0.73-1.21],0.6245198293642618
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZFYVE19,Abscission/NoCut checkpoint regulator,24062,176,1.10 [0.94-1.28],0.2531211781206768
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZHX2,Zinc fingers and homeoboxes protein 2,24131,176,1.23 [0.87-1.72],0.2380507581392748
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZNF174,Zinc finger protein 174,23501,175,0.98 [0.67-1.43],0.9181352504968672
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZNF75D,Zinc finger protein 75D,23735,176,0.92 [0.72-1.18],0.5288257394819049
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZNF830,Zinc finger protein 830,24051,179,1.06 [0.90-1.25],0.4675288410645389
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZNRD2,Protein ZNRD2,24062,176,0.99 [0.80-1.22],0.9001425452853249
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24051,179,1.06 [0.82-1.36],0.6694340845593294
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZP3,Zona pellucida sperm-binding protein 3,23566,168,0.93 [0.88-0.99],0.014494258101461
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZP4,Zona pellucida sperm-binding protein 4,23311,173,1.11 [0.75-1.64],0.615491823322958
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZPR1,Zinc finger protein ZPR1,23404,170,1.11 [0.97-1.27],0.1396420018762127
